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1. Adhesion formation in the minimal invasive era 
Adhesions are filmy or dense scar tissues which develop between intra-abdominal organs 
and the abdominal wall after peritoneal trauma. Abdominal surgery is the main contributor 
to peritoneal trauma. Over 90% of patients develop adhesions after open surgery, and 45-
62% do so after minimally invasive surgery.1-4 Other precipitants of adhesion formation 
include intra-abdominal infections, tumors and radiotherapy.5 Adhesions impart 
tremendous clinical and economic burdens, carrying a life-long risk of adhesion-related 
complications, including adhesive small bowel obstruction (ASBO), female infertility, 
chronic visceral pain, and difficulties during reoperations.6 ASBO is a surgical emergency in 
which the obstruction of the small intestine hinders passage of intestinal contents, which 
may necessitate an emergency reoperation to resolve the obstruction. During reoperations, 
the need to cut adhesions in order to gain access to the operative area creates a risk of 
iatrogenic injuries to organs and structures, particularly to the bowel. The incidence of 
iatrogenic bowel injury during reoperation is estimated to be 6%, resulting in an increase in 
post-operative complications including sepsis and surgical site infections, as well as 
increased mortality.7 The Surgical and Clinical Adhesion Research (SCAR) study, published 
two decades ago, was the first population-based study to report incidence rates of 
adhesion-related readmissions. One in three patients was found to be readmitted after 
abdominal surgery for a cause possibly related to adhesions.4 With the publication of this 
study surgeons and researchers became more aware of the magnitude of the problem of 
adhesions, resulting in increased attention to adhesion reduction strategies. 
In the same decade, there was a rapid growth of minimally invasive operations. Through its 
peritoneal tissue sparing character and minimal blood loss, laparoscopy was soon claimed 
to reduce adhesion formation and associated complications. Consequently, surgeons 
started to advocate laparoscopic surgery as the most relevant adhesion reduction strategy.8 
At present, the laparoscopic approach has replaced open surgery as the standard of care 
for a wide spectrum of intra-abdominal procedures. In the Netherlands, over 75% of all 
colorectal procedures are performed laparoscopically.9 Indications for laparoscopic surgery 
are rapidly expanding in recent years, for example, esophagectomy and hepato-pancreato-








introduction of laparoscopy, however, is still is considered potentially hazardous for a small 
number of procedures, such as Whipple procedures.10 
Several studies have reported a reduction in adhesion extent and severity after minimally 
invasive surgery.2,3 However, it is unknown whether a reduction in adhesion formation will 
result in a proportionate decrease in the rate of adhesion-related complications. For 
example, ASBO can be caused either by extensive dense abdominal adhesions or by even a 
single adhesive band. Studies on the risk of ASBO after minimally invasive surgery report 
conflicting evidence.6,11 The primary reason is that most trials on minimally invasive surgery 
are not designed and powered for adhesion formation, let alone specific long-term 
complications such as ASBO. 
Further complicating the topic of adhesion-related morbidity after minimally invasive 
surgery are differences in definitions and management of ASBO reported between different 
studies. ASBO is often defined as an episode of small bowel obstruction (SBO) with 
operative confirmation of adhesions. However, adhesions cannot be confirmed as the cause 
of the SBO when it is treated by conservative (i.e. non-operative) means. Thus, the true 
incidence of ASBO may be substantially underestimated using a definition that relies on 
operative visualization. A second definition of ASBO is an episode of SBO suspected to be 
related to adhesions via radiological imaging, excluding other potential causes of SBO, such 
as a groin hernia or a tumor. The incidence determined under this definition is affected by 
the portion of patients who have imaging upon diagnosis, the timing of imaging in the 
disease course, and the imaging modality.12-14 The limitations of both definitions make it 
difficult to truly compare different studies’ results on the incidence of ASBO and re-ASBO, 
after both minimally invasive and open surgery.  
The lack of reliable data on the risk of ASBO and other adhesion-related complications after 
minimally invasive surgery not only jeopardizes daily practice; it also paralyzes initiatives to 
develop and introduce new and current adhesion reduction strategies. To stimulate 
progress in this field, it is essential to collect and analyze big epidemiological data on the 





2. Burden of adhesive small bowel obstruction 
Adhesions are known to cause over  55% of all episodes of SBO.6 Morbidity associated with 
ASBO is high, resulting in an average of 7.8 days hospital admission and in-hospital mortality 
of 2.5%.6 The incidence of ASBO in the first years after abdominal surgery is estimated at 2-
3%.6 ASBO risk varies depending on the location of the inciting surgery, from 0.5 percent in 
abdominal wall surgery to 3.2 percent in lower gastro-intestinal tract surgery.6 Recent 
reports on emergency surgery in the UK and USA show that ASBO is a major contributor to 
morbidity, mortality, and costs. In 2016, 51% of all emergency laparotomies in the UK were 
for ASBO.15 In the USA between 2008 and 2011, adhesiolysis for SBO ranked among the top 
five most common emergency surgical procedures.16 Associated health care costs are likely 
much higher than reported, as most studies on the costs of ASBO only include (incomplete) 
in-hospital costs or cost based on reimbursement prices.17,18 
Despite the high incidence of ASBO and its associated morbidity, treatment of ASBO is 
mostly determined by personal preferences of physicians rather than evidence-based 
protocols. Many recommendations set forth by existing guidelines are based on low-quality 
and/or conflicting evidence. Patient characteristics and disease parameters that indicate a 
need for operative treatment are not specific, and the choice of operative treatment 
depends largely upon the judgement of the consulting surgical team. 
Operative management of ASBO historically consists of adhesiolysis by open surgery. The 
primary immediate drawback of operative ASBO management is the risk of iatrogenic bowel 
injury due to a severely distended and vulnerable bowel.7 Due to repeat peritoneal trauma 
imparted by open surgery for ASBO, lysed adhesions reform, an new adhesions form at 
other injured areas in the peritoneal cavity, risking a new episode of ASBO and inciting a 
potentially vicious cycle. 
Given the risk of exacerbating peritoneal trauma, it is considered an advantage that more 
than 70 to 90 percent of all episodes of ASBO are managed non-operatively with gastric 
decompression, fluid resuscitation, and nil per os.6,19,20 However, while conservative 
management may ease a particular episode of SBO, the offending underlying adhesions are 








a first episode of ASBO, the risk of recurrence was found lower after operative management 
compared with non-operative management (13% vs. 21% after a median of 3.6 years follow-
up).21,22 When an ASBO recurs, the time interval between episodes tends to decrease with 
every new episode.21 Despite the long-term lower risk of recurrence of ASBO after 
adhesiolysis, a trial of non-operative management is recommended by the guidelines, trying 
to avoid the immediate complications of surgical intervention.23  
In cases where a decision is made to proceed operatively, the next important question is 
whether a laparoscopic approach to ASBO is more effective compared with open 
adhesiolysis. Laparoscopic surgery may not only prevent formation of new adhesions, but 
also adhesion reformation and formation at other areas. Over the past several decades, a 
few case series of laparoscopic treatment of ASBO have been described.24 Early adopters 
have emphasized the advantages of a minimally invasive approach to ASBO, including 
reduced post-operative length of stay, improved gastro-intestinal recovery, and minimal 
wound problems. However, long-term benefits have not been substantiated and compared 
with results from open adhesiolysis. Critics of laparoscopic adhesiolysis for ASBO draw 
attention to the small laparoscopic working space, the increased risk of iatrogenic bowel 
perforations in case of a severely extended bowel, and the selected “easy” operative cases 
included in the series.25 Selection criteria to indicate which patient may benefit the most of 
laparoscopic surgery for ASBO, and which red flags should demand open surgery, are 
important questions for researchers to address. 
In this thesis, I will comprehensively assess the existing literature on management of ASBO, 
with a particular focus on the proper role of minimally invasive surgery, to provide 
treatment recommendations based upon the best available evidence to date.  
 
3. Adhesion prevention in contemporary surgery 
Aside from ‘optimal surgical technique’, a predominant means of preventing adhesion 
formation is the intraoperative application of an adhesion barrier at the end of a surgical 




are intended to separate peritoneal wound surfaces until adhesion-free wound healing can 
occur. Studies on adhesion barriers have proven these devices to be safe and effective.26 
This evidence is mainly derived from trials in open surgery. Yet despite the evidence, 
barriers have not been widely adopted by the surgical community. An important factor 
limiting broad use of barriers is doubt about their cost-effectiveness, as well as lack of 
reimbursement in many countries, burdening hospitals with the marginal increase in 
expense. 
Today, a vast majority of surgical procedures are routinely performed through minimally 
invasive means. In 2010, only 13 percent of Dutch surgeons indicated they had used an 
adhesion barrier in the previous year.27 Adhesion barriers were said to be superfluous due 
to a strong belief in the adhesion prevention potential of minimally invasive techniques. In 
contrast, opinion leaders in adhesion prevention have highlighted the use of adhesion 
barriers in minimally invasive surgery, showing evidence of adhesion-related complications 
after major gynecological and general laparoscopic surgery.4,28 However, hindering the fight 
for adhesion prevention in minimally invasive surgery is the fact that most barriers on the 
market were developed and studied in open surgical settings, as opposed to minimally 
invasive surgery. For example, film barriers are difficult to handle in laparoscopic surgery; 
they cannot pass through a trocar, they are challenging to unroll or fragment, and they are 
difficult to place at the desired location due to rapid adhesiveness when they come into 
contact with fluid. Icodextrin (Adept®, Baxter, Deerfield, IL, USA) was developed to be used 
in open and laparoscopic surgery; however, it has only been approved for a limited number 
of benign gynecological laparoscopic operations.29  
Solid evidence of adhesion barriers’ cost-effectiveness in preventing adhesion-related 
complications is key to progressing with next steps in adhesion prevention and 
reimbursement of barriers, both in open and minimally invasive surgery. Previous studies 
on cost-effectiveness made use of incomplete cost estimations, and only included direct 
cost savings for the prevention of ASBO, not taking in to account other common 
complications of adhesions such as difficulties during reoperations. Furthermore, costs in 









In this thesis I will assess healthcare costs from ASBO using micro-costing methods to 
provide a more accurate estimate of the true financial burden of ASBO on healthcare 
systems. This analysis will form a firm basis for a cost-effectiveness study on the routine use 
of adhesion barriers in procedures with a high risk of adhesion formation, such as colorectal 
surgery. Outcomes may serve to increase surgeons’ awareness of the importance and cost-
effectiveness of adhesion prevention, when performing open or minimally invasive 
operations in the peritoneal cavity. 
Interest in adhesion prevention and barrier use may also be stimulated through better 
understanding of the impact of intra-operative adhesiolysis on post-operative morbidity. 
The necessity to lyse adhesions during repeat surgery delays the main operation and 
imparts an increased risk of post-operative complications. Previous studies have showed an 
increase in mortality (OR 5.19), sepsis (OR 5.12), intra-abdominal complications (OR 3.46), 
wound infections (OR 2.45), hospital stay (2.06 ± 1.06 days) and hospital costs ($18.600 
compared with $14.000 in surgery without adhesiolysis) in case of adhesiolysis during 
reoperations.7,30 Despite these unfavorable outcomes, many surgeons do not recognize the 
relationship between intra-operative complications associated with adhesiolysis and 
adverse post-operative outcomes. This is partly explained by the lack of consensus 
regarding the severity of intra-operative adverse events. 
Recently, a scoring system of intra-operative adverse events has been validated for all types 
of surgeries.31 In this thesis, I will determine the inter-rater agreement of the Classification 
of Intra-operative Adverse Events (ClassIntra®), and its predictive value on post-operative 







Objectives of this thesis 
The first objective is to delineate the impact of minimally invasive surgery on adhesion-
related complications on a population level. 
The secondary objective is to increase the evidence base regarding the treatment of ASBO, 
discussing the optimal treatment while taking into account the advent of widespread 
laparoscopic adhesiolysis. 
The third objective is to increase awareness of the importance of adhesion prevention in 
contemporary surgery in the peritoneal cavity through improved mapping of intra-
operative and post-operative adverse events, and demonstration of the cost-effectiveness 
of adhesion barriers in open and laparoscopic surgery. 
 
Outline of this thesis 
In Chapter 2, the impact of minimally invasive surgery on adhesion-related readmissions is 
assessed in a population based cohort study. While minimally invasive surgery reduces 
adhesion formation, it is unknown whether a reduction in adhesions leads to a 
proportionate reduction in adhesion-related complications needing readmissions. Data is 
collected on adhesion-related readmissions after open and minimally invasive abdominal 
or pelvic surgery from a large established Scottish registry database. The results of this study 
will provide insight into the burden of adhesions due to minimally invasive surgery, and the 
need and the magnitude of future adhesion prevention measures.  
In Chapter 3, detailed information on the impact of laparoscopic colorectal surgery on 
adhesion-related readmissions is gathered in a subgroup of the population-based cohort 
described in chapter 2. The colorectal subgroup represents a large proportion of abdominal 
surgeries, and harbors the highest risk of adhesion formation and adhesion-related 
complications. Furthermore laparoscopy has become the modality of choice in colorectal 








In Chapter 4, recent literature is reviewed concerning the diagnosis and treatment of ASBO, 
inclusive of minimally invasive approaches. Since both radiological imaging techniques and 
operative techniques have improved in recent years, an update of the current Bologna 
guideline on treatment of ASBO was considered to be necessary. New and better evidence 
is presented for both diagnosis and management of ASBO, with practical recommendations 
provided. It is anticipated that diagnosis and treatment will improve for the individual 
patient with ASBO, independent from treating physician´s preferences and local resources. 
In Chapter 5, the current literature is systematically reviewed and meta-analyzed regarding 
minimally invasive and open surgery for ASBO. Minimally invasive surgery may reduce 
peritoneal wound surfaces, thereby theoretically resulting in fewer reformed adhesions, in 
addition to the general post-operative advantages such as decreased pain, faster gastro-
intestinal recovery, and minimal wound problems. However, due to a small working space 
as a result of distended bowels, concerns are raised for an increase in iatrogenic bowel 
perforations associated with the laparoscopic approach. The results of this review may 
assist surgeons in making evidence-based decisions concerning the optimal operative 
approach to a patient with ASBO, while taking into account both early and long-term post-
operative consequences. 
In Chapter 6, the inter-rater agreement of the newly proposed ClassIntra® score for intra-
operative adverse events and its predictive value for post-operative complications is 
assessed. ClassIntra® defines all deviations from the ideal intra-operative course as an 
adverse event, and has been validated in a large prospective series of all-type surgeries. 
However, in this validation, the impact of the type of intra-operative complication was not 
assessed. In previous studies, our research group demonstrated that the specific type of 
adhesiolysis-associated intra-operative complication had clinical significance; for example, 
a bowel serosal injury versus a bowel perforation. In this study, the ClassIntra® score has 
been applied to a dataset of patients who have had elective abdominal (re-)surgery, and 
whose adhesiolysis-associated intra- and post-operative complications have been 
documented in a rigorous prospective way.7 Results of this study will be valuable regarding 
uniform scoring of adverse events in abdominal surgery, and the awareness that 




In Chapter 7, a detailed cost analysis of ASBO admissions is performed. In 39 consecutive 
cases of ASBO, hospital costs are calculated using micro costing methods. Costs are 
presented for operative and non-operative management of ASBO separately. Results of this 
study will provide a greater insight regarding when and how to introduce adhesion 
prevention means.  
In Chapter 8, a decision tree model is constructed to model the cost-effectiveness of the 
routine use of adhesion barriers in open and minimally invasive colorectal surgery on 
adhesions and ASBO, based on the best available evidence. There is a gap between evidence 
of barriers’ clinical effectiveness and their clinical use, which is attributed to prior equivocal 
reports on barriers’ cost-effectiveness. For laparoscopic surgery, limited information of this 
sort was previously available. Results of this study will help both surgeons and policy makers 
both inside and outside the hospital to develop a substantiated program of (routine) 
adhesion prevention in open and laparoscopic colorectal surgery. 
In Chapter 9, I will discuss minimally invasive surgery in the context of adhesive bowel 
obstruction, addressing the findings of the studies in this thesis and those of existing 
literature. 
In Chapter 10, a summary of the chapters of this thesis is presented, and a perspective 
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Adhesions are the most common driver of long-term morbidity after abdominal surgery. 
Although laparoscopy can reduce adhesion formation, the effect of minimally invasive 
surgery on long-term adhesion-related morbidity remains unknown. We aimed to assess 
the impact of laparoscopy on adhesion-related readmissions in a population-based cohort. 
Methods  
We did a retrospective cohort study of patients of any age who had abdominal or pelvic 
surgery done using laparoscopic or open approaches between June 1, 2009, and June 30, 
2011, using validated population data from the Scottish National Health Service. All patients 
who had surgery were followed up until Dec 31, 2017. The primary outcome measure was 
the incidence of hospital readmissions directly related to adhesions in the laparoscopic and 
open surgery cohorts at 5 years. Readmissions were categorised as directly related to 
adhesions, possibly related to adhesions, and readmissions for an operation that was 
potentially complicated by adhesions. We did subgroup analyses of readmissions by 
anatomical site of surgery and used Kaplan-Meier analyses to assess differences in survival 
across subgroups. We used multivariable Cox-regression analysis to determine whether 
surgical approach was an independent and significant risk factor for adhesion-related 
readmissions. 
Findings  
Between June 1, 2009, and June 30, 2011, 72 270 patients had an index abdominal or pelvic 
surgery, of whom 21 519 (29·8%) had laparoscopic index surgery and 50 751 (70·2%) had 
open surgery. Of the 72 270 patients who had surgery, 2 527 patients (3·5%) were 
readmitted within 5 years of surgery for disorders directly related to adhesions, 12 687 
(17·6%) for disorders possibly related to adhesions, and 9 436 (13·1%) for operations 
potentially complicated by adhesions. Of the 21 519 patients who had laparoscopic surgery, 
359 (1·7% [95% CI 1·5–1·9]) were readmitted for disorders directly related to adhesions 
compared with 2 168 (4·3% [4·1–4·5]) of 50 751 patients in the open surgery cohort 
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27 
were readmitted for disorders possibly related to adhesions compared with 9 244 (18·2% 
[17·8–18·6]) of 50 751 patients in the open surgery cohort (p<0·005). In multivariate 
analyses, laparoscopy reduced the risk of directly related readmissions by 32% (hazard ratio 
[HR] 0·68, 95% CI 0·60–0·77), and of possibly related readmissions by 11% (HR 0·89, 0·85–
0·94) compared with open surgery. Procedure type, malignancy, sex, and age were also 
independently associated with the risk of adhesion-related readmissions. 
Interpretation  
Laparoscopic surgery reduces the incidence of adhesion-related readmissions. However, 
the overall burden of readmissions associated with adhesions remains high. With further 
increases in the use of laparoscopic surgery expected in the future, the effect at the 
population level might become larger. Further steps remain necessary to reduce the 






Adhesions are one of the most important drivers of long-term complications in 
contemporary abdominal surgery.1–4 Adhesions develop in 79–90% of patients who have 
open abdominal or pelvic surgery.5–7 The original Surgical and Clinical Adhesions Research 
(SCAR) study,3 published in 1999, was the first large epidemiological study to assess the 
morbidity and clinical impact of adhesions. In the 10 years after open surgery, 
approximately one in three patients were readmitted to a hospital for causes possibly 
related to adhesions and 5·7% of patients were admitted for causes directly related to 
adhesions. The landmark papers published after the subsequent colorectal and 
gynaecological SCAR studies contributed substantially to increased awareness of the impact 
of adhesion-related complications.8,9  
A number of surgical practice reforms have occurred in the two decades since publication 
of the SCAR study, several of which might have contributed to reductions in post-surgical 
adhesions. The two most prominent developments have been the increased use of 
minimally invasive surgery (eg, laparoscopy) and the use of anti- adhesion barriers. During 
the original SCAR study period, use of laparoscopy was mostly limited to diagnostic 
procedures, whereas a wide range of complex procedures are now commonly done 
laparoscopically, such as colorectal resections. At present, adhesion barriers are rarely used, 
despite high quality evidence for their efficacy in reducing adhesion formation.10,11 By 
contrast, laparoscopic surgery has now been widely adopted, mainly because of benefits 
such as reduced postoperative pain and improved cosmetic results.12 Laparoscopic surgery 
reduces the extent and severity of adhesion formation by roughly 50%, mostly at the 
incision line.5,13 Reduction of adhesion formation does not necessarily correlate with a 
proportional reduction in the risk of adhesion-related complications; a single adhesive band 
can sometimes cause a life-threatening bowel obstruction, whereas extensive dense 
abdominal adhesions might be asymptomatic.14 Several studies have suggested that 
laparoscopic surgery might also be associated with a lower incidence of adhesion-related 
complications.1,5 However, adhesion-related complications are often only measured as a 
secondary, underpowered endpoint.15 Thus, it remains unknown whether changes in 
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burden of adhesion formation and adhesion-related complications. In this study, we aimed 
to assess the incidence of adhesion-related readmissions at the population level after open 




Data sources and study population  
We did a retrospective cohort study using validated data from the Scottish Medical Record 
Linkage Database, managed by the National Health Service (NHS) Scotland. The database 
contains records for all inpatient and day- case hospital admissions in Scotland, excluding 
maternity and psychiatry admissions. Data from the NHS are validated annually at the 
hospital level by comparing 1% of local hospital clinical data with centrally held data.16 The 
database has been described in detail previously.2,3 
We included all patients of any age who had initial abdominal or pelvic surgery between 
June 1, 2009, and June 30, 2011, to ensure a follow-up period of 5 years. Patients with a 
previous history of pelvic or abdominal surgery were excluded. All patients who had surgery 
were followed up until Dec 31, 2017. Migration data and deaths in the cohort were also 
extracted. 
Procedures 
We used the Office of Population Censuses and Surveys Classification of Interventions and 
Procedures version 4 (OPCS-4) codes to identify operation types and approaches. All 
operations were classified as open or laparoscopic according to OPCS-4 codes. Some  
OPCS-4 codes incorporated laparoscopic approaches in their original coding (eg, Q48·3, 
laparoscopic oocyte recovery); in most other cases, laparoscopic operations could be 
identified by the use of an additional code for laparoscopic surgery (eg, Y50·8, laparoscopic 




laparoscopic approaches or identified by the use of an additional code for laparoscopic 
surgery were coded as laparoscopic. 
We identified hospital readmissions using OPCS-4 codes and International Classification of 
Diseases, tenth edition (ICD-10) codes. Consistent with previous SCAR methods,2,3 all 
readmissions were screened for their possible association with adhesions. All potentially 
relevant readmissions were classified as readmission directly related to adhesions (eg, 
adhesiolysis, adhesive small bowel obstruction); readmission possibly related to adhesions 
(eg, unspecified small bowel obstruction); or readmission with reoperation that could 
potentially be complicated by adhesions (eg, right hemicolectomy after appendectomy). 
We classified the association between readmissions and adhesions using relevant OPCS-4 
and ICD-10 codes. Readmissions were only included in one of three categories. We excluded 
readmissions from analyses that were unlikely to be associated with adhesions. Only 
readmissions with an explicit reference to adhesions in the ICD-10 or OPCS-4 coding were 
classified as directly related.  
Consistent with the methods of previous SCAR studies,2,3 subgroup analyses were done by 
anatomical site: midgut and hindgut (small intestine, abdominal wall, appendix, rectum, 
colon), foregut and other abdominal organs (stomach, gallbladder, pancreas, kidney, 
bladder), and the female reproductive tract. Additionally, we introduced a new anatomical 
site classification to enable better comparison between laparoscopic and open surgeries. 
We compared readmission rates between open and laparoscopic surgeries for ten 
categories of frequent surgical procedures that comprise more than 80% of all surgical 
procedures. Common surgical procedures were categorised as appendectomy, 
cholecystectomy, procedures on the colon, rectum, liver, or upper gastrointestinal tract, 
urological, gynaecological procedures without uterus extirpation, gynaecological 
procedures with uterus extirpation, retroperitoneal surgeries, or other. Procedures were 
classified such that each patient would only be included in one category. For patients who 
were eligible for inclusion in more than one category, patients were assigned to the 










The primary outcome measure was the incidence of hospital readmissions directly related 
to adhesions in the open and laparoscopic surgery cohorts at 5 years. Our secondary 
outcome measure was the incidence of possibly related readmissions. In the analysis of 
readmissions possibly related to adhesions, the incidence of first directly or possibly related 
readmissions was recorded. Additional outcome measures were annual cumulative 
readmission rates, association between index procedure anatomical location and adhesion- 
related readmissions, and association between indication for index surgery and adhesion- 
related readmissions. All outcome measures were analysed collectively for the overall 
cohort and separately for patients with open and laparoscopic index surgeries. 
Statistical analysis 
We used Kaplan-Meier analyses to assess differences in survival for all subgroups. The log-
rank test was used to determine significant differences in survival between the subgroups. 
Multivariable survival analyses were done using Cox-regression analysis, to determine if the 
approach to the abdominal and pelvic cavity was an independent and significant risk factor 
for adhesion-related readmissions. Any independent variables associated with the 
dependent variables in the univariate analyses (p<0·2) were entered into the multivariate 
analyses. Multivariable analyses were done using backward selection. Descriptive statistical 
analyses were done using SPSS software (version 22.0). Univariate and multivariate survival 
analyses were done using R (version 3.5.1). A p value of less than 0·05 was considered to 
indicate a statistically significant difference. 
 
Results 
Between June 1, 2009, and June 30, 2011, 72 270 patients had an index abdominal or pelvic 
surgery. 21 519 (29·8%) patients had laparoscopic surgery, which was converted to open 
surgery in 1822 (8·5%) patients. Table 1 shows the baseline characteristics of both cohorts. 
Clinically relevant differences were identified in the distribution of surgical procedures 




Table 1 Demographics of study population 
 Total Open Laparoscopy 
Patients 72 270 50 751 21 519 
Admissions 111 942 80 959 30 983 
Sex 
  Male 
  Female 
 
23 334 (32·3%) 
48 934 (67·7%) 
 
16 577 (32·7%) 
34 172 (67·3%) 
 
6 757 (31·4%) 
1 4761 (68·6%) 
Age (years) 
  Range 
  Mean 
 
0* - 101 
50 
 
0* - 101 
51 
 
0* - 98 
47 
Follow-up (months) 
  Min 
  Mean 
 
0$ - 95·1 
70·2 
 
0$ - 95·1 
68·4 
 
0·2 - 91·4 
74·5 
Operation level 
  Foregut or other 
  Mid- or hindgut 
  Female reproductive tract  
 
29 804 (41·2%) 
24 088 (33·3%) 
18 378 (25·4%) 
 
15 383 (30·3%) 
18 754 (37·0%) 
16 614 (32·7%) 
 
14 421 (67·0%) 
5 334 (24·8%) 
1 764 (8·2%) 
Common surgeries 
  Liver 
  Retroperitoneal 
  Urologic 
  Upper GI 
  Cholecystectomy 
  Appendectomy 
  Gynaecological 
    No uterus extirpation 
    Uterus extirpation 
  Rectum 
  Colon  
  Other 
 
415 (0·6%) 
1 827 (2·5%) 
3 708 (5·1%) 
2 777 (3·8%) 
14 177 (19·6%) 
7 385 (10·2%) 
 
10 080 (13·9%) 
7 641 (10·6%) 
3 270 (4·5%) 
5 869 (8·1%) 
15 121 (20·9%) 
 
325 (0·6%) 
1 746 (3·4%) 
2 737 (5·4%) 
1 838 (3·6%) 
2 114 (4·2%) 
4 115 (8·1%) 
 
8 657 (17·1%) 
7 342 (14·5%) 
2 913 (5·7%) 
5 041 (9·9%) 






12 063 (56·1%) 
3 270 (15·2%)n 
 




1 198 (5·6%) 
Diagnosis (index admission) 
  Malignancy 
  Foregut and other 
  Mid- or hindgut 
  Female reproductive tract 
  Crohn’s disease 
  Diverticulitis  
 
 
4 148 (5·7%) 
5 420 (7·5%) 





3 266 (6·4%) 
4 608 (9·1%) 










* cohort consists of all patients undergoing abdominal or pelvic surgery, including paediatric cases, $ patients with 
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occasions (mean 1·7 times [SD 1·7]) during the 5-year follow-up for any cause related to 
adhesions.  
Overall, 2 527 (3·5%) of 72 270 patients were readmitted a total of 3 442 times for a cause 
directly related to adhesions, with a mean of 1·4 readmissions per patient [SD 0·9] during 
the 5-year period. 2 168 (4·3% [95% CI 4·1–4·5]) of 50 751 patients were readmitted at least 
once for a disorder directly related to adhesions in the open surgery cohort (mean number 
of readmissions 1·4 [SD 0·9]) compared with 359 (1·7% [1·5–1·9]) of 21 519 patients in the 
laparoscopic surgery cohort (mean number of readmissions 1·3 [0·6]), and this difference 
was statistically significant (p<0·0001; figure A). During the total follow-up period (mean 
follow-up 70·2 months), 2 314 (57·5%) of 4 021 directly related readmissions were for 
adhesive small bowel obstruction, 917 (39·6%) of which were treated surgically. All 
readmissions directly related to adhesions by anatomical site of index surgery during the 
full study period (mean follow-up 70·2 months) are shown in table 2. 
In the 5 years after index surgery, 12 687 (17·6%) of 72 270 patients were readmitted a total 
of 21 778 times for a cause possibly related to adhesions, with a mean of 1·7 readmissions 
per patient (SD 1·8). In the open surgery cohort, 9 244 (18·2%; 95% CI 17·8–18·6) of 50 751 
patients were readmitted for a cause possibly related to adhesions, with a mean 1·7 
readmissions per patient (SD 1·9). In the laparoscopic surgery cohort, readmissions were 
lower, with 3 443 (16·0%; 95% CI 15·6–16·4) of 21 519 patients readmitted at a mean rate 
of 1·7 readmissions per patient (SD 1·6; p<0·0001; figure B). The diagnostic codes for 
possibly related readmissions did not differ between the open and laparoscopic surgery 
cohorts. The most frequent causes of readmission were abdominal or pelvic pain, change in 
bowel habits, nausea, and vomiting (appendix p 1). 
Overall, 9 436 (13·1%) of 72 270 patients were readmitted a total of 11 821 times for 
reoperations potentially complicated by adhesions, with a mean of 1·3 reoperations per 
patient (SD 0·7) recorded during the 5-year period after surgery. Reoperations were done 
laparoscopically in 1 572 (13·3%) of 11 821 reoperations. Patients in the laparoscopic 
surgery cohort were less frequently readmitted for reoperations potentially complicated by 





Figure Adhesion-related readmissions among patients who had open surgery and 
laparoscopic surgery. Directly-related readmissions (A), possibly-related readmissions (B) 
and reoperations potentially complicated by adhesions (C), among patients who had open 
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in the laparoscopic surgery cohort vs 7 592/50 751 [15·0%; 95%CI 14·6–15·4] in the open 
surgery cohort; figure C). In the open surgery cohort, 592 (6·2%) of 9 578 reoperations were 
done laparoscopically compared with 980 (43·7%) of 2 243 reoperations in the laparoscopic 
surgery cohort. Reoperation codes did not differ substantially between the open and 
laparoscopic surgery cohorts (appendix p 2). 
1 548 (38·5%) of 4 021 patients who were readmitted for a disorder directly related to 
adhesions were readmitted within the first 2 years after index surgery. No differences were 
identified in the time to first readmission between the open and laparoscopic surgery 
cohorts (appendix pp 47, 48). 
The finding that the rate of adhesion-related readmissions was lower among patients who 
had laparoscopic procedures than patients who had open surgeries was consistent with 
subgroup analyses by anatomical site of surgery, with the exception of patients who had 
surgery of the female reproductive tract; the proportion of readmissions directly related to 
adhesions did not differ significantly between the open and laparoscopic surgery cohorts at 
this anatomical site (4·1% vs 3·3%; table 2; appendix p 11). 
Of all procedure types, patients who had surgery of the colon or rectum were the most 
frequently readmitted for disorders directly related to adhesions (5-year readmission rate 
10·1% for colon surgery and 11·0% for rectum surgery). Patients who had a cholecystectomy 
or liver surgery were the least frequently readmitted for disorders directly related to 
adhesions (5-year readmission rate 1·3% for cholecystectomy and 2·9% for liver surgery). 
Patients who had laparoscopic surgery were less frequently readmitted for direct adhesion 
related reasons than those in the open surgery cohort across all ten categories of frequent 
surgical procedures, with the exception of patients who had a gynaecological procedure 
with hysterectomy (appendix pp 14-46). 
Univariate hazard ratios for readmissions directly related to adhesions and readmissions 
possibly related to adhesions are shown in the appendix (pp 3, 4). In univariate analysis, 
surgical approach (open or laparoscopic), age, sex, malignancy as primary indication for 
surgery (no malignancy, malignancy of foregut, malignancy of midgut or hindgut, 
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 Table 3 Multivariable analysis for direct adhesion-related readmissions 
* older patients are at higher risk 
 
  






2 462/50 751 (4·9%) 
423/21 519 (2·0%) 
 
Ref.  
0·68 (0·60 - 0·77) 
 
 
P < 0·001 
Age* (per year) 
 






1 004/23 334 (4·3%) 
1 881/48 934 (3·8%) 
 
Ref.  
1·19 (1·09 - 1·30) 
 
 
P < 0·001 
Malignant disease 
 No malignancy 
 Mid- or hindgut 
 Foregut and other 
 Female reproductive tract 
 
 
2 011/60 710 (3·3%) 
523/5 420 (9·6%) 
194/4 148(4·7%) 
157/1 992 (7·9%) 
 
Ref. 
0·34 (0·28 - 0·41) 
0·39 (0·32 - 0·48) 
0·44 (0·34 - 0·56) 
 
 
P < 0·001 
P < 0·001 
P < 0·001 
Type of procedure 




 Upper GI 
 Appendectomy  
 Gynaecological no uterus extirpation 





180/14 177 (1·3%) 
12/415 (2·9%) 
83/1 827 (4·5%) 
129/3 708 (3·5%) 
91/2 777 (3·3%) 
164/7 385 (2·2%) 
268/10 080 (2·7%) 
222/7 641 (2·9%) 
359/3 270 (11·0%) 
592/5 869 (10·1%) 
785/15 121 (5·2%) 
 
Ref. 
1·58 (0·80 - 3·13) 
2·67 (1·96 - 3·64) 
2·08 (1·85 - 2·75) 
2·20 (1·65 - 2·94) 
1·81 (1·42 - 2·30) 
1·56 (1·24 - 1·96) 
1·22 (0·95 - 1·56) 
6·87 (5·45 - 8·64) 
6·32 (5·08 - 7·85) 
3·47 (2·83 - 4·25) 
 
 
P = 0·186 
P < 0·001 
P < 0·001 
P < 0·001 
P < 0·001 
P < 0·001 
P = 0·124 
P < 0·001 
P < 0·001 




associated with risk of readmission and thus were entered into the multivariate analyses. In 
multivariable Cox-regression analyses, the use of a laparoscopic approach in the abdominal 
or pelvic cavity was a significant independent protective factor for both readmissions 
directly related to adhesions (hazard ratio [HR] 0·68, 95% CI 0·60–0·77) and readmissions 
possibly related to adhesions (HR 0·89, 0·85–0·94). In multivariable analyses, type of 
procedure, malignancy, sex, and age were also independent significant factors for 
readmissions directly or possibly related to adhesions (tables 3, 4). 
 
Discussion 
The rate of readmissions directly related to adhesions was approximately 30% lower among 
patients who had laparoscopic surgery compared with open surgery. Overall, we found that 
approximately one in every four patients who had surgery of the abdomen or pelvic cavity 
was readmitted within 5 years, for an adhesion-related cause or for a reoperation that was 
potentially complicated by adhesions. Half of these readmissions occurred within the first 2 
years after initial surgery. The anatomical site of operation was an important predictor of 
directly related readmissions; patients who had surgeries of the colon or rectum were most 
frequently readmitted. Despite our finding that the incidence of readmissions directly 
related to adhesions was significantly lower among patients who had laparoscopic surgery 
than open surgery, this difference did not seem to translate into a subsequent decrease in 
overall adhesion-related readmissions at the population level compared with the original 
SCAR studies.3 However, assuming that the use of laparoscopic surgery continues to 
increase, it is possible that a larger effect might be observed in the future. 
This study assessed the effect of laparoscopic surgery on adhesion-related hospital 
readmissions at the population level. Previous studies have demonstrated a reduction in 
adhesion formation after laparoscopic surgery when compared with open surgical 
procedures, with the main advantage of laparoscopy being the lower incidence of adhesion 
formation at incision lines.5 At present, the effect of this decrease on adhesion-related 
complications and overall postsurgical morbidity remains unclear because clinical trials of 
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related outcomes.17 By using comparable methods to the original SCAR studies, we have 
been able to clearly assess the extent of any progress made since the widespread adoption 
of laparoscopy across a range of surgical subspecialties. 
A major strength of this study is the use of validated high-quality data from the Scottish 
Medical Record Linkage Database, managed by the NHS. Centralised reporting and low 
population migration enabled us to do an accurate nationwide study.16 The study includes 
an unselected group of patients who had index surgeries over several years, reflecting every 
day surgical practice. NHS Scotland data is of high quality, and generalisable for high-income 
countries. This database is ideal for population-based studies due to Scotland’s 
geographically self-contained location, low level of migration (2·4% over the years included 
in this study), and its derivation from a national health service with centralised reporting.  
A limitation of this study is the difficulty associated with defining overall morbidity from 
adhesions. We considered the number of directly related readmissions as our primary 
outcome, although this reflects an underestimate of the true burden of adhesions. A larger 
number of readmissions are classified as possibly related than directly related, because 
symptoms of adhesion-related complications are often nonspecific and might also be 
caused by other conditions. Confirmation that adhesions are the true cause of symptoms 
often itself necessitates surgical exploration. However, most patients with adhesion-related 
complications are not treated operatively, and adhesiolysis is not always accurately 
documented in surgical reports.18 By contrast, by primarily evaluating directly related 
readmissions, we can safely conclude that overestimation of the true association between 
adhesions and these hospital readmissions is unlikely. Compared with the original SCAR 
studies, we found that the proportion of readmissions classified as directly related to 
adhesions increased by 40% (10·1% in the present study vs 5·7% in the SCAR studies). This 
higher proportion of readmissions might be attributable to an increased awareness of 
adhesions and better coding, rather than a true increase in readmissions directly related to 
adhesions.3,11 
Compared with the original SCAR studies, we observed an increase in the proportion of 




Table 4 Multivariable analysis for possibly adhesion-related readmissions 
 N/N total (%) HR (95% CI) P-value 
Approach 
  Open 
  Laparoscopic 
 
10 548/50 751 (20·8%)  
3 923/21 519 (18·2%) 
 
Ref. 
0·89 (0·85 - 0·94) 
 
 
P < 0·001 
 
Age* (per year) 
 
 1·00 (0·99 - 1·00) P < 0·001 
Sex 
  Male 
  Female 
 
 
4 051/23 334 (17·4%) 
10 420/48 934 (21·3%) 
 
Ref. 
1·42 (1·36 - 1·48) 
 
 
P < 0·001 
Malignant disease 
  No malignancy 
  Mid- or hindgut 
  Foregut and other 
  Female reproductive tract 
 
 
11 907/60 710 (19·6%) 
1 339/5 420 (24·7%) 
760/4 148 (18·3%) 
465/1 992 (23·3%) 
 
Ref. 
0·63 (0·57 - 0·71) 
0·62 (0·54 - 0·70) 
0·68 (0·59 - 0·78) 
 
 
P < 0·001 
P < 0·001 
P < 0·001 
Type of procedure 
  Cholecystectomy  
  Liver 
  Retroperitoneal 
  Urologic 
  Upper GI 
  Appendectomy  
  Gynaecological no uterus extirpation 
  Gynaecological uterus extirpation 
  Rectum 
  Colon 
  Other 
 
2 622/14 177 (18·5%) 
97/415 (23·4%) 
366/1 827 (20·0%) 
659/3 708 (17·8%) 
552/2 777 (19·9%) 
1 199/7 385 (16·2%) 
1 829/10 080 (18·1%) 
1 211/7 641(15·8%) 
908/3 270 (27·8%) 
1 604/5 869 (27·3%) 
3 424/15 121 (22·6%) 
 
Ref. 
1·39 (1·12 - 1·72) 
1·24 (1·10 - 1·41) 
1·01 (0·91 - 1·12) 
1·09 (0·98 - 1·20) 
0·86 (0·80 - 0·94) 
0·77 (0·71 - 0·83) 
0·61 (0·56 - 0·67) 
1·78 (1·62 - 1·96) 
1·72 (1·58 - 1·87) 
1·18 (1·10 - 1·27) 
 
 
P = 0·003 
P = 0·001 
P = 0·836 
P = 0·126 
P < 0·001 
P < 0·001 
P < 0·001 
P < 0·001 
P < 0·001 
P < 0·001 
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related to adhesions. The larger proportion of possibly related readmissions observed in our 
study is most likely to be explained by the increase in conservative treatment of adhesive 
small bowel obstruction that has been adopted since the SCAR studies were published; non-
operative management of adhesive small bowel obstruction accounted for 66% of all 
possibly related readmissions. In contrast to traditional surgical practice, recent studies19–21 
have shown that it is safe to manage most cases of adhesive small bowel obstruction non- 
operatively for 72 h, a finding which has been adopted by the international guidelines. At 
present, approximately 70% of adhesive small bowel obstruction cases are treated non-
operatively.21 
Although the relative number of laparoscopic resections greatly increased compared with 
the original SCAR studies, the use of laparoscopy only began to increase substantially in the 
past few years. For example, in an analysis of colorectal procedures in the Netherlands in 
2018, 75% of procedures were laparoscopic;22 however, follow-up is too short to assess 
adhesion-related readmissions. The lower rate of laparoscopies might indicate some 
selection bias. The net effect of this potential source of bias on the overall results are 
unclear. On the one hand, surgeons captured in the study might still have been in the earlier 
stages of their respective laparoscopic learning curves. Adhesion-related morbidity in 
laparoscopy might be higher for surgeons with less laparoscopic experience. On the other 
hand, laparoscopic surgery is typically used for routine cases initially, and open surgery is 
increasingly reserved for more extensive surgical procedures and cases that are anticipated 
to be difficult.23 Some of the severe adhesion formation often observed following difficult 
surgeries might have been induced by the disease process and peritoneal inflammation 
rather than from the surgical approach used. The effect of laparoscopic surgery also seemed 
to decrease after correcting for case-mix variables, such as type of procedure in multivariate 
analysis. More in-depth surgical and patient-related case-mix variables (such as surgical 
duration, surgeon experience, exact reason for surgical conversion to open surgery, body-
mass index, American Society of Anesthesiologists class, and socio- economic status of 
patients) were not available for analysis in the population database, and thus could not be 




On a population level, 35% of patients were readmitted in the original SCAR studies during 
the 10-year follow- up period compared with 27% in the present study during the 5-year 
follow-up period. Considering that approximately 70% of all adhesion-related complications 
occur in the first 5 years after index surgery,2,3 the readmission rates are roughly 
comparable. Although at present the use of laparoscopic techniques continues to increase, 
future population effects on adhesion-related morbidity might be more substantial. 
Improved registration and awareness of adhesion-related complications might have also 
contributed to the fact that readmission rates remained comparable. This population-based 
analysis with long-term follow-up remains one of the most robust assessments to date of 
the long-term impact of the introduction of laparoscopy on overall morbidity of adhesions 
and resulting health-care utilisation. 
Our study demonstrates that even after the widespread adoption of laparoscopic surgery, 
morbidity related to adhesions remains substantial. As many as one in six patients treated 
laparoscopically were readmitted for a possible adhesion related complication, 1·7% of 
whom were readmitted for a direct adhesion related complication. Most admissions for 
adhesions were for adhesive small bowel obstruction. Health-care costs for adhesion-
related complications are also substantial. For example, treatment costs for adhesive small 
bowel obstruction are estimated at €16 305 for operative treatment and €2 277 for non- 
operative treatment.24 Furthermore, the true burden of adhesions is even higher, since 
these figures do not account for the morbidity of chronic pain that often results in 
outpatient visits.25 Additionally, chronic abdominal pain after surgery rarely results in 
readmission. Chronic pain related to adhesions has a considerable societal impact, including 
opioid use, reduced quality of life, and employment disruptions.26,27 Although accurate 
assessment of the burden of chronic pain related to adhesions is difficult, promising 
diagnostic developments such as cine-MRI hold promise for the differentiation of chronic 
pain from adhesions and other causes, thereby improving personalised treatment of 
adhesions and research in this field.26 
The impact of adhesions after laparoscopic surgery seems to be frequently underestimated; 
only 35% of surgeons routinely inform patients of the risk of adhesions before a 
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colorectal operations, might further be reduced with the use of adhesion barriers.1,13 Many 
of the barriers currently available are not suitable for laparoscopic surgery because they are 
difficult to place laparoscopically or because few safety assessments have been done in the 
context of bowel anastomoses. More research is therefore needed to develop measures 
that can be easily applied have relatively low costs. 
Laparoscopic surgery reduces the incidence of adhesion-related readmissions. However, 
despite this effect, the overall burden of adhesion-related readmissions remains high at the 
population level. The continued increase in laparoscopic procedures is expected to further 
reduce adhesion-related morbidity at the population level. Future research is needed with 
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 Adhesion-related readmissions after open 
and laparoscopic colorectal surgery in 16 524 







Colorectal surgery is associated with a high risk of adhesion formation and subsequent 
complications. Recent evidence shows that laparoscopic surgery reduces adhesion 
formation by 50% in colorectal surgery but the effect on adhesion-related complications 
remains unknown. The aim of this study was to assess the effect of the implementation of 
laparoscopic colorectal surgery on the incidence of adhesion-related readmissions. 
 
Methods 
Population data from the Scottish National Health Service were used to identify patients 
who underwent colorectal surgery between June 2009 and June 2011. Readmissions were 
registered and screened until December 2017 and categorized as being either directly or 
possibly related to adhesions, or as reoperations potentially complicated by adhesions. The 
primary outcome measure was the difference in incidence of directly adhesion-related 
readmissions between the open and laparoscopic cohort. 
 
Findings 
Colorectal surgery was performed in 16 524 patients; 4 455 (27%) underwent laparoscopic 
surgery. Readmission rates for any adhesion-related cause were 4 658/12 069 (39%) in the 
open and 1 179/4 455 (26%) in the laparoscopic cohort. Patients undergoing laparoscopic 
surgery were readmitted less frequently for directly adhesion-related complications, 2.4% 
(95% CI 2.0 - 2.8%) vs. 7.5% (95% CI 7.1 - 7.9%) in the open cohort. Readmissions for possibly 
adhesion-related complications were less frequent in the laparoscopic cohort, 16.8% (95% 
CI 15.6 - 18.0%) vs. 21.7% (95% CI 20.9 - 22.5%), as well as reoperations potentially 
complicated by adhesions, 9.7% (95% CI 8.9 - 10.5%) vs. 16.9% (95% CI 16.3 - 17.5%).  
 
Interpretation 
Overall any adhesion-related readmissions occurred in one in three patients after open 
colorectal surgery and one in four in laparoscopic surgery. Incidence rates of adhesion-









After colorectal surgery the vast majority of patients develop intra-abdominal or pelvic 
adhesions.1,2 The clinical impact of adhesion formation varies, but can be substantial, 
including a lifelong risk of readmissions for adhesive small bowel obstruction (ASBO), 
chronic pain or infertility.2-4 Moreover adhesions can necessitate adhesiolysis during 
reoperations increasing the risk of inadvertent bowel injury.5 In over one in four operative 
procedures complicated by adhesions, inadvertent bowel injury occurs, with a subsequent 
increased incidence of post-operative complications.5,6  
Two decades ago the population based Surgical and Clinical Adhesions Research (SCAR) 
studies were the first to determine the extent to which adhesion formation contributes to 
hospital readmissions.7,8 These landmark studies revealed that over one in three patients 
were readmitted for adhesion-related causes in the ten years after colorectal surgery.2 The 
first and most important effect of the publication of these studies was the emergence of 
awareness of adhesion-related complications. The study group stated in 2001 that in order 
to reduce the substantial clinical impact of adhesion formation, implementation of adhesion 
prevention strategies should be given a high priority.8  
In addition to the use of adhesion prevention agents, minimizing the peritoneal damage of 
surgery by means of a laparoscopic approach was considered the most viable strategy. A 
common assumption of many surgeons is that the problem of postoperative adhesion 
formation is fairly minimal due to the wide implementation of laparoscopic surgery over the 
past decades.9 Studies report reduced incidence rates of adhesion formation after 
laparoscopic colorectal cancer surgery compared with open surgery.1,10 However, three in 
five patients still develop adhesions after laparoscopic colorectal procedures.1 Moreover, 
the reduction in adhesion formation might not correlate with a proportional reduction in 
long-term adhesion-related complications. A single adhesive band can cause a severe case 
of ASBO, while extensive dense adhesions can be asymptomatic.11 Studies on the incidence 
of ASBO after laparoscopic surgery do not consistently show a risk reduction.12-16 Some 
retrospective cohort studies report a reduced risk of ASBO after laparoscopic colorectal 




SCAR update study, a nationwide retrospective cohort study, revealed an undiminished high 
incidence of adhesion-related readmissions (including ASBO) after abdominal surgery in the 
minimally invasive era.17  
Results from this study are of the utmost importance for colorectal surgeons, since 
colorectal surgery is known for its adhesion formation propensity and the vast majority of 
contemporary colorectal procedures are performed laparoscopically. 1,2 Laparoscopic 
surgery reduces adhesion formation, however the effects on clinically relevant parameters 
(e.g. readmissions) is lacking. The current population based study aims to compare the 
incidence of adhesion-related readmissions after laparoscopic and open colorectal surgery.  
 
Methods 
In this study population data were used from the Scottish Medical Record Linkage Database, 
managed by the Scottish National Health Service (NHS Scotland) Information and Statistics 
Division. All Scottish individual patients’ records on inpatient hospital admissions and day 
care hospital admissions were included. Data from the NHS were validated at hospital level 
by an annual audit.18,19 The database was previously described in detail by the SCAR 
research group.7,8 
All patients undergoing open or laparoscopic colorectal surgery between June 2009 and 
June 2011 were included. Patients with a history of abdominal or pelvic surgery were 
excluded. Colorectal surgery was defined by the Office of Population Censuses and Surveys 
Classification of Interventions and Procedures version 4 (OPCS-4) codes for surgery on the 
colon (H01 - H19) or the rectum (H33 - H 36, H 41). Based on the OPCS-4 coding, patients 
were categorized as open or laparoscopic approach to the abdominal cavity. Procedures 
were classified in such a way that each individual patient would only fit in one of the 
predefined categories.  
Readmissions were screened and registered until December 2017 based on relevant 
predefined International Classification of Diseases, tenth edition (ICD-10) and OPCS-4 
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1) directly related to adhesions (e.g. adhesive small bowel obstruction, adhesiolysis), 2) 
possibly related to adhesions (e.g. small bowel obstruction) or 3) reoperations potentially 
complicated by adhesions (e.g. left colectomy after sigmoid resection). Readmissions which 
were considered to be unrelated to adhesions fell outside the scope of this study. Directly 
adhesion-related readmissions were only scored if there was an explicit reference to 
adhesions in the OPCS-4 or ICD-10 code. The most common ICD-10 codes for possibly 
adhesion-related readmissions are reported in a previous publication, mainly consisting of 
different codes for abdominal pain or absence of stool.17 
The primary outcome measure was the incidence of directly adhesion-related readmissions 
at 5 years following index surgery, in the open and laparoscopic colorectal surgery cohort. 
Secondary outcome measures were the incidence of possibly adhesion-related 
readmissions and reoperations potentially complicated by adhesions. In the analysis of 
readmissions possibly related to adhesions, the incidence of first directly or possibly 
adhesion-related readmissions was recorded.  
Malignancy is the usual indication for rectal surgery; for colonic surgery a malignancy is not 
always the indication for surgery. Colonic surgery could be instigated for benign reasons like 
diverticulosis or inflammatory bowel diseases. Results from our analysis could be biased by 
the indication for surgery. For these reasons primary and secondary outcomes were 
analyzed separately for the overall cohort and for procedures on the colon or rectum. 
Subgroup analyses were performed for frequent surgical procedures: appendectomy, left 
hemicolectomy, right hemicolectomy, (sub)total colectomy, sigmoidectomy, rectal excision 
(including low anterior resection), rectal prolapse, colostomy or other colorectal 
procedures. 
The incidence of adhesion-related readmissions was demonstrated by Kaplan-Meier plots. 
Log-rank tests were used to determine significant differences in survival between groups. 
Multivariate Cox regression analysis was performed to determine if a laparoscopic or open 
approach to the abdominal cavity was an independent and significant risk factor for 
adhesion-related readmissions. All variables associated with adhesion-related readmissions 




multivariate analysis. Backward stepwise selection was performed. Statistical analysis was 
performed using SPSS software (version 22.0) and R 3.5.1. Significant differences were 
defined as p<0.05. 
Role of the funding source 
This study received no funding for the design, data collection, analysis, interpretation, or 
writing of the report. The corresponding authors had full access to all the data in the study 
and had final responsibility for the decision to submit for publication. 
 
Results 
A total of 16 524 patients underwent colorectal surgery. Surgery on the colon was 
performed in 13 254 patients of whom 30.9% underwent laparoscopic surgery. Surgery on 
the rectum was performed in 3 270 of whom laparoscopic surgery was performed in 10.9%. 
Demographics of the study population are reported in table 1. The mean follow up for all 
cohorts was 67 months. In the 5 years following index surgery 5 837 (35.3%) patients were 
readmitted at least once for an adhesion-related cause. In the laparoscopic cohort patients 
were readmitted less frequently for an adhesion-related cause compared with the open 
cohort, 26.5% vs. 38.6% respectively, p < 0.005 (figure 1). 
 
Directly adhesion-related 
In the overall cohort 1 008 (6.1%) patients were readmitted at least once for a complication 
directly related to adhesions, (table 2). In the laparoscopic cohort less patients were 
readmitted for a complication directly related to adhesions compared with the open cohort, 
107/4 455 (2.4%) vs. 901/12 069 (7.5%), p < 0.005 (figure 2). Sub-analyses of the colon and 
rectum group showed similar trends. In the colon group 596/9 156 (6.5%) of all patients 
with open surgery were readmitted compared with 82/4 098 (2.0%) in the laparoscopic 
cohort, p < 0.005 (figure 3). In the rectum group 305/2 913 (10.5%) and 25/357 (7.0%) 
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Table 1 Demographics of study population 
 
 Colon Rectum Total 
Open 
N = 9 156 
Laparoscopy 
N = 4 098 
Open 
N = 2 913 
Laparoscopy 
N = 357 
Open 
N = 12 069 
Laparoscopy 
N = 4 455 
Sex 
  Male 
  Female 
 
 
4 936 (53.9%) 
4 219 (46.1%) 
 
2 038 (49.7%) 
2 060 (50.3%) 
 
1 408 (48.3%) 





6 344 (52.6%) 
5 724 (47.4%) 
 
2 210 (49.6%) 
2 245 (50.4%) 
Age 
  Min 
  Max 
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  Right hemicolectomy 
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Figure 1 Cumulative percentage of adhesion-related readmissions. Patients with multiple 
readmissions were counted only once. If a patient had both a directly and possibly adhesion-





















































































































































































































































































































































A total of 3 362 (20.3%) patients were readmitted for possibly adhesion-related 
complications. Possibly adhesion-related readmissions in the laparoscopic cohort were less 
frequent compared with the open cohort, 749/4 455 (16.8%) vs. 2 613/12 069 (21.7%), p < 
0.005. Laparoscopic surgery on the colon was associated with lower rates of readmissions 
compared with open surgery, 671/4 098 (16.4%) vs. 1 859/9 156 (20.3%), p < 0.005. Possibly 
adhesion-related readmissions did not differ between the open and laparoscopic cohort in 
surgery on the rectum, (table 2). 
 
Reoperations potentially complicated by adhesions 
A total of 2 475 (15.0%) patients were readmitted for a reoperation potentially complicated 
by adhesions in the five years following initial surgery. Of these, 9.6% of reoperations were 
performed laparoscopically. Less patients in the laparoscopic cohort underwent 
reoperations compared with the open cohort, 430/4 455 (9.7%) vs. 2 045/12 069 (16.9%), 










Figure 4 Cumulative directly adhesion-related readmission rates for patients operated on 
the rectum 
 
index surgery was laparoscopic compared with open index surgery, 86/430 (20.0%) vs. 
151/2 045 (7.4%), p < 0.005. Reoperations in patients with surgery on the colon were less 
common in the laparoscopic cohort compared with the open cohort, 328/4 098 (8.0%) vs.  
1 161/9 156 (12.7%). Incidence rates of reoperations did not differ between laparoscopic 
and open surgery in patients who underwent surgery on the rectum, (table 2). 
 
Time to first adhesion-related readmission 
In the first year following index surgery 2.3% of all patients in the overall cohort were 
readmitted for a complication directly related to adhesions, increasing to 4.4% after 5 years. 
In the open cohort 2.9% of patients were readmitted for directly adhesion-related 
complications in the first year which increased to 5.4% after 5 years. In the laparoscopic 
cohort 1.0% of patients were readmitted for directly adhesion-related complications in the 
first year after index surgery rising to 1.6% after 5 years. Readmission rates for possibly 
adhesion-related complications and reoperations potentially complicated by adhesions are 




Type of surgical procedure 
Five year adhesion-related readmission rates for all common types of colorectal procedures 
are presented in table 3 and survival curves are presented in appendix figure 1a-12c. 
Patients who underwent a laparoscopic appendectomy, right hemicolectomy or 
sigmoidectomy were readmitted less frequently for directly adhesion-related complications 
compared with open procedures. There were no differences in directly adhesion-related 
readmissions between the open and laparoscopic cohort for left hemicolectomies, 
(sub)total colectomies, procedures for a rectal prolapse, rectal excisions, colostomy 
procedures or other colorectal procedures. Readmissions for directly adhesion-related 
complications were the least frequent for patients who underwent an appendectomy, 
151/7 385 (2.0%). Patients who underwent a (sub)total colectomy were readmitted the 
most for directly adhesion-related complications, 121/802 (15.1%). 
 
Uni- and multivariate analysis 
In univariate analysis laparoscopic surgery was associated with a decrease in directly 
adhesion-related readmissions, HR 0.31 (95% CI 0.26 - 0.38). Parameters associated with an 
increased risk of directly adhesion-related readmissions were type of surgical procedure, 
malignancy as the indication for surgery, female sex and increasing age, (appendix table 1). 
In multivariate analysis laparoscopic surgery was associated with a decrease in directly 
adhesion-related readmissions, HR 0.52 (95% CI 0.42 - 0.64). In multivariate analyses 
parameters that significantly and independently increased the risk of directly adhesion-
related readmissions were type of surgical procedure and female sex, (table 4). 
 
Discussion 
The implementation of laparoscopic surgery for colorectal procedures has resulted in a 
decrease of adhesion-related readmissions. Of 16 524 patients who underwent colorectal 
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Table 3 Directly adhesion-related readmission rates per common colorectal procedure 
Index surgery Total number 










  Open 
  Laparoscopic  
 
4 115 (55.7%) 
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  Open 
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12 069 (73.0%) 















the five years following surgery for any adhesion-related complication. Readmission rates 
for any adhesion-related complication were one in four patients in laparoscopic surgery and 
one in three patients in open surgery. Directly adhesion-related readmissions were reduced 
threefold in laparoscopic surgery compared with open colorectal surgery. Possibly 
adhesion-related readmissions and reoperation rates were lower in laparoscopic surgery 
but the decrease was less striking. Despite the decrease in adhesion-related readmissions 
after laparoscopic surgery, the burden of adhesions in colorectal surgery remains 
substantial. 
 
A major strength of this study is the specifically chosen colorectal population, for which the 
potential reduction of adhesion-related complications by implementation of laparoscopy 
could be most important. Colorectal surgery is frequently performed for multiple common 
diagnoses and is notorious for the greatest risk of inducing adhesion-related 
complications.7,17 The promise that laparoscopy holds for this population is amplified by the 
fact that at present laparoscopy has become the preferred approach for many colorectal 
procedures.20,21 Previous studies reported a lower incidence of adhesions after laparoscopic 
colorectal surgery.1,10 However, the effect of the broad implementation of a laparoscopic 
approach in colorectal surgery on clinically relevant parameters remains unknown. This 
study is the first to provide insight into differences between open and laparoscopic surgery 
on clinically and patient relevant outcome parameters. 
 
Another strength is the use of a population database that reports the impact on adhesion-
related readmissions of the implementation of laparoscopy in colorectal surgery. Data from 
the NHS lend themselves perfectly for population based studies due to Scotland’s’ 
geographically self-contained location with centralized reporting. Data from the NHS are 
validated annually by an audit of 1% of local hospital data compared with centrally held 
data.22 
 
To assess the true effect of adhesions on hospital readmissions all readmissions were 
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Table 4 Multivariate analysis for directly adhesion-related readmissions 
 N/N total (%) HR (95% CI) P-value 
Approach 
  Open 
  Laparoscopic  
 
 
901/12 069 (7.5%) 
107/4 455 (2.4%)  
 
Ref. 
0.52 (0.42 - 0.64) 
 
 
p < 0.005 
Age 
 
 0.99 (0.99 - 1.00)  p = 0.084 
Sex 
  Male 
  Female 
 
 
474/8 554 (5.5%) 
534/7 969 (6.7%) 
 
Ref. 
1.23 (1.08 - 1.39) 
 
 
p < 0.005 
Indication surgery 
  No malignancy 
  Malignancy colon 
  Malignancy rectum 
 
 
508/11 088 (4.6%) 
284/3 457 (8.2%) 
216/1 979 (10.9%) 
 
Ref. 
1.12 (0.93 - 1.36) 
1.08 (0.85 - 1.37) 
 
 
p = 0.236 
p = 0.549 
Type of colorectal procedure 
  Appendectomy 
  Left hemicolectomy  
  Right hemicolectomy  
  (sub)total colectomy 
  Sigmoidectomy 
  Rectal prolapse 
  Rectal excision 
  Colostomy 
  Other 
 
151/7 385 (2.0%) 
27/395 (6.8%) 









2.96 (1.90 - 4.61) 
3.24 (2.49 - 4.21) 
6.69 (5.17 - 8.65) 
4.06 (3.00 - 5.49) 
1.17 (0.59 - 2.33) 
4.97 (3.73 - 6.63) 
5.00 (3.67 - 6.82) 
2.80 (1.89 - 4.16) 
 
 
p < 0.005 
p < 0.005 
p < 0.005 
p < 0.005 
p = 0.653 
p < 0.005 
p < 0.005 
p < 0.005 
 
 
explicit reference to adhesions were classified as being directly related to adhesions. 
Unfortunately, adhesions can only be confirmed during reoperation. An explicit reference 
to adhesions for patients who are not operated during their readmission is therefore rare. 
Using this strict definition, only the verifiable effect of adhesions was studied, probably 





The proportion of patients in this study that underwent a laparoscopic procedure seems 
relatively low. In our study one in three patients underwent laparoscopic surgery between 
June 2009 and June 2011, while in the Netherlands in 2018 over 75% of all colorectal 
resections were performed using a laparoscopic approach.20 The relatively low rate of 
laparoscopic procedures might indicate that laparoscopic surgery was only utilized for 
selected cases and that surgeons are still in their laparoscopic learning curves. Moreover, 
due to the retrospective design of this study with five year follow-up, current practice has 
evolved with changes in laparoscopic techniques (e.g. extracorporeal versus intracorporeal 
anastomosis23, trans anal total mesorectal excison (TA-TME)24,25) potentially resulting in less 
peritoneal wound surface, decreased adhesion formation and subsequent complications. 
Over the past few decades laparoscopy became the standard approach for routine 
procedures and also increasingly for more difficult procedures. When correcting for the type 
of colorectal procedure performed, laparoscopic surgery was associated with less directly 
adhesion-related readmissions compared with open surgery in appendectomies, right 
hemicolectomies and sigmoidectomies. When reviewing the Kaplan-Meier curves critically 
for directly adhesion-related readmissions of all other colorectal procedures, readmission 
rates seem to differ visually but differences between groups were not statistically 
significant. Differences between groups may not be statistically significant due to the 
relatively low number of patients in these groups. In patients with a (sub)total colectomy, 
directly adhesion-related readmission rates do not seem to differ between groups, (14.9% 
in laparoscopic and 15.1% in open procedures). (Sub)total colectomies are associated with 
a large peritoneal wound surface regardless of the surgical approach. The reduction in 
peritoneal wound surface in laparoscopic procedures compared with open is relatively 
small. Therefore, adhesion formation might not be significantly impacted by a laparoscopic 
approach in this procedure. With the increase of laparoscopic procedures and the 
improvement of laparoscopic techniques, the overall impact of laparoscopic surgery on 
adhesion-related readmissions on population level is likely to increase. 
 
Peritoneal wound surface is not the only parameter that predicts adhesion formation. Other 
factors that predict adhesion formation are intra-operative blood loss, indication for 
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infections.2,26,27 Laparoscopic surgery reduces peritoneal wound surface as well as intra-
operative blood loss but, often prolongs operative time. Type of procedure and incidence 
of post-operative intra-abdominal infections are not affected by a laparoscopic or open 
approach. We were not able to correct for intra-operative blood loss, operative time and 
incidence of post-operative complications, since these data were not included in the NHS 
database. To the authors’ knowledge no other nationwide database holds more detailed 
information on adhesion-related readmissions. 
 
In multivariate analysis laparoscopic surgery was associated with a lower rate of directly 
adhesion-related readmissions (HR 0.52). More extended surgical procedures and female 
sex were associated with an increase in directly adhesion-related readmissions (table 4). 
The increase in adhesion-related readmissions in women is explained by fertility problems 
caused by adhesions. Adhesions are a major contributor to sub- or infertility in woman, 
reoperations for these indications increase the rate of readmissions for adhesion-related 
causes.3 
 
A potential limitation that needs to be discussed is the lack of data on emergency 
procedures compared with elective procedures. Emergency surgical procedures are often 
complicated by severe infections or perforations of the bowel due to disease itself of 
peritoneal inflammation. For these reasons emergency abdominal procedures are more 
prone to adhesion formation. Unfortunately, data on emergency procedures were not 
available for analysis and therefore could not be included. 
 
The colorectal SCAR study by Parker et al. in 2004, reported a four year readmission rate for 
directly adhesion-related readmissions after open colorectal surgery of 4.8%.2 In the 
present study 7.5% of all patients after open colorectal surgery were readmitted for directly 
adhesion-related complications in the 5 years following surgery, so readmission rates for 
patients who underwent open colorectal surgery did not decrease in the past few decades 
and might even have increased. An increase in adhesion-related readmissions after open 
colorectal surgery can possibly be explained by selection of less complex cases for 




and extensive surgical procedures, open surgery is still considered more appropriate. Part 
of the adhesion formation might therefore be explained by the peritoneal inflammatory 
response induced by the extensive surgical procedure or disease itself, rather than from the 
surgical approach. This hypothesis is supported by our data on extensive surgical 
procedures (i.e. (sub)total colectomy); no difference was observed in directly adhesion-
related readmissions between the open and laparoscopic cohort.  
 
In a study on adhesion formation after colorectal surgery confirmed by second-look surgery, 
laparoscopy reduced adhesion formation primarily to the ventral wall.1 However, three in 
five patients still developed adhesions after laparoscopic surgery. A reduction in the extent 
of adhesion formation is not guaranteed to reduce adhesion-related complications.11 
However, a decrease in adhesion formation and severity will likely decrease the need for 
(extensive) adhesiolysis during reoperations and therefore reduce adhesiolysis-related 
complications, e.g. enterotomies. Some studies reported lower incidence rates of ASBO 
after laparoscopic surgery. However comparative trials report no difference in incidence 
rates.12-16 In the present study laparoscopic surgery was associated with decreased 
incidence rates of directly adhesion-related readmissions compared with open surgery, 
2.4% vs. 7.5% respectively. Moreover, in the laparoscopic cohort less patients were 
readmitted for reoperations potentially complicated by adhesions compared with the open 
cohort, 10% vs. 17%. Data from the present study support the hypothesis that laparoscopic 
surgery reduces adhesion-related post-operative morbidity. However, a substantial 
proportion of patients who underwent laparoscopic colorectal procedures were still 
readmitted for adhesion-related complications.  
 
This study provides solid evidence that, contradictory to common opinions9, laparoscopic 
surgery does not ensure complete banishment of adhesion-related complications. Still over 
one in twenty patients were readmitted for directly adhesion-related complications, one in 
six for possibly and one in seven for a reoperation potentially complicated by adhesions in 
the five years following index laparoscopic colorectal surgery. Given the high impact of 
adhesion-related readmissions on a population level, better techniques are necessary to 
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barriers have proven to be safe to use, reduce adhesion formation and are cost-effective in 
routine use after open surgery.28,29 Despite these results adhesion barriers are still seldom 
applied.30 Most of the currently available adhesion barriers are developed and studied for 
open surgery. Future research should focus on barriers that are easy to apply in laparoscopic 
surgery (e.g. sprays, gels) and can be manufactured on a large scale at relatively low costs. 
Most of the current trials only report adhesion-related complications as a secondary 
endpoint with a short term follow-up, resulting in a suboptimal research design for 
adhesion-related complications. Results from the current study show that over 65% of 
directly adhesion-related readmissions occur in the first 2 years after index surgery. Future 
studies on adhesion prevention strategies should be powered on relevant adhesion-related 
outcome parameters and should focus on long -term follow-up to determine the true effect 
on the burden of adhesions. 
 
Conclusion 
Laparoscopic surgery is associated with a decrease in adhesion-related readmissions. 
However, the incidence of adhesion-related readmissions remains high, even in 
laparoscopic colorectal surgery. The risk of adhesion-related readmissions in particular was 
determined by the extent of the surgical procedure (either open or laparoscopic). In 
multivariate analysis laparoscopic surgery was associated with a decrease in adhesion-
related readmission rates (HR 0.52), while more extended colorectal surgical procedures 
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 In-hospital costs of an admission for 






Previous research on the costs of treatment for ASBO is outdated and often based on 
reimbursements, rather than true healthcare provider costs of the admission and related 
interventions. An accurate estimate of the true costs of treatment is necessary to 
understand the healthcare burden and to model cost-efficacy of adhesion strategies. The 
aim of this study was to provide an accurate cost estimate of the in-hospital costs for 
treatment of adhesive small bowel obstruction (ASBO) using micro-costing methods. 
Methods 
Consecutive patients admitted for ASBO to the Radboud University Medical Center from 
November 2013 to November 2015 were included. An episode of ASBO was defined as an 
admission for SBO with operative confirmation of adhesions or after radiological exclusion 
of other causes for SBO. For the purpose of generalization we used the costs of medication 
and interventions as provided by the Dutch Healthcare Authority and only if these were not 
available local hospital costs. We evaluated costs separately for operative and non-
operative treatment for ASBO. 
Results 
During the study period 39 admissions for ASBO were eligible for analysis. An operative 
treatment was required in 19 patients (48.7 %). Mean hospital stay for ASBO with operative 
treatment was 16.0 ± 11 days versus 4.0 ± 2.0 days for non-operative treatment (P = 0.003). 
A total of 12 patients developed complications, 2 in the non-operative group (10 %) and 10 
in the operative group (52.6 %; P = 0.004). Overall costs for an admission for ASBO with 
operative treatment were €16 305 (SD €2 513), and for non-operative treatment € 2 277 
(SD € 265) (p = <0.001). The highest expenditure with operative treatment for ASBO was 
made for ward stay (mean €7 856, SD €6 882), OR time (mean €2 6845, SD €1 434), ICU stay 
(mean €2 183, SD €4 305) and (parenteral) feeding costs (mean €1 797, SD €2 070). A table 
with correction coefficient to correct for differences in price levels for goods and services 









The in-hospital costs of an admission for ASBO are higher than previously thought. These 
costs can be used to guide hospital reimbursement policy and for the development of a 






Adhesive small bowel obstruction (ASBO) is the most common pathology of the small bowel, 
and frequently results in surgical emergencies.1 In a national audit in the UK small bowel 
obstructions accounted for 51 % of all emergency laparotomies.2 In the United States both 
adhesiolysis and small bowel resection appeared in the top seven of emergency general 
surgeries, that count for 80% of morbidity and death related to emergency surgery.3 The 
supplementary data from this report confirmed that small bowel obstruction was the most 
common diagnosis in both procedures.3 Part of the huge burden small bowel obstructions 
cause to patients and the healthcare system might be preventable.4,5  
Post-operative adhesions are the cause of small bowel obstruction in 60 % of cases.6 
Application of an adhesion barrier during the index operation can reduce the risk of 
adhesion formation and subsequent clinical complications of adhesions.4 In a meta-analyses 
of randomized controlled trials, application of a hyaluronate carboxymethylcellulose barrier 
reduced the risk of reoperations for ASBO after colorectal surgery with RR 0.49, 95 % CI 
0.28–0.88.4 Despite the evidence for efficacy these barriers are seldom applied.7 A reason 
why barriers are often not applied is that policy makers question their cost-effectiveness 
and consider routine application too expensive.8,9 Remarkably, there is little data on the 
financial implications of adhesion-related complication such as ASBO that can guide 
policymakers in developing guidance for reimbursement, management, and prevention of 
this condition. The studies that modelled cost-effectiveness of adhesion barriers have used 
incomplete estimates or the negotiated reimbursement prices for treatment of ASBO, 
rather than true healthcare provider costs.7,8,10 By using such incomplete estimates and 
reimbursement prices the conclusions about cost-effectiveness of barriers might be 
falsified. Moreover, concerns have been raised that reimbursement prices indeed are too 
low, resulting in a net loss for hospitals treating patients with ASBO.11  
In a recent study, the hospital costs of patients undergoing an emergency laparotomy in 
general were estimated at €15 500 per patient, which is on average €7 000 more than its 
reimbursement.11 The estimate was based on operating room time, ICU and hospital stay, 
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underestimate the actual healthcare provider costs. The costs of emergency laparotomies 
were also not specified for ASBO in this study.11 More accurate and up to date data is 
necessary to provide a better guide to reimbursement policies, adhesion prevention, and 
unveil opportunities for cost reduction.  
In the present study we modelled the costs of an admission for ASBO based on accurate 
data that in addition to the operating room times, ICU and ward stay comprised full detailed 
information on all relevant interventions made during the admission, including medication, 
parenteral feeding, imaging studies, and laboratory studies.  
 
Methods  
All consecutive patients admitted with ASBO to the Radboudumc between November 2013 
and November 2015 were eligible for inclusion. A waiver for ethical approval was obtained 
by local institutional review board after review of the protocol. To identify cases, the 
hospitals’ discharge registry was searched for patients with a reimbursement code for small 
bowel obstruction. The Radboudumc is a university teaching hospital in Nijmegen, the 
Netherlands, with complete electronic patient files. Electronic patient files of the identified 
records were reviewed for an admission for ASBO during the study period. ASBO was 
defined as an episode with operative confirmation of adhesions, or in the non-operative 
group as an episode of postoperative SBO in which other potential causes of bowel 
obstruction were excluded by appropriate means. Patients who were treated non-
operatively received tube decompression and no oral feeding. Operative treatment of ASBO 
consisted of an explorative laparotomy with cleaving of adhesions and if necessary partial 
resection of small bowel. None of the patients had laparoscopic cleaving of adhesions. 
Complications were defined according to the criteria of the International Classification of 
Diseases, Tenth Revision, the National Nosocomial Infections Surveillance System, the 
Center for Disease Control and Prevention, or according to the decision of the senior 
medical staff of the department. Complications were categorized according to the Clavien-






The total costs of the admission were divided in nine categories: operation (materials and 
occupancy of operating room), medication, radiology, laboratory, microbiology, ward stay, 
ICU days, feeding, and blood products administered during admission. All data needed for 
an accurate estimate of admission costs were derived from the electronic patients file. A 
standardized price list from the Dutch Healthcare Authority was used for the calculation of 
costs for occupancy of operating room, medication, radiology, laboratory, microbiology, 
ward stay, ICU stay, feeding and blood products.13 No standardized price list was available 
for materials used during the operation. Therefore we used local prices for operation 
materials instead.  
The price for occupancy of the operating room was based on the total anaesthesia time, 
and a standardized price of €16.70 per minute. Medication costs comprised the costs of all 
medications prescribed during the admission. The costs of medication were updated per 
April 2016.14 Costs for radiology, laboratory, microbiology were all calculated in accordance 
to the table provided by the Dutch healthcare authority.13 The prices for ICU, ward stay, 
feeding and blood products were based on the 2015 version of the manual for costs 
research.15 The costs of a day on the ICU were determined at €2 015 per day. The costs of 
ward stay were determined at €435 per day. The prices for ward stay and ICU comprise 
honorarium for medical specialists, the costs for a resident managing the ward, nursing 
personnel, consumable goods, housing and overhead. The ICU price also counted for 
expenditures on respiratory support.15 Oral feeding was also counted for in the price of 
ward stay. Additional expenditures for other types of feeding, such as parenteral feeding, 
were calculated separately and presented under the feeding category.  
The average costs of operation materials were €155 if no bowel resection was performed 
and €436 if bowel resection was performed. The difference in price of materials was mainly 
attributable to the use of stapling devices. A table of correction coefficients was added to 
allow for quick comparison of costs between different countries.16 These correction 
coefficients are published by the European Union’s statistics department (EUROSTAT) and 
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between countries. Thus, these coefficient provide a rough estimate of the prices for 
treatment of ASBO in other countries than the Netherlands. For convenience the 
coefficients as published by EUROSTAT were adjusted setting the Dutch price levels as the 
reference standard.  
Data and statistical analysis  
Baseline data consisted of patients age, sex, Charlson comorbidity index, ASA classification 
and the number of previous abdominal operations. Comparison was made between 
patients undergoing operative treatment and non- operative treatment using a Chi-square, 
Fisher’s exact test, independent t-test or Mann-Whitney U test where appropriate. 
Continuous variables are presented as means with standard deviation, or medians with 
interquartile range (25–75) if non-normal distribution. Dichotomous or categorical variables 
are presented as absolute numbers and percentages. P < 0.05 was considered significant. 
All analyses were performed using SPSS version 23.0 (Armonk, NY: IBM Corp).  
 
Results  
From the hospital registry we identified 185 cases with a code of SBO. We excluded 49 
patients because they were not admitted but only seen on the outpatient clinic. A total of 
97 admitted patients were excluded because adhesive aetiology of SBO was not confirmed 
(Fig. 1). Thirty-nine patients had a total of 46 admissions for ASBO during the study period. 
We excluded 7 admissions because patients were transferred to other hospitals for further 
treatment of ABSO. A total of 39 admissions of ASBO during the study period were included 
in the analysis (Fig. 1). Operative treatment of ASBO was required in 19 admissions (48.7%), 
20 patients were managed non-operatively (51.3%). Indications for operative treatment 
were failure of nonoperative management in 14 patients (73.7%), suspected strangulation 
in 4 patients (21.0%), and 1 patient had a diagnostic laparotomy (5.2%). Patient 
characteristics are shown in Table 1. There were no significant differences between groups 
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Table 1 Baseline patient characteristics 
 Conservative treatment 
(n = 20) 
Operative treatment 




63.6 ± 15.7 63.4 ± 14.6 0.962 
Female 
 
12 (60.0%) 14 (73.7%) 0.365 
Previous abdominal operations a 
 
 
2 (IQR 2-3) 1 (IQR 1-3) 0.111 
Charlson score 
 
3.3 ± 2.4 3.6 ± 1.7 0.568 
ASA score 
  Class 2 











  Home 









Values are presented as mean ± standard deviation or N (percentage) 
a median + inter quartile range (IQR) 
Of 19 operated patients, 9 were operated within the first 24 h. Median time from admission 
till operation was 2 days (IQR 1–4 days). One patient was operated after 16 days. This 
patient had developed an adhesive small bowel obstruction after a previous appendectomy, 
during late pregnancy. She was treated with parenteral feeding and had explorative 
laparotomy delayed to be combined with caesarean section at 32 weeks of gestational age. 
Her bowel obstruction quickly resolved after laparotomy, and mother and child were 
discharged in good condition 4 days after surgery. 
Operative treatment of ASBO led to a mean hospital stay of 16.0 days (SD 11.0 days) while 
non-operative treatment of ASBO led to a mean hospital stay of 4.0 days (SD 2.0 days  
P = 0.003). A total of 12 patients developed complications, two in the non-operative group 
(10.0 %) and 10 in the operatively treated group (52.6 %; P = 0.004). Complications in the 




patient in the operative group developed a staphylococcal sepsis, for which prolonged ICU 
admission was indicated. Other complications in the operative group comprised pneumonia 
(n = 2), wound infection (n = 2), intra-abdominal abscess formation (n = 1), de novo atrial 
fibrillation (n = 1), urinary tract infection (n = 1), bacteremia (n = 1), and delirium (n = 1). 
Two operative patients had a second-look laparotomy. In the first patient almost the entire 
small bowel was entrapped in the adhesions and appeared ischemic at the initial explorative 
laparotomy. Because there was doubt about the reversibility of this bowel ischemia a 
second look laparotomy was performed the next day, at which the bowel had normal 
appearance and peristalsis. The second patient underwent a second look laparotomy to 
inspect the anastomosis made following bowel resection at initial laparotomy. The 
indication for this second look was made after the patients became septic on the ICU and 
an anastomotic leakage was expected based on clinical evaluation. At second look on day 3 
a sufficient anastomosis without signs of leakage was found. Origin of sepsis remained 
unsure, but a pulmonary origin was suspected after negative second look. The patient fully 
recovered with intravenous antibiotic treatment.  
Costs 
Mean hospital stay for ASBO with operative treatment was 16.0 ± 11 days versus 4.0 ± 2.0 
days for non-operative treatment (P = 0.003), resulting in a mean overall costs of €16 305 
(SD €2 513) and €2 277 (SD €265) respectively. Mean costs were significantly different 
between both groups (P < 0.005). Costs of the different components are shown in Table 2. 
For both treatment strategies, ward and ICU stay were the largest component of costs  
(Fig. 2). The costs for operative treatment were €14 315 (SD €3 352) in uncomplicated cases 
and €18 095 (SD €3 776) in complicated cases, the difference was not significant. Four of 
the patients in the operative treatment group underwent bowel resection during 
laparotomy (21.5%). Mean costs were significantly different between operative treatment 
with or without bowel resection, €25 395 versus €13 058 respectively. The additional 
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Correction coefficients  
An overview of correction coefficients is presented in Table 3. The correction coefficients 
give a global impression of differences in price levels between countries, and were 
standardized to the Dutch price levels. For example the correction coefficient for the United 
Kingdom is 1.29. This means that prices for goods and services in the United Kingdom are 
generally 1.29 times higher than the costs for the same goods and services in the 
Netherlands. The price for a non-operative treatment for ASBO in the United Kingdom are 
roughly estimated at 1.29*€ 2 227 = €2 872.  
 Table 2 Comparison of costs for operative vs. non-operative management for ASBO 
 
Discussion  
Adhesive small bowel is associated with high morbidity and costs. The average costs for a 
non-operative episode were over €2 000 and for a surgical episode over €16 000. The 
majority of costs were related to ward and ICU stay. The costs for operative treatment of 
ASBO determined in this study were comparable to the €15 500 Shapter et al. reported in 
their estimation of the costs for an unspecified emergency laparotomy.11 In their study, 
the costs for an emergency laparotomy were estimated from only the ICU stay, hospital 
stay, and duration of the operation. In our study these three parameters made up for only  
 Operative Non-operative P-value 
 Mean SD Mean  SD  
Operation - anesthesia time € 2 684.71 € 1 434.29 NA NA NA 
Operation - materials  € 259.90 € 148.74 NA NA NA 
Medication € 634.13 € 816.08 € 99.34 € 93.17 P = 0.011 
Feeding € 1 797.37 € 2 069.71 € 91.65 € 288.56 P < 0.005 
Blood products € 31.74 € 100.79 NA NA NA 
Radiology € 510.00 € 467.70 € 154.92 € 159.88 P < 0.005 
Laboratory € 324.49 € 223.20 € 69.82 € 38.94 P < 0.005 
Microbiology € 69.70 € 98.10 € 11.06 € 37.34 P = 0.023 
Ward € 7 855.74 € 6 881.54 € 1 850.47 € 913.92 P < 0.005 
ICU € 2 183.00 € 4 304.93 NA NA NA 




Figure 2 Pie chart of treatment costs for ASBO 
77% of total hospital costs in operative cases, indicating that Shapter’s estimate is too low. 
Local differences in price levels between the United Kingdom and the Netherlands might 
account for the discrepancy, implicating that true costs in the United Kingdom are higher. 
Indeed the correction coefficient for the United Kingdom was 1.29, indicating that goods 
and services are generally more expensive in the United Kingdom as compared to the 
Netherlands. The most important additional expenditure in operative patients is the costs 
for parenteral feeding. Parenteral feeding made up for 11% of total healthcare costs in our 
group. The costs for operative treatment of ASBO are much higher than reimbursements 
for emergency laparotomies found by Shapter et al., implicating that hospitals in the United 
Kingdom bear a financial loss for treating patients with ASBO.11  
Correction coefficients can be used to calculate a quick estimate of the costs in a different 
country. However, a more precise estimate would require to recalculate the prices from the 
different components as listed in Table 2. An important limitation to the correction 
coefficients is that they are not specific for healthcare services.16 Attempts to create more 
specific coefficients for healthcare have been complicated by the fact that for most 
condition not only the price levels of goods and services vary between countries, but also 
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Table 3 Correction coefficients for differences in prizes of goods and surfaces 































United Kingdom 1.29 
United States 1.05 
Source: Eurostat (http://ec.europa.eu/eurostat/web/civil-servants-remuneration/correction-coefficients)  




differences in ASBO treatment decreasing over recent years by the use of international 
guidelines. Adherence to the international Bologna guidelines for treatment of ASBO in this 
study was high.1 As a rule, a non-operative treatment was initially instigated, unless there 
were signs of strangulation or ischemia. Most operative patients underwent surgery within 
3 days as suggested by these guidelines. 
The cost estimates in our study are useful to guide reimbursement policies and model cost-
effectiveness of adhesion barriers. The study had a high adherence to the international 
guidelines and the morbidity found was comparable with reported morbidity in 
literature.6,11,18,19 However, the retrospective nature of the study and its low power 
impaired analyses of the impact of  factors such as complications on costs.  
The relative small sample size is explained by the methodology used in this study. We 
included only recently admitted patients from our own institution with high ascertainment 
of adhesive etiology to enable the micro-costing method. Micro-costing is the gold standard 
for accurately defining healthcare provider costs, but seldom applied because of the large 
quantity of data that needs to be collected from each patient.15 In our institution all patient 
data, including medication, radiology orders etc. are entered into the electronic patient file, 
which enabled this highly accurate method of cost estimation. For the same reasons the 
number of patients undergoing operative treatment was relative high in our cohort. In 
previous literature, non-operative treatment is successful in more than 70% of patients with 
ASBO.20,21 We only included patients with high ascertainment of adhesive aetiology and in 
many of the non-operative cases the presence of adhesions could not be proved. We 
included only patients with high ascertainment of ASBO in this study because costs rather 
than treatment result was the primary endpoint. Without additional imaging or a history of 
previous episodes of ASBO, adhesions count for only 60% of all cases of post-operative 
bowel obstruction.6 The other 40 % might have somewhat different clinical course and 
costs.  
We also excluded a larger number of paediatric patients with Hirschsprung’s disease. Our 
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has no separate reimbursement code in the Dutch reimbursement system, it often received 
the same code as used for bowel obstruction.22  
Our results show that the largest part of the expenditures in treatment of ASBO are related 
to the duration of hospital stay. Several studies have reported a reduced length of stay and 
lower incidence of postoperative ileus when adhesiolysis is performed through laparoscopy 
instead of laparotomy.23-25 However, no randomized trials have been performed. In general, 
it will be more difficult to perform laparoscopic surgery on patients with multiple operations 
in history and when the bowel is very distended, increasing the risk of bowel injuries.26 In 
the study of Wullstein et al. incidence of bowel injuries was higher during laparoscopic 
surgery for ASBO compared with open surgery, despite a possible favourable selection in 
laparoscopic cases.24 Thus, the results that laparoscopic surgery for ASBO reduces hospital 
stay and subsequent costs should be interpreted with caution.  
The results of our study have important implications for policies regarding reimbursements. 
Reimbursement for operative cases of ASBO is generally too low.11 The costs that we found 
for operatively treated episodes of ASBO were also much higher than the estimate Wilson 
applied in a cost-effectiveness model for adhesion barriers.8 With the higher costs we found 
for operative cases of ASBO, it becomes more likely that adhesion barriers are cost effective 
in high risk procedures such as colorectal surgery. Adhesion barriers are proven to be 
effective in reducing the risk of reoperation for ASBO in randomized controlled trials.4,5,27,28 
Moreover, a complete evaluation of cost-effectiveness of adhesion barriers should also 
count for other complications of adhesions, such as complications associated with 




The costs of an admission for ASBO are higher than reported in the previous literature. Our 
results can be used to guide reimbursement policy and the development of a cost-
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Bologna guidelines for diagnosis and manage-
ment of adhesive small bowel obstruction 
(ASBO): 2017 update of the evidence-based 
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Adhesive small bowel obstruction (ASBO) is a common surgical emergency, causing high 
morbidity and even some mortality. The adhesions causing such bowel obstructions are 
typically the footprints of previous abdominal surgical procedures. The present paper 
presents a revised version of the Bologna guidelines to evidence based diagnosis and 
treatment of ASBO. The working group has added paragraphs on prevention of ASBO and 
special patient groups. 
Methods 
The guideline was written under the auspices of the World Society of Emergency Surgery by 
the ASBO working group. A systematic literature search was performed prior to the update 
of the guidelines to identify relevant new papers on epidemiology, diagnosis, and treatment 
of ASBO. Literature was critically appraised according to an evidence-based guideline 
development method. Final recommendations were approved by the workgroup, taking 
into account the level of evidence of the conclusion. 
Recommendations 
Adhesion formation might be reduced by minimally invasive surgical techniques and the use 
of adhesion barriers. Non-operative treatment is effective in most patients with ASBO. 
Contraindications for non-operative treatment include peritonitis, strangulation, and 
ischemia. When the adhesive etiology of obstruction is unsure, or when contraindications 
for non-operative management might be present, CT is the diagnostic technique of choice. 
The principles of non-operative treatment are nil per os, naso-gastric, or long-tube 
decompression, and intravenous supplementation with fluids and electrolytes. When 
operative treatment is required, a laparoscopic approach may be beneficial for selected 
cases of simple ASBO. Younger patients have a higher lifetime risk for recurrent ASBO and 












This guideline presents recommendations that can be used by surgeons who treat patients 
with ASBO. Scientific evidence for some aspects of ASBO management is scarce, in particular 
aspects relating to special patient groups. Results of a randomized trial of laparoscopic 






Adhesive small bowel obstruction (ASBO) is one of the leading causes of surgical 
emergencies and in particular of surgical emergencies that require an emergent 
operations.1-4 In the UK, small bowel obstruction was the indication for 51% of all 
emergency laparotomies.2 Scott et al. reported on seven emergency surgical procedures 
that account for 80% of all general surgery emergency admissions, morbidity, deaths, and 
healthcare expenditures in the USA.3 Adhesive small bowel obstruction was the most 
common diagnosis for both the top 2 (small bowel resection) and top 5 (adhesiolysis) 
procedures.3 Post-operative adhesions are the leading cause of small bowel obstructions, 
accounting for 60% of cases.1 
ASBO causes considerable harm, resulting in 8 days of hospitalization on average and an in-
hospital mortality rate of 3% per episode.5-8 Between 20 and 30% of patients with adhesive 
small bowel obstruction require operative treatment.1,9-11 Length of hospitalization and 
morbidity depend on the need for surgical intervention. Average hospitalization after 
surgical treatment of ASBO is 16 days, compared to 5 days following non-operative 
treatment.12 Associated costs in a Dutch study in 2016 were estimated at €16 305 for 
surgical and €2 227 for non-operative treatment.12 
Although adhesive small bowel obstruction is a common condition, the prevention and 
treatment is often characterized by surgeons’ personal preferences rather than 
standardized evidence-based protocols. There is a large amount of conflicting and low-
quality evidence in publications regarding treatment of adhesive small bowel obstruction.  
Therefore, the World Society of Emergency Surgery (WSES) working group on ASBO has 
developed evidence-based guidelines to support clinical decision making in diagnosis and 
management of ASBO.11,13 In the present revision of these guidelines, all recommendations 
were updated according to the latest evidence available from the medical literature. 











The guideline was written under the auspices of the WSES by the ASBO working group. 
Systematic searches of the MEDLINE and Embase databases were carried out in October 
2016 using the keywords relevant to each section. Terms relevant to each section of the 
guideline were mapped to MEDLINE Medical Subjects Headings (MeSH) terms, as well as 
searched for as text items. Articles describing randomized controlled trials and systematic 
reviews were searched for using the methodological filters of the Scottish Intercollegiate 
Guidelines Network (http://www.sign.ac.uk/methodological-principles.html). The 
bibliographies of included articles were subsequently hand-searched for other relevant 
references, and experts in the field were asked if they found any relevant reports missing. 
Critical appraisal 
Articles selected to support recommendations were assessed using the levels of evidence 
as published by the Centre for Evidence-Based Medicine of the University of Oxford 
(www.cebm.net; Table 1). Articles were classified according to the type of article and 
individually assessed for methodological quality using the GRADE method as proposed by 
the GRADE working group. That working group has developed a common, sensible, and 
transparent approach to grading the quality of evidence and strength of recommendations 
(http://www.gradeworkinggroup.org). The main literature on which the conclusion for each 
relevant topic is based is stated with the conclusion, accompanied by the level of evidence 
(Table 2).14,15  
Conclusions and recommendations are graded according to the level of evidence from 
strong (“there is strong evidence for,” level A) to weak (“we cannot be confident,” level D). 
Recommendations were graded as strong recommendations (level I) or weak 
recommendation or suggestions (level II). Recommendations were considered strong 
recommendations if there is sufficient evidence (level A or B) demonstrating that the 
benefits of an intervention are of clinical importance and clearly outweigh the harm of the 
intervention. A concept guideline was sent to all involved for comment and approval after 








The term “peritoneal adhesions” or simply “adhesions” is defined as fibrous tissue that 
connects surfaces or organs within the peritoneal cavity that are normally separated. Such 
adhesions are the results of a pathological healing response of the peritoneum upon injury, 
as opposed to the normal “ad integrum” repair.16 Typical adhesions form after peritoneal 
injury from abdominal surgery. Other conditions that may cause peritoneal injury resulting 
in adhesion formation include radiotherapy, endometriosis, inflammation, and local 
response to tumors. Adhesions from a non-operative etiology are often part of a more 
complex pathology that can cause chronic pain and complications as the result of adhesions 
and other mechanisms.17 Management of chronic abdominal complications by adhesiolysis 
is controversial.18,19 The scope of the present guideline is limited to diagnosis and 
management of acute bowel obstructions. 
Adhesive small bowel obstruction 
Small bowel obstruction is a surgical emergency in which the obstruction of the small 
intestine hinders passage of intestinal contents. Small bowel obstruction is characterized by 
abdominal pain, vomiting, distention, and constipation. Adhesions are the single most 
common cause for small bowel obstruction.1,20 Nonadhesive etiologies of bowel obstruction 
include incarcerated hernias, obstructive lesions (malignant and benign), and a number of 
infrequent causes for bowel obstruction such as bezoars, inflammatory bowel disease, and 
volvulus.21-25 Definitive confirmation of the adhesive etiology of bowel obstruction is made 
during operative treatment. Methods to confirm the adhesive etiology of bowel obstruction 
non-invasively include a history of previous episodes of bowel obstruction by adhesions or 
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Table 1 Classification of evidence per article 
Level of 
evidence 





Systematic review/meta-analysis of at least 2 independently performed level A2 studies 
A2 Double-blind controlled 
randomized comparative 
clinical trial of good study 
quality with an adequate 
number of study participants 
 
Diagnostic test compared to reference test; criteria and 
outcomes defined in advance; assessment of test results by 
independent observers; independent interpretation of test 
results; adequate number of consecutive patients enrolled; 
all patients subjected to both tests 
B 
 
Comparative studies, but 
without all the features 
mentioned for level A2 
(including patient-control 
studies, cohort studies) 
 
Diagnostic test compared to reference test, but without all the 
features mentioned in A2 
 
C Noncomparative studies 
 




Adhesiolysis refers to releasing adhesions either by blunt or sharp dissection during surgery. 
It can be the primary indication for an operation, as in a reoperation for small bowel 
obstruction caused by adhesions. Adhesiolysis is also performed during reoperations for 
indications not related to adhesions in order to obtain sufficient access to the operative 
field. Complicated adhesiolysis refers to the event of inadvertent injury while performing 
adhesiolysis. Injuries during adhesiolysis are most frequently made to the bowel. These 




– Seromuscular injury: injury to the visceral peritoneum (serosa) and smooth muscle layer 
of the bowel. The lumen of the bowel or leakage of bowel contents is not visible.  
– Enterotomy: a full thickness injury to the bowel. The mucous layer or lumen of the bowel 
is visible, or there may be leakage of intestinal contents.  
– Delayed diagnosed perforation: bowel injuries made during surgery that initially go 
unrecognized. Typically, the abdomen is closed at the end of procedure with the bowel 
injury still in place, causing patients to deteriorate during the postoperative course.  
 
Table 2 Grading of the conclusions and recommendations according to the level of 
evidence and strength of recommendation 
Level Conclusion based on 
A Systematic review (A1) or at least 2 independent studies with evidence level A2 
(‘there is evidence that …’) 
 
B One study with evidence level A2 or at least 2 independent studies with evidence level B 
(‘it is likely that …’) 
 
C One study with evidence level B or level C 
(‘there are indications that …’) 
 
D Expert opinion 
(‘the working group recommends …’) 
 
Level Recommendation 
I Strong recommendation  
 












The risk of SBO is highest following colorectal, oncologic gynecological, or pediatric 
surgery.1,26-28 One in ten patients develops at least one episode of SBO within 3 years after 
colectomy.7 Reoperations for ASBO occur in between 4.2 and 12.6% of patients after 
pediatric surgery patients, and 3.2% of colorectal patients.1,29 Recurrence of ASBO is also 
frequent; 12% of non-operatively treated patients are readmitted within 1 year, rising to 
20% after 5 years. The risk of recurrence is slightly lower after operative treatment: 8% after 
1 year and 16% after 5 years.30 
Classification of adhesions 
The most frequently used classification of adhesions in general surgery is the adhesion score 
according to Zühlke et al. (Table 3).31 The score is based on the tenacity and some 
morphologic aspects of the adhesions. The merits of this score are that it is easy to use and 
classifications are self-explanatory to most surgeons and gynecologists. The major 
drawback to the score is that it does not measure the extent of adhesions and that tenacity 
of adhesions can vary between different parts of the abdomen. The most used grading 
system in gynecological surgery is the American Fertility Society (AFS) score.32 The score is 
designed for grading adhesions in the small pelvis. Adhesions are scored for extent and 
severity at four sites: right ovary, right tube, left ovary, and left tube. The scores for the right 
and left side are summed, and the final AFS score is the score for the side with the lowest 
summed score while discarding the score for the other side. Thus, a patient with an AFS 
score of 0 can still have adhesions. Further critiques for this score include a relatively low 
inter-observer reproducibility.33 A modified AFS has therefore gained popularity in more 
recent studies.34  
A recently introduced score by the ASBO working group is the peritoneal adhesion index 
(PAI), which measures tenacity on a 1–3 scale at 10 predefined sites, to integrate tenacity 
and extent of adhesions in a single score (Fig. 1).35 This score is the only score that has been 




during adhesiolysis.36 A limitation to all these adhesion scores is that they are only 
applicable to operative cases because they require operative assessment. Furthermore, 
none of them has yet been validated to correlate with the long-term risk for (recurrence of) 
adhesion-related complications.  
Table 3 Classification of adhesions according to Zühlke et al. 
Grade Definition 
0 No adhesions or insignificant adhesions 
 
1 Adhesions that are filmy and easy to separate by blunt dissection 
 
2 Adhesions where blunt dissection is possible but some sharp dissections necessary, beginning 
vascularization 
 
3 Lysis of adhesions possible by sharp dissection only, clear vascularization 
 
4 Lysis of adhesions possible by sharp dissection only, organs strongly attached with severe 
adhesions, damage to organs hardly preventable 
 
A different type of classification in the field of ASBO is risk stratification that predicts the 
need for surgery. Zielinski reported on three radiological and clinical signs that correlate 
with the need for surgical exploration: mesenteric edema, absence of the small-bowel feces 
sign, and obstipation. The score was validated in 100 cases of ASBO and predicted the risk 
with a concordance index of 0.77.37 A more accurate model was reported by Baghdadi et al. 
This score comprises radiological findings, sepsis criteria, and comorbidity index. Although 
the score is somewhat complex to assess, it correlates with an area under the curve of 0.80 
in a validation study of 351 cases.38 
Prevention 
Surgical technique 
The main principles of prevention of adhesions and related complications are minimizing 
surgical trauma and the use of adjuvants to reduce adhesion formation. Laparoscopy is 
often believed to reduce adhesion formation and the risk for ASBO. In a systematic review 
of cohort studies, the incidence of reoperation for ASBO was 1.4 (95% CI 1.0–1.8%) after 
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differences in both the type and indications for surgery.1 In a recent meta-analysis of SBO 
after colorectal operations, the incidence of ASBO after laparoscopic surgery was somewhat 
lower than after open colorectal procedures (OR 0.62, 95% CI 0.54 to 0.72). However, no 
significant difference was found in the three randomized trials included in this review (OR 
0.50, 95% CI 0.20 to 1.20).39 In summary, there is some evidence that the incidence of ASBO 
is lower after laparoscopy. However, the effect seems modest when correcting for type and 
indication of surgery. Thus, performing (colorectal) surgery by laparoscopy is not a complete 
solution to preventing adhesive SBO.  
 




Many other aspects of surgical technique have been associated with adhesion formation, 
although there are little or no epidemiological data concerning their impact on the 
incidence of ASBO. Nevertheless, a number of important risk factors for aggravated 
adhesion formation are worth considering. One of the most important risk factors is the 
foreign body reaction, for example as seen with starch-powdered gloves, and meshes used 
for abdominal wall reconstruction.40,41 The choice of energy device might also impact 
adhesion formation. Peritoneal injury is lower in bipolar electrocautery and ultrasonic 
devices as compared to monopolar electrocautery.42,43 Animal data suggest that both 
systemic and intraperitoneal application of antibiotics, and metronidazole in particular, can 
reduce adhesion formation in septic conditions.44,45 
Adhesion barriers 
Adhesion barriers are adjuvants for peritoneal administration that can effectively reduce 
adhesion formation. Adhesion barriers are produced in several forms: solid membranes, 
gels, and liquids. The concept behind barriers is that they do not actively interfere with 
inflammation and wound healing. Rather, they act as a spacer which separates injured 
surfaces of the peritoneum, allowing these surfaces to heal without forming fibrinous 
attachments which eventually lead to adhesions. In order to accomplish this task, such 
barriers should ideally be inert to the human immune system and be slowly degradable.  
There is moderate evidence that a hyaluronate carboxymethylcellulose adhesion barrier 
can reduce the incidence of reoperations for ASBO in colorectal surgery. In three trials 
involving 1132 patients undergoing colorectal surgery, hyaluronate carboxymethylcellulose 
reduced the incidence of reoperations for adhesive small bowel obstruction (RR 0.49, 95% 
CI 0.28–0.88).46-48 The use of such barriers seems cost-effective in open colorectal surgery.49 
An overview of common used adhesion barriers and their efficacy is found in Table 4. 
Secondary prevention 
Adhesion barriers might also be useful to prevent recurrence after surgical treatment of 
ASBO. One randomized trial with an adhesion barrier included patients undergoing surgery 
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Table 4 Overview of most common applied adhesion barriers and their impact on 
adhesion formation and incidence of ASBO  
Barrier Marketed as Comments 
Hyaluronate 
carboxymethylcellulose 
Seprafilm® Solid barrier most suitable for open surgery although 
laparoscopic placement have been described. 
Studies in both general surgery and gynecological 
procedures. 
Reduces adhesions formation, as well as the risk for 
reoperations for adhesive small bowel obstruction 




Interceed®  Solid barrier most suitable for open surgery 
Only studied in gynecological procedures 
Reduces incidence of adhesion formation relative risk 
0.51, 95% CI 0.31–0.86. 
No studies available on subsequent risk of ASBO. 
 
This workgroup does not recommend use of this 
barrier to prevent ASBO in general surgery. 
 
Icodextrin Adept® Liquid barrier, easy to apply in both open and 
laparoscopic surgery. 
Good safety record in both general surgery and 
gynecological surgery.  
Reduces recurrence of ASBO following surgery for 
ASBO in one trial (relative risk 0.20, 95% CI 0.04–0.88). 
 
Polyethylene glycol Sprayshield®/ 
Spraygel® 
Gel barrier, easy to apply in both open and 
laparoscopic surgery.  
Reduces adhesion score in both general surgery and 
gynecological trials. 
Relative few and small studies, impact on long-term 
adhesion related complications not described. 
Adapted from: ten Broek, Stommel MWJ, Strik C, et al. Benefits and harms of adhesion barriers for abdominal 




or standard operative treatment without an adhesion barrier. The ASBO recurrence rate 
was 2.19% (2/91) in the icodextrin groups versus 11.11% (10/90) in the control group after 
a mean follow-up period of 41.4 months (p < 0.05).20 In this trial, the barrier was applied in 
patients treated for ASBO by laparotomy. However, the icodextrin 4% adhesion barrier can 
also be administered in laparoscopic surgery. Other trials with icodextrin as an adhesion 
barrier indicated that it actually might not be the most potent barrier to prevent adhesion 
reformation, which is typically more challenging than prevention of de novo adhesions.50 
Favoring the use of icodextrin are its low costs and good safety record.51 From the results 
of other trials, we suggest that a hyaluronate carboxymethylcellulose might be more 
efficacious, but this barrier is less practical in laparoscopic surgery.46–48,52 
Approach to the patient with ASBO 
An algorithm for the diagnostic and therapeutic approach to the patient with ASBO is 
presented in Fig. 2. The initial diagnosis of ASBO is of utmost importance. Failure to diagnose 
or having a delayed diagnosis represents 70% of malpractice claims in ASBO.53,54  
The primary goals in the initial evaluation of patients in whom adhesive small bowel 
obstruction is suspected are:  
– Differentiating between adhesive small bowel obstruction and other causes of bowel 
obstruction  
– Assessing the need for urgent surgical exploration  
– Identifying and preventing complications from bowel obstruction 
History taking and physical examination 
History taking in a patient suspected for ASBO includes assessment of potential causes of 
bowel obstruction (previous operations, radiotherapy) and nutritional status. Signs of 
dehydration should also be assessed. Traditionally, ASBO is clinically diagnosed in a patient 
with intermittent colicky abdominal pain, distention, and nausea (with or without vomiting), 
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certain in a patient in whom all of these symptoms are present, there are some specific 
pitfalls that can result in delayed or misdiagnosis of bowel obstruction upon initial 
presentation. In patients with incomplete obstruction, watery diarrhea may be present. The 
presence of watery diarrhea can cause an episode of ASBO to be mistaken for gastro-
enteritis. Stool might also be present in patients with a relatively high obstruction who are 
admitted early after onset of symptoms. Moreover, not all of these symptoms may be 
present, especially in the elderly in whom pain is often less prominent.55,56  
During physical examination, signs of peritonitis that might reveal strangulation or ischemia 
should be evaluated. Differential diagnostic considerations that can be assessed during 
physical examination include the presence of any abdominal wall or groin hernias. The 
evaluation of ASBO by history taking and physical examination has a low sensitivity for 
detecting bowel strangulation and ischemia. Sensitivity of physical examination for 
detection of strangulation is only 48%, even in experienced hands.57 
Laboratory test 
The minimum of laboratory tests include blood count, lactate, electrolytes, CRP, and 
BUN/creatinine. Laboratory values that might indicate peritonitis are a CRP > 75 and white 
blood cell count > 10.000/mm3, although sensitivity and specificity of these tests are 
relatively low.6,57,58 Electrolytes are often disturbed in patients with a bowel obstruction; in 
particular, low values of potassium are frequently found and need to be corrected. 
BUN/creatinine needs to be assessed as patients with ASBO are frequently dehydrated 
which could result in acute kidney injury. 
Imaging studies 
Plain X-rays 
The value of plain X-rays complementary to physical examination is limited. In high-grade 
obstruction, a triad of multiple air-fluid levels, distention of small bowel loops, and absence 
of gas in the colon are pathognomonic for small bowel obstruction, but overall sensitivity 
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pneumoperitoneum secondary to bowel perforation in ASBO can also be detected on plain 
X-rays, preferably by an erect chest X-ray. Plain X-rays, however, do not detect the more 
early signs of peritonitis or strangulation.59-61 Furthermore, a plain abdominal X-ray does 
not provide anatomical information that helps differentiate between the various causes of 
bowel obstruction. 
Water-soluble contrast studies 
Several systematic reviews and meta-analyses have established the usefulness of water-
soluble contrast agents in the diagnostic work-up of ASBO.62-64 If the contrast has not 
reached the colon on an abdominal X-ray taken 24 h following administration of the 
contrast, this is highly indicative of failure of non-operative management. Multiple studies 
have shown that the use of water-soluble contrast agents accurately predicts the need for 
surgery and reduces hospital stay.62,63 Some authors also suggest that water-soluble 
contrast studies reduce the need for surgery, which is attributed to an active therapeutic 
role of the contrast.62,63 
CT scans 
Current helical CT scans not only have good test characteristics for diagnosing small bowel 
obstruction but also have approximately 90% accuracy in predicting strangulation and the 
need for urgent surgery.37,60,65-68 Diagnostic value of CT scan can be enhanced with the use 
of water-soluble contract. As with water-soluble contrast studies, progress of the contrast 
can be evaluated by X-ray at 24 h after CT scan.  
Although adhesions are not directly visible even on CT scan, a CT scan can differentiate 
accurately between different causes of bowel obstruction by excluding other causes. The 
workgroup therefore considers CT scan to be the preferred imaging technique if there is any 
doubt about the diagnosis of ASBO, and to assess the need for urgent surgery.  
A CT scan should help to differentiate between a complete obstruction of the bowel and 
help facilitate the decision for a trial of non-operative management versus a decision to 
proceed to surgery. It may also help to define the location of the obstruction (e.g., high in 




signs that suggest the need for surgery without delay. In addition, radiological and clinical 
scores can be used to predict the need for surgery as described above.37,38 
Ultrasound and MRI 
Although the working group considered CT scan to be the preferred technique for diagnosis 
of ASBO, ultrasound and MRI might be useful in specific situations. Ultrasound is operator 
dependent but in experienced hands can provide more information than plain X-rays, and 
is also available in most low income settings. Apart from distension of bowel loops, 
ultrasound enables detection of free fluid (that might indicate the need for urgent surgery) 
and assessment of the degree of shock in dehydrated patients.61,69 Ultrasound can also be 
of value in situations in which exposure to radiation is undesirable, such as in pregnant 
patients. In these cases, ultrasound might be complemented with MRI for more anatomical 
information if the diagnosis of bowel obstruction is confirmed.70 
Diagnosis: summary 
Recommendations can be found in Table 5. In summary, CT scan with oral water-soluble 
contrast is the preferred technique of imaging in the initial evaluation. Progress of the 
contrast should be monitored after 24 h of non-operative treatment by X-ray. If the 
diagnosis of ASBO is certain (e.g., because other causes have been excluded with recent 
imaging), and there are no signs that immediate surgery might be warranted, only a water-
soluble contrast study is considered sufficient. Ultrasound and MRI can be useful in specific 
situations, such as pregnancy or (in low income countries) when CT scan is unavailable. 
Management 
Initial decision making 
Non-operative management should always be tried in patients with adhesive small bowel 
obstruction, unless there are signs of peritonitis, strangulation, or bowel ischemia.71 
Although the risk of recurrence is slightly lower after operative treatment, this is not a 
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exploration is high; there is a considerable risk for bowel injury, and surgical treatment may 
significantly reduce post-operative quality of life.1,72–74 
Non-operative management 
The cornerstone of non-operative management is nil per os and decompression using a 
naso-gastric tube or long intestinal tube. Non-operative management is effective in 
approximately 70–90% of patients with ASBO.1,75,76 There has been some debate in the 
literature over the use of long intestinal tubes or naso-gastric tubes. In an older trial, no 
significant difference in failure rates was found between naso-gastric tubes and long 
intestinal tubes.77 In a more recent trial, 186 patients were randomized between a newly 
designed trilumen long tube and a naso-gastric tube. Long tubes seemed more effective in 
this trial with a failure rate of 10.4% in this group compared with 53.3% in the naso-gastric 
tube group.78 Results from this trial should be interpreted with care, because the failure 
rate of naso-gastric tube compression is much higher than would be expected from other 
literature. Moreover, a drawback of trilumen tubes is the need for endoscopic placement. 
Non-operative management should further include fluid resuscitation, correction of 
electrolyte disturbances, nutritional support, and prevention of aspiration.  
Duration of the period in which non-operative management can be tried is subject to 
debate. Several retrospective series and databases have shown that delays in surgery 
increase morbidity and mortality.30,71,79,80 Evidence for the optimal duration of non-
operative treatment is absent, but most authors and the panel consider a 72 h period as 
safe and appropriate.11,58,76,79,80 Continuing non-operative treatment for more than 72 h in 
cases with persistent high output from a decompression tube, but no other signs of clinical 
deterioration, however, remains subject to debate. Common medical complications in 
patients with small bowel obstruction are dehydration with kidney injury, electrolyte 
disturbances, malnutrition, and aspiration. 
Non-operative management: summary 
The panel recommends a trial of non-operative management in all patients with ASBO, 




optimal duration of non-operative is absent, but most authors and the panel consider a  
72 h period as safe and appropriate. Further recommendations are found in Table 5. 
Operative management 
Historically, abdominal exploration through laparotomy has been the standard treatment 
for adhesive small bowel obstruction. In recent years, however, laparoscopic surgery for 
ASBO has been introduced. The potential benefits of laparoscopy include less extensive 
adhesion (re)formation, earlier return of bowel movements, reduced post-operative pain, 
and shorter length of stay.81–83 In a recent systematic review and meta-analysis of 14 non-
randomized studies, laparoscopic adhesiolysis reduced risk of morbidity, in-hospital 
mortality, and surgical infections.84 However, there also seems strong selection bias in these 
series allocating mainly the less severe cases to laparoscopy. In a questionnaire among 
surgeons, 60% of the respondents reported to have performed laparoscopic adhesiolysis 
for ASBO in their practice, but half of them in less than 15% of cases.11  
Although laparoscopy might provide some benefits to some patients for ASBO, surgeons 
should carefully select candidates for laparoscopic treatment. Laparoscopy in an abdomen 
with very distended loops of bowel and multiple complex adhesions could increase the risk 
of severe complications such as enterotomies and delayed diagnosis of perforations.85,86 
Indeed, some authors have reported bowel injury in 6.3 to 26.9% of patients treated with 
laparoscopic adhesiolysis for ASBO.87–89 In a recent population-based study, bowel 
resections were significantly more frequent in laparoscopic surgery. Incidence of bowel 
resection was 53.5% versus 43.4% in laparoscopic versus open procedures.90 Farinella et al. 
reported that predictors for a successful laparoscopic treatment of ASBO are the following: 
≤ 2 laparotomies in history, appendectomy as the operation in history, no previous median 
laparotomy incision, and a single adhesive band.91 Laparoscopic adhesiolysis also seems 
more difficult in patients who have previously been treated by radiotherapy.92  
More compelling evidence on the role of laparoscopy in surgery for ASBO is from an ongoing 
randomized trial and is still awaited.93 In this trial, strict inclusion and exclusion criteria have 
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Operative management: summary 
Laparoscopic surgery has been introduced in recent years and might decrease morbidity in 
subgroups of patients undergoing surgery for ASBO. The risk of bowel injuries seems higher 
in laparoscopic surgery for ASBO. Therefore, careful selection of patients for laparoscopic 
surgery is required. Further recommendations are found in Table 5. 
Special patient groups 
Young patients 
The risk of adhesion-related complications is life-long. Although most small bowel 
obstructions will occur within the first 2 years after surgery, new cases continue to develop 
many years after the primary operation.1,30,72,94,95 Also, the risk of requiring a future 
reoperation for unrelated causes is higher in younger patients.96 Pediatric patients, who are 
at the extreme of young age, have a high risk for adhesion-related complications.1 In a 
recent cohort of patients who underwent surgery at a pediatric age, the incidence of 
adhesive small bowel obstruction was 12.6% after a median follow-up of 14.7 years.29  
Young patients therefore might have the highest lifetime benefit from adhesion 
prevention.49 No trials with adhesion barriers have been performed in pediatric surgery, but 
a recent cohort study in pediatric patients showed a significant reduction in ASBO with the 
use of a hyaluronate carboxymethylcellulose adhesion barrier.97 After a follow-up of 24 
months, 2.0% of pediatric patients operated with adhesion barrier versus 4.5% of patients 
operated on without adhesion barrier developed ASBO. 
Elderly patients 
In elderly patients, quality of life considerations are extremely important in decision making. 
Patients with a high frailty index have a prolonged recovery after a surgical procedure and 
may not be able to return to their previous functional state and quality of life.98,99  
The principles of treatment for adhesive small bowel obstruction might interfere with 




Table 5 Overview of conclusions and recommendations 
Level A Adhesive small bowel obstruction is a leading cause of morbidity, deaths, and healthcare 
expenditures in emergency surgery. 
A2 Scott 2016; NELA project team 2016 
 
Level B Adhesive small bowel obstruction causes high morbidity, with average hospital stay of 8 
days and 3% in-hospital mortality per episode. Recurrence of adhesive small bowel 
obstruction is high. Risk for adhesive small bowel obstruction may be somewhat lower 
after laparoscopic compared to open colorectal surgery, but that results could not be 
confirmed in randomized trials. 
A2 ten Broek, 2013; Yamada 2016; B Krielen 2016; Foster 2006 
 
Level IB Laparoscopic surgery reduces adhesion formation and might reduce subsequent incidence 
of ASBO. 
B Lundorff 1992; ten Broek 2013; Yamada 2016 
 
Level IA Hyaluronate carboxymethylcellulose reduces adhesion formation and the risk of 
subsequent reoperations of adhesive SBO. Use of this barrier seems cost-effective in open 
colorectal surgery. 
A1 ten Broek 2014 
A2 Fazio 2006; Park 2009; Kusunoki 205 
 
Level IIC In the absence of signs that require emergent surgical exploration (i.e. peritonitis, 
strangulation, or bowel ischemia), non- operative management is the treatment strategy 
of choice. 
C Fevang 2002; Fevang 2004; Ten Broek 2013; Jeppesen 2016 
 
Level IIB A trial of non- operative management can be continued safely for 72 hours. 
B Keenan 2014; Sakakibara 2007 
 
Level IID Initial evaluation should be complemented with assessment of nutritional status and 
laboratory tests evaluating at least blood count, lactate, electrolytes, and BUN/ Creat 












Level IIC Plain x-rays have only limited value in the work-up of patients with small bowel 
obstruction and are not recommended. 
B Maglinte 1996 
Level IB Optimal diagnostic work-up should include CT-scan in the assessment and water soluble 
oral contrast. In the absence of the need to perform immediate surgery, a follow-up 
abdominal x-ray should be made after 24 hours. If the contrast has reach the colon this is 
indicative for resolution of the bowel obstruction. 
A2 Ceresoli 2016; Branco 2010; Abbas 2005 
B Goussous 2013; Zielinski 2011; Zielinski 2010; Daneshmat 1999; Makita 1999; Zalcman 
2000 
 
Level IIC Long trilumen naso-intestinal tubes are more efficacious than naso-gastric tubes in non-
operative management, but require endoscopic placement. 
A2 Chen2012 
 
Level IIC Laparoscopic adhesiolyis might reduce morbidity in selected cases of ASBO that require 
surgery. Results of a randomized trial are awaited. 
B Sajid 2016; Farinella 2009; Sallinen 2014 
 
Level IIB Adhesion barriers reduce the risk of recurrence for ASBO following operative treatment. 
A2 Catena 2012 
 
Level IIC Younger patients, and pediatric patients in particular, have higher life-time risk of 
developing adhesion- related complications and might therefore benefit most from 
adhesion prevention. 
A1 ten Broek 2013; A2 Strik 2016; B Fredriksson 2016 
 
Level C More research is needed to the impact of comorbidities in elderly patients on optimal 
management of adhesive small bowel obstruction. Patients with diabetes might require 
more early operative intervention. 






on the consequences of stopping or withholding oral medications when a patient is put on 
nil per os for non-operative treatment of small bowel obstruction. A recent cohort showed 
that patients with diabetes might require earlier intervention although the level of evidence 
is rather low. Patients with diabetes were shown to suffer from a 7.5% incidence of acute 
kidney injury and 4.8% incidence of myocardial infarction if the operation was delayed more 
than 24 h.100 The incidence of these complications was significantly higher when compared 




Small bowel obstruction in pregnancy is very rare but represents an important clinical 
challenge with significant risk of fetal loss. In a recent review, 46 cases of bowel obstruction 
during pregnancy were found in literature from case series and case reports.101 
Approximately half of cases were attributed to adhesions, most commonly from previous 
abdominal operations. Imaging studies performed to diagnose SBO in the case reports 
included ultrasound in ten cases (83%), abdominal X- ray in four patients (33%), MRI in four 
patients (33%), and a CT scan in three patients (25%). Strikingly, the failure rate of non-
operative treatment in pregnant patients with ASBO was high. A total of 23 cases with ASBO 
were reported, in 17 of whom initial management was by a non-operative trial. Non-
operative treatment failed in 16 cases (94%). Risk of fetal loss was 17% (n = 8) and risk of 











The conclusions and recommendations of this guideline have been summarized in Table 5. 
ASBO is a common surgical emergency, causing high morbidity and even some mortality. 
Surgeons should be aware that the adhesions causing such bowel obstructions are typically 
the footprints of previous abdominal surgical procedures or disease. Part of the adhesion 
formation can be prevented by application of minimal invasive surgical techniques and the 
use of adhesion barriers. Most cases of ASBO can be treated non-operatively. If operative 
treatment is required, a laparoscopic approach might be beneficial for simple cases. 
However, there is a considerable risk for conversion to an open laparotomy and care needs 
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Laparoscopic versus open approach 
for adhesive small bowel obstruction, 
a systematic review and meta-analysis 






Adhesive small bowel obstruction (ASBO) is one of the most frequent causes of emergency 
hospital admissions and surgical treatment. Current surgical treatment of ASBO consists of 
open adhesiolysis. With laparoscopic procedures rising, the question arises if laparoscopy 
for ASBO is safe and results in better patient outcomes. Although adhesiolysis was among 
the first surgical procedures to be approached laparoscopically, uncertainty remains about 
its potential advantages over open surgery. Therefore, we performed a systematic review 
and meta-analysis on the benefits and harms of laparoscopic surgery for ASBO.  
Methods 
A systematic literature review was conducted for articles published up to May 2019. Two 
reviewers screened all articles and did the quality assessment. Consecutively a meta-
analysis was performed. To reduce selection bias, only matched studies were used in our 
primary analyses. All other studies were used in a sensitivity analyses. All the outcomes 
were measured within the 30th postoperative day. Core outcome parameters were 
postoperative mortality, iatrogenic bowel perforations, length of postoperative stay [days], 
severe postoperative complications, and early readmissions. Secondary outcomes were 
operative time [min], missed iatrogenic bowel perforations, time to flatus [days], and early 
unplanned reoperations. 
Results 
In our meta-analysis, 14 studies (participants = 37.007) were included: 1 randomized 
controlled trial, 2 matched studies, and 11 unmatched studies. Results of our primary 
analyses show no significant differences in core outcome parameters (postoperative 
mortality, iatrogenic bowel perforations, length of postoperative stay, severe postoperative 
complications, early readmissions). In sensitivity analyses, laparoscopic surgery favored 
open adhesiolysis in postoperative mortality (relative risk [RR], 0.36; 95% CI, 0.29 to 0.45), 
length of postoperative hospital stay (mean difference [MD], −4.19; 95% CI, −4.43 to −3.95), 
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−1.28 to −0.68), severe postoperative complications (RR, 0.51; 95% CI, 0.46 to 0.56) and 
early unplanned reoperations (RR, 0.82; 95% CI, 0.70 to 0.96). 
Conclusion 
Results of this systematic review indicate that laparoscopic surgery for ASBO is safe and 
feasible. Laparoscopic surgery is not associated with better or worse postoperative 
outcomes compared with open adhesiolysis. Future research should focus on the correct 
selection of those patients who are suitable for laparoscopic approach and may benefit 






Small bowel obstruction (SBO) is one of the leading causes of an emergency admission to a 
general surgical ward and one of the most frequent indications for emergent abdominal 
operations worldwide.1,2 Adhesions are the most common etiology for SBO in developed 
world countries and account for approximately 60% of all episodes.3–5 The incidence of 
adhesive SBO (ASBO) is related to the extent of peritoneal injury in patients who underwent 
surgery, or with a history of inflammatory bowel disease.6 Hospital stay for an episode of 
ASBO can easily be prolonged for over 1 week, regardless from nonoperative or operative 
management.7,8 Recurrence rates for an episode of ASBO are high,9 operative management 
of a first episode of ASBO might reduce the risk of readmission for ASBO.10 Operative 
management of ASBO usually consists of an exploratory laparotomy with adhesiolysis. With 
the rise of laparoscopic surgery, and its many benefits, laparoscopic adhesiolysis has been 
suggested as a new surgical approach to ASBO. Potential benefits of laparoscopic 
adhesiolysis include faster recovery, less pain, and fewer recurrences of adhesions.11 The 
first laparoscopic adhesiolysis for ASBO was performed in 1972 by Mouret.12 Since several 
papers have published favorable results of the laparoscopic approach. Implementation of 
laparoscopic surgery for ASBO, however, is slow, and there is concern for an increased risk 
of iatrogenic bowel injury.13 Unfortunately, evidence supporting laparoscopy over open 
surgery in reducing the risk for ASBO recurrence is not strong.14  
With the aim to assess feasibility, safety, and efficacy of laparoscopic adhesiolysis, we 
conducted a systematic review in 2009, according to the recommendations of The Cochrane 
Collaboration and the Cochrane Colorectal Group.15 Search results included no randomized 
controlled trials (RCTs) or prospective observational studies which compared laparoscopy 
with open surgery for patients with ASBO.16  
Nowadays, we have performed an updated systematic review and meta-analysis, analyzing 
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Material and methods 
We performed a systematic review of literature up to 20 May 2019 according to the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.17 The 
protocol of this systematic review and meta-analysis has been registered on PROSPERO 
CRD42018107087 (http://www.crd.york.ac.uk/prospero). This systematic review included 
RCTs, matched studies, and unmatched studies, irrespective of their publication status or 
language. General population (children and adults), irrespective of race, sex, health status, 
or geographical location, who have undergone full laparoscopic or laparoscopy-assisted 
versus open adhesiolysis for ASBO were included in this review. 
Types of outcome measures 
All the outcomes were measured within the 30th postoperative day. Primary outcome were 
the results of comparison of laparoscopic and open surgery for ASBO in RCTs and matched 
cohort studies on core clinical outcomes. Five core clinical outcome parameters were 
defined: postoperative mortality, iatrogenic bowel perforation, severe postoperative 
complications, length of postoperative hospital stay (LOS) [days] and early unplanned 
readmissions (within 30 days of discharge). Severe postoperative complications were 
classified as Clavien-Dindo III–IV.18 Secondary outcome measures were operative time 
[minutes], missed iatrogenic bowel injuries, unplanned reoperations (within 30 days of 
discharge), and time to flatus [days]. A radar chart was constructed to visualize differences 
in core clinical outcome parameters. 
Literature search strategy 
A systematic literature search was performed in PubMed, Scopus andWeb of Science, for 
studies reporting data on laparoscopic management of ASBO, published between 1980 and 
2019. The search was performed by entering the following keywords: (“laparoscopic 
adhesiolysis” OR “laparoscopic lysis” OR “laparoscopic management”) “AND (“small bowel 
obstruction” OR “adhesive bowel obstruction”). Two independent reviewers (RC, NV) 
individually assessed all titles and abstracts focusing on laparoscopic adhesiolysis for ASBO. 




was discussed with a third reviewer. Successively the full-text of relevant studies were 
obtained and evaluated. After inclusion, data from each study were independently 
extracted by two reviewers. If necessary, we contacted the corresponding author of the 
study to obtain additional research data. 
Assessment of risk of bias in included studies 
The risk of bias of the included studies was independently assessed by two independent 
reviewers (RC, NV). To evaluate the methodological quality of the included studies the 
Cochrane “risk of bias” assessment tool for RCTs19,20 and the methodological index for 
nonrandomized studies (MINORS) were used.21 In RCTs, the risk of bias was considered high 
if a high risk was scored in one or more of the five key domains. In nonrandomized studies, 
the risk of bias was considered high if the MINORS score resulted in greater than 20 points, 
or groups were not adequately matched (see below). Analysis of publication bias was 
performed using a funnel plot. 
Matching methods were assessed in all included studies.  
For a study to be included in the matched study group, matching should have been based 
on relevant surgical items. The definition of relevant surgical items for matching results 
from discussion between the authors and reflect selection criteria for patients in RCTs. 
Consensus was reached that we considered matching of sufficient quality to consider a 
study as low risk of bias, if matching factors comprised at least the following three domains: 
(1) expected or observed extend and type of adhesions (e.g., number of previous abdominal 
operations performed laparoscopic or open, type of adhesions observed [single band/dense 
adhesions]); (2) descriptors indicating critical illness (e.g. suspected perforation before 
surgery, sepsis, suspected strangulation); (3) medical history (e.g., American Society of 
Anesthesiologists [ASA] status, comorbidity). If studies were not matched on all three 
domains, we considered them high risk of bias, and the study was not used in the primary 
analyses of the primary and secondary outcome measures for this review. Thus, these 










Core clinical outcome parameters and secondary outcome parameters were separately 
analyzed for RCTs and matched studies and for unmatched studies. All matched studies 
were included in the analysis of primary and secondary outcome measures. Unmatched 
studies were included only in sensitivity analyses. We used the Mantel-Haenszel method for 
dichotomous data, presented as relative risks (RR) with 95% confidence intervals (CIs). We 
used the inverse variance method to pool continuous data; results are presented as mean 
difference with 95% CIs. Analyses were based on “intention-to-treat,” that is, all patients in 
whom laparoscopic surgery was converted to open surgery were analyzed in the 
laparoscopic group. The I2 test was used for heterogeneity assessment. A value exceeding 
50% was significant of heterogeneity. In the absence of statistical heterogeneity, we used a 
fixed-effect model; otherwise, we used a random-effects model. The data analysis was 
performed using the meta-analysis software Review Manager (RevMan) v 5.3.5 
(Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2018). 
Sensitivity analysis 
As a sensitivity analysis, we performed analysis of all studies, including the unmatched 
cohorts. Outcome measures were compared between the matched studies and all studies 
(including the unmatched studies). 
 
Results 
We retrieved 1.927 records with our search strategy, 973 records were excluded because 
they were duplicated. Subsequently, 954 titles and abstracts were evaluated, 930 abstracts 
were excluded because they did not meet inclusion criteria. Full text was evaluated in 24 
studies: 14 studies included22–35 and 10 excluded36–45 (Fig. 1).  
The characteristics of excluded studies and the reasons for the exclusion are reported in 





Figure 1 PRISMA flow diagram, PRISMA Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis. 
Characteristics of the studies included 
In 14 studies 37.007 patients were enrolled, including 1 RCT (n = 100).22–35 After assessment 
of matching methods, 2 studies (n = 154) were classified as matched studies, and 11 studies 
were classified as unmatched studies (n = 36.753) (Supplemental Digital Content 2, Table 
2). The RCT, laparoscopic versus open adhesiolysis for adhesive small bowel obstruction 
(LASSO) trial, was performed in two countries (Finland and Italy) and enrolled 100 patients 
between 2013 and 2018.22 The duration of the enrolment of the participants reported, 
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Methods of matching 
Matching in the study of Hackenberg et al. was performed using propensity score-matching 
based on items in all three matching categories. Surgical aspects included: ASA 
classification, number of previous abdominal operations, number of previous 
conservatively managed ASBO episodes, duration of symptoms, suspected bowel 
strangulation, hemodynamically unstable. Based on these items, there was a low risk of 
selection bias.  
Yao et al. matched on items in all three categories using propensity score matching, 
including: Systemic Inflammatory Response Syndrome (SIRS) (at presentation), ASA 
classification, comorbidities, type of adhesions (isolated band, simple, dense), time to 
operation, number of previous abdominal operations, comorbidities, and maximum bowel 
diameter on CT. This study was marked as a low risk of selection bias.  
Some other studies attempted matching but did not match on all three predetermined 
domains. 
Quality assessment of the studies included 
Intention to treat design was applied in 10 studies (Supplemental Digital Content 2, Table 
2). According to the author's judgment, the assessment of the RCT showed a “low risk of 
bias” in the greatest number of analyzed items (random sequence generation, selection 
bias, allocation concealment, selection bias), whereas a high risk of bias was reported for 
blinding of participants and personnel (performance bias). The mean score of the 
methodological assessment of the matched studies was 20 (moderate risk) (Supplemental 
Digital Content 3, Table 3). Mean score for unmatched studies was 18 (high risk) 
(Supplemental Digital Content 3, Table 3). A summary of the main findings per study is 





Core clinical outcomes 
Postoperative 30-day mortality 
Mortality was reported in the RCT, and all two matched studies. There was no significant 
difference in mortality between the laparoscopic (1.6%, 2/128) and open adhesiolysis 
cohort (2.4%, 3/126) (RR, 0.70; 95% CI, 0.14 to 3.51; I2 = 0%; Fig. 2A). 
Iatrogenic bowel perforation 
This parameter was reported in the RCT and one matched study. There was no significant 
difference in iatrogenic bowel perforations between the laparoscopic (10.5%, 8/76) and 
open adhesiolysis cohort (4.1%, 3/74) (RR, 2.61; 95% CI, 0.72 to 9.42; I2 = 0%; Fig. 2B). 
Length of postoperative hospital stay (days) 
The LOS was only reported in the RCT. There was no significant difference in LOS between 
the laparoscopic and open adhesiolysis cohort (MD, −1.30; 95% CI, −1.30 to 0.74, I2 = not 
applicable [NA]; Fig. 2C). 
Severe postoperative complications 
The RCT and one matched study reported this outcome parameter. There was no significant 
difference in the incidence of severe postoperative complications between the laparoscopic 
(5.3%, 4/76) and open adhesiolysis cohort (4.1%, 3/74) (RR, 1.28; 95% CI, 0.30 to 5.43; I2 = 
NA; Fig. 2D). 
Early readmissions (within 30 days of discharge) 
Only the RCT reported this outcome. There was no significant difference in the incidence of 
early unplanned readmissions between the laparoscopic (5.9%, 3/51) and open adhesiolysis 
cohort (2.0%, 1/49) (RR, 2.88; 95% CI, 0.31 to 26.78; I2 = NA; Fig. 2E). 
























Operative time (min) 
Operative time was not reported in the RCT or any of the matched studies. 
Missed iatrogenic bowel perforation 
The RCT and one matched study presented this outcome. There was no significant 
difference in the incidence of missed iatrogenic bowel perforations between the 
laparoscopic (1.3%, 1/76) and open adhesiolysis cohort (0%, 0/74) (RR, 2.88; 95% CI, 0.12 
to 69.16; I2 = NA) (Supplemental Digital Content 5, Figure 1). 
 




Time to flatus (days) 
Time to flatus was only reported by Yao et al. Patients in the laparoscopic cohort had a 
decrease in time to flatus compared with the open adhesiolysis cohort (MD, −1.00; 95% CI, 
−1.58 to −0.42; I2 = NA) (Supplemental Digital Content 6, Figure 2). 
Early unplanned reoperation (30 postoperative days) 
The incidence of unplanned reoperations was only reported by the RCT. There was no 
significant difference in the incidence of early unplanned reoperations between the 
laparoscopic (2.0%, 1/51) and open adhesiolysis cohort (0%, 0/49) (RR, 2.88; 95% CI, 0.12 
to 69.16; I2 = NA) (Supplemental Digital Content 7, Figure 3). 
Sensitivity analyses 
All studies included (including unmatched studies) 
In sensitivity analyses (Supplemental Digital Content 8, Figs. 4–12), laparoscopic surgery 
favored open adhesiolysis in postoperative mortality (RR, 0.36; 95% CI, 0.29 to 0.45; I2 = 
0%), LOS (MD, −4.19; 95% CI, −4.43 to −3.95; I2 = 97%), operative time (MD, −18.19; 95% CI, 
−20.98 to −15.40; I2 = 65%), time to flatus (MD, −0.98; 95% CI, −1.28 to −0.68; I2 = 0%), 
severe postoperative complications (RR, 0.51; 95% CI, 0.46 to 0.56; I2 = 55%), and early 
unplanned reoperations (RR, 0.82; 95% CI, 0.70 to 0.96; I2 = 0%). There were no differences 
in other parameters. 
 
Discussion 
Fourteen studies were identified that met the criteria to answer our primary or secondary 
research questions. Results of this systematic review and meta-analysis showed no 
evidence of superiority for one technique over the other on core clinical outcomes. In 
sensitivity analysis laparoscopic adhesiolysis for ASBO was associated with a decrease in  
30-day mortality, LOS, operative time, time to flatus, risk of severe postoperative 
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limitations of the unmatched studies, these results might be attributable to patient 
selection. 
Laparoscopic surgery for ASBO theoretically offers a number of potential benefits over open 
surgery (e.g., shorter length of stay, reduction in adhesion reformation), the choice of the 
best surgical approach in a clinical setting should be made according to many factors. 
Situations with contraindications for pneumoperitoneum, such as hemodynamic instability, 
sever bowel distention, or cardiopulmonary impairment, will require an open approach.36,46 
Other factors possibly influencing the selection of surgical approach are: laparoscopic skills 
of the surgeon and availability of laparoscopic equipment and instruments. Eligibility criteria 
for a laparoscopic approach to ASBO are: the absence of peritonitis or severe intra-
abdominal sepsis, less than severe distension of the bowel on radiological imaging, 
anticipated single band or limited extent of adhesions, and surgical skills.37 As reported in 
most recent guidelines on the management of ASBO, open surgery is indicated for 
strangulating ASBO or in case of ischemic bowel loops, while laparoscopic approach is most 
suitable for selected patients presenting at their first episode and with an anticipated single 
band detected at preoperative radiological imaging.5,9 
Strengths and limitations 
The major strengths of this review are the systematic approach and the inclusion of data 
from the first randomized trial comparing laparoscopic with open adhesiolysis for ASBO. We 
thoroughly screened all included articles for matching methods. Only studies that were 
matched on relevant surgical items were included in the primary analysis, all other studies 
were used in the sensitivity analysis. Unmatched studies were not used in the primary 
analysis to reduce the risk of selection bias. Critically ill patients presenting with ASBO are 
less likely to undergo laparoscopic procedures for many reasons, including the inability to 
tolerate pneumoperitoneum and are more prone to postoperative complications. For this 
reason, outcome parameters are likely to favor the laparoscopic surgery group by selection. 
Sensitivity analyses indeed showed a favorable effect of laparoscopic surgery for ASBO on 




Potential limitations of this study should be also discussed. Data on severity of adhesions 
and preoperative findings were not available in all the included studies, making it more 
difficult to define criteria for selection of patients for laparoscopy. We included only studies 
in the matched group if an attempt was made to match for the expected or observed extend 
and type of adhesions (e.g., number of previous abdominal operations performed 
laparoscopic or open, type of adhesions observed [single band/dense adhesions]). Due to 
strict selection criteria meta-analysis of some outcomes was based only on one study. These 
results of the meta-analysis are, therefore, somewhat less reliable. Core clinical outcomes 
that were only based on only one study were LOS and early readmissions. These parameters 
were only reported in the LASSO trial.22 The LASSO trial was powered on length of hospital 
stay. In their analysis of the geometric means a significant difference was found, although 
this was not confirmed in our analysis using inverse variance for continues outcomes. The 
difference was also smaller than accounted for in the sample size calculation of the LASSO 
trial (1.3 days vs 2.5 shorter hospital stay). A potential beneficial effect of laparoscopy on 
LOS therefore still needs to be confirmed in future studies that are well matched and 
powered. Timing of surgery for ASBO also remains a controversial issue; within the included 
studies there was heterogeneity regarding the timing of surgery. In a recent update of the 
Bologna guidelines and a Delphi consensus study, for patients not requiring emergent 
surgical exploration, a trial of nonoperative management can be continued safely as far as 
for 72 hours.9,38 When surgery is performed after more than 72 hours of conservative trial, 
an increase in mortality is observed.9,39 
A potential limitation of our study is the intention to treat design, therefore, not considering 
laparoscopic conversions to open surgery. Several studies did not report the causes and 
outcomes for conversion,22,26,28–30,32,34,35 or they did not report conversion rates at all. The 
matched studies had an accurate description of standardized surgical techniques used in 
the laparoscopic group. Nevertheless, technical biases might occur because laparoscopic 
surgery for ASBO is a highly complex procedure and results depend on the experience of 
the surgeon and also the characteristics and localization of the adhesions which requires a 
tailored surgical approach and a standardized technique. The choice of the surgical 
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matching in nonrandomized studies. Examples, however, of factors that are difficult to 
control for in nonrandomized studies include the laparoscopic skills of the surgeon, 
experience of the full operative team, and the impact of performing surgery at night hours. 
There is no broad accepted outcome for restore of bowel function. Many of the included 
studies use a wide variety of outcome parameters to predict restore of bowel function. 
Recently, a study was started to develop a core outcome set for gastrointestinal recovery in 
the context of postoperative ileus and small bowel obstruction.40 Since, to date, there is no 
consensus on a single parameter for restore of bowel function, we designed a set of key 
clinical outcome parameters as primary endpoint for this study. Radar charts are 
increasingly used in recent years to compare the total value (and sometimes costs) of 
different interventions, as opposed to comparison on a single outcome parameter.41 
Comparison to other literature 
Over the past decades, laparoscopic surgery became the standard of care in several fields 
of elective surgery. A retrospective study which included over 13.000 patients from the 
American College of Surgeons prospective National Surgical Quality Improvement Program 
data set reported a significant increase of application of laparoscopy from 17% in 2006 to 
29% in 2013.42 Grafen et al.43 found that patients who underwent successful laparoscopic 
adhesiolysis for ASBO had fewer prior operations and were younger with a lower ASA score, 
had shorter operative time and postoperative length of stay compared with patients who 
underwent open or converted adhesiolysis for ASBO. A recent systematic review which 
included 18 comparative nonrandomized studies ranging from 1990 to 2017 reported that 
the ASA score of patients who underwent laparoscopic adhesiolysis was significantly lower 
compared with the open group.44 
Unlike the results of a recent review, where iatrogenic bowel injury is less frequent in 
laparoscopic surgery,44 our review showed no significant difference in the risk of iatrogenic 
bowel injury in open or laparoscopic adhesiolysis. Moreover, there was no significant 
difference in missed bowel injuries. Previous studies showed a higher risk of missed bowel 
injures in the presence of distended bowel and multiple complex adhesions45,47 and during 




A review published in 2012 concluded that laparoscopy can significantly reduce the duration 
of postoperative ileus, as well as the incidence of pulmonary complications with no 
statistically significant reduction of intraoperative bowel injuries rates and overall 
mortality.49 In our review, laparoscopic surgery was not associated with a reduction of time 
to flatus. More recently, another review of 14 nonrandomized studies showed that 
laparoscopic adhesiolysis can reduce risk of morbidity, in-hospital mortality, and surgical 
infections.50 In our primary analyses, we found no difference in postoperative mortality or 
postoperative complications; however, in sensitivity analysis, laparoscopic surgery might be 
associated with a decrease in postoperative mortality (RR, 0.36; 95% CI, 0.29 to 0.45), and 
severe postoperative complications (RR, 0.51; 95% CI, 0.46 to 0.56).  
 
Conclusion  
The present systematic review showed that laparoscopic surgery for ASBO is feasible, as it 
is associated with similar adverse events rates compared with open surgery. Nevertheless, 
we found no evidence for superiority of one technique over the other. Future research 
should focus on the correct selection criteria to identify which patients are suitable for a 
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 Inter-rater agreement of the classifi cation 







Adverse events in surgical patients can occur pre-operatively, intra-operatively and post-
operatively. Universally accepted classification systems are not yet available for intra-
operative complications. ClassIntra® was recently developed, and seems to be a promising 
tool for standardized grading of intra-operative events.  
 
Objective 
The aim of this study is to assess the inter-rater agreement of ClassIntra® and assess its 
predictive value for post-operative complications in elective abdominal surgery. 
 
Design, Setting, and Participants 
This study is a secondary use of data from the LAPAD study, a prospective cohort study with 
detailed data on incidence and management of intra-operative events and post-operative 
complications. In the LAPAD study data were collected in a well-defined cohort of elective 
abdominal surgeries. For the purpose of the present study, two teams graded all recorded 
events according to ClassIntra®.  
 
Main Outcomes and Measures 
Cohen’s Kappa coefficient was calculated to determine inter-rater agreement. Uni- and 
multivariable linear regression was used to assess the predictive value of the ClassIntra® 
grade for post-operative complications measured by the Comprehensive Complication 
Index (CCI®).  
 
Results 
IAEs were rated in 333/755 (44%) surgeries by team 1, and in 324/755 (43%) surgeries by 
team 2. Cohen’s kappa coefficient for ClassIntra® grades was 0.87 (95% CI 0.84 – 0.90). 
Discrepancies in grading were most frequent for intra-operative bleeding and adhesions’ 
associated injuries. At least one post-operative complication was observed in 278 (37%) 
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20.9 – 39.5). The risk of a post-operative complications increased with every increase in 
severity grade of ClassIntra®. Intra-operative hypotension (mean difference (MD) 23.41, 
95% CI 12.93 – 33.90) and other organ injuries (MD 18.90, 95% CI -4.22 – 42.02) were the 
strongest predictors for post-operative complications.  
 
Conclusion and Relevance 
ClassIntra® has a good inter-rater agreement for the classification of iAEs. An increasing 
grade of ClassIntra® was associated with a higher incidence of post-operative complications. 
Discrepancies in grading related to common complications in abdominal procedures mostly 
consisted of intra-operative bleeding and adhesion-related injuries. Grading of 
interoperative events in abdominal surgery might further improve by consensus regarding 






In surgery, adverse events and medical errors occur pre-operatively, intra-operatively and 
post-operatively. Standardized classification of post-operative complications, e.g. using the 
Clavien-Dindo classification, is widely adopted, and has proven relevant to research and 
quality improvement programs.1-3 Prospectively validated classification systems for intra-
operative adverse events (iAEs) are not yet broadly adopted.4-6 IAEs have a major impact at 
many levels. First, there is an association between iAEs and post-operative outcome.5,7,8 
Second, hospital stays for patients experiencing iAEs are 40 percent more expensive 
compared with patients without iAEs.9,10 Third, readmission rates in patients whose surgery 
is complicated by an iAE are twofold higher.11 
To improve insight and transparency in outcomes of care, a standardized definition and 
classification of iAEs is required. A validated score of iAEs facilitates comparability of data 
from studies, and can be used to assess safety of new surgical techniques and devices, for 
educational purposes, and for institutional benchmarking. In a recent survey, as many as 
77% of all surgeons considered iAEs an important topic in surgery, and endorsed 
development of a classification for iAEs.12 However, in a critical appraisal of surgical 
randomized controlled clinical trials (RCT), less than 10% reported and classified iAEs.13  
Recently a new and practical classification system for iAEs was proposed, the classification 
of intra-operative complications (CLASSIC). CLASSIC defines iAEs as any deviation from the 
ideal intra-operative course occurring between skin incision and skin closure, irrespective 
of the cause (i.e. technical failures, surgical and anesthesiological difficulties).12,14 Recently 
CLASSIC was modified to accommodate 5 grades of severity in analogy to the widely 
adopted Clavien-Dindo score for post-operative complications, and named ClassIntra®. 
ClassIntra® was validated in a large multi-center prospective cohort study and showed to 
be a promising tool for measuring iAEs.5 However, so far the inter-rater agreement of 
ClassIntra® has only been assessed in fictious cases and a retrospective pilot study.5,12 
In the LAPAD (LAParotomy or LAParoscopy and ADhesiolysis) study, intra-operative events, 
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an independent observer.15 This database provides a unique opportunity to determine the 
inter-rater agreement of ClassIntra® in a large cohort of elective abdominal surgery. 
The aim of this study was to assess the inter-rater agreement of ClassIntra®. The secondary 
objective was to assess the association between ClassIntra® and post-operative 





This study was conducted using the data from the LAPAD study.15 In the LAPAD study the 
incidence and impact of adhesiolysis on intra-operative and post-operative complications 
was assessed in a cohort of consecutive patients planned for elective abdominal surgery at 
the Department of Surgery of the Radboud University Medical Center. A total of 755 
procedures were included, of which 91% were open procedures. Detailed surgical and 
anesthesiological intra-operative data were prospectively gathered and entered in a real-
time database by a trained physician who was present in the operating theater during all 
operations. Collected data included any surgical or anesthesiological iAEs and their 
management. The observer did not take part in the operation. Post-operative complications 
were registered and scored according to the Clavien-Dindo classification.16,17 The full 
protocol of the LAPAD study is described elsewhere (clinicaltrials.gov registration number: 
NCT01236625).15 
 
Grading of iAEs 
Two teams, team 1 (PK, MS), and team 2 (LG, RB), both consisting of a dedicated and trained 
researcher and a surgeon, graded all iAEs according to the definitions of ClassIntra® (table 
1). The teams were not involved in the development of the score. The teams had access to 
detailed intra-operative data collected in the LAPAD study, operation reports and 




complications and their grading were entered in an Access database (Microsoft office, 
2007).  
ClassIntra® provides general examples on the grading of several frequent complications.5 
On top of the examples provided by ClassIntra®, the authors felt that pre-arranged 
definitions for two frequent complications that were not illustrated by an example were 
inevitable for this study, adhesiolysis and hypotension. Adhesiolysis and hypotension due 
to bleeding are common in abdominal surgery and have previously been shown to be 
associated with postoperative complications.15,18 We defined adhesiolysis as a complication 
if it took more than 30 minutes or seromuscular injuries occurred, according to relevant 
literature.15 The definition of intra-operative hypotension varies in literature, we defined 
hypotension as a drop of blood pressure of more than 25% of patient-specific normal blood 
pressure for a period longer than 10 minutes.19-21 In case of hypotension secondary to a 
simultaneous extensive bleeding, hypotension was not registered as a separate 
complication, but regarded a symptom due to extensive bleeding.  
 
Endpoints 
The primary endpoint of this study was the inter-rater agreement of ClassIntra® as 
measured by Cohen’s kappa. The secondary endpoint was the association between the 
grade of the most severe iAE and the sum of all post-operative complications, calculated by 
the Comprehensive Complication Index (CCI®).22,23 The CCI is a weighted sum of all post-
operative complications of one patient, graded by Clavien-Dindo, on a scale from zero to 
100, with zero being no post-operative complication and 100 being post-operative death. 
 
Data analysis 
The inter-rater agreement, calculated by Cohen’s kappa coefficient, was interpreted as: 
slight agreement if κ ≤0.20, fair 0.21 ≤ κ ≤ 0.40, moderate if 0.41 ≤ κ ≤ 0.60, substantial if 
0.61 ≤ κ ≤ 0.80, almost perfect agreement if κ > 0.80.24-26 After the grading of all iAEs by both 
teams, a meeting was held to discuss discrepancies and reach consensus on the registration 
and grading of all iAEs. The association between ClassIntra® and post-operative 
complications was separately analyzed for team 1, team 2 and the consensus between both 





Inter-rater agreement of the ClassIntra® in abdominal surgery  
 
153 
Table 1 Classification of iAEs according to ClassIntra®  
 
Grade Definition 
The classification exclusively relates to any event occurring between skin incision and skin 
closure and should be rated directly after surgery. Any event during the index surgery 
must be considered, regardless whether it is surgery or anesthesia related.1 Prerequisite: 
the indication for surgery and the interventions conform to current guidelines. 
 Grade 0 No deviation from the ideal intra-operative course 
 
Grade 1 Any deviation from the ideal intra-operative course 
● Without the need for any additional treatment or intervention 
● Patient asymptomatic or mild symptoms 
 
Grade 2 Any deviation from the ideal intra-operative course 
● With the need for any additional minor treatment or intervention 
● Patient with moderate symptoms, not life-threatening and not leading to 
permanent disability 
 
Grade 3 Any deviation from the ideal intra-operative course 
● With the need for any additional moderate treatment or intervention 
● Patient with severe symptoms, potentially life-threatening and/or potentially 
leading to permanent disability 
 
Grade 4 Any deviation from the ideal intra-operative course 
● With the need for any additional major and urgent treatment or intervention 
● Patient with life-threatening symptoms and/or leading to permanent disability 
 
Grade 5 Any deviation from the ideal intra-operative course 
• With intra-operative death of the patient 
1 The following events are not defined as intraoperative adverse events: sequelae, failures of cure, events related 
to the underlying disease, wrong-site or wrong-patient surgery or errors in indication  
 
predictive value of the most severe iAE on the sum of post-operative complications. 
Potential confounders and risk factors for post-operative complications were derived from 
the LAPAD study; gender, age, body mass index (BMI), alcohol abuse27, American Society of 
Anesthesiologists physical status classification (ASA)28, number of previous abdominal 
operations, number of previous laparotomies, number of previous laparoscopies, operation 
site (fore gut/mid or hind gut/other), and adhesiolysis.15 For multivariable regression 
analysis, all variables that were related to post-operative complications in univariate 
analysis (p<0.2) or were relevant based on clinical rationale were taken into account. Post-
hoc multivariable analysis was performed to determine the impact of the type of iAE 




adhesiolysis, bowel injury, other organ injury, other surgical, hypotension, cardiac ischemia) 
on post-operative complications. For the purpose of this analysis, each patient was assigned 
to the category of iAE with the highest predictive value for post-operative complications in 
univariable analysis. 
IAEs were classified as being of surgical or anesthesiological origin. A stratified analysis was 
performed for the association between surgical and anesthesiological iAEs, and post-
operative complications. 
Statistical analysis was performed using SPSS 25.0 software (SPSS, Chicago, IL, 2018) with a 





During the study period, 844 elective surgeries were eligible, of which 89 were excluded. 
Reasons for exclusion were cancellation of the operation (n=38), patient declined to 
participate (n=11), communication difficulties (n=8), miscellaneous (n=32).15 Seven hundred 
fifty-five elective surgeries were included in this study. Patient demographics and surgical 
characteristics are shown in table 2.  
 
Classification 
Team 1 classified 447 iAEs in 333 (44.1%) procedures, team 2 classified 426 iAEs in 324 
(42.9%) procedures. In 21 procedures, an iAE was identified only by one team. An overview 
of all iAEs assessed by both teams and the interventions performed to manage the iAEs is 
presented in table 3.  
 
Inter-rater agreement 
In 656/755 (86.9%) procedures, there was an agreement in the classification of iAEs 
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Table 2 Patient demographics and surgical characteristics 
 
$Based on P-POSSUM score42, ■ Number of cases (% of total), * Mean ± standard deviation; † Median (range) 
 





  Male 




Age* 59 ± 14 
BMI ■ 
  <  20 
  20 - 25 
  26 - 30 






Smoking Status ■ 
  Nonsmoker 
  Ex-smoker 
  Smoker 






Alcohol abuse ■ 
  Low risk 
  Moderate risk 
  High risk 






Laparotomies in history† 1 (0-56) 
Laparoscopies in history† 0 (0-2) 
Pre-operative risk assessment 
ASA classification ■ 
  I 
  II 
  III 






Complexity of surgery ■, $ 
  Minor 
  Moderate 
  Large 






Characteristics of planned operation 
Open surgery/laparoscopy ■ 
  Open surgery 




Anatomical site of primary intervention ■ 
  Upper gastrointestinal tract 
  Lower gastrointestinal tract 
  Hepato-pancreato-billary  
  Abdominal wall 







Surgical experience ■ 
  Board-certified surgeon 







Discrepancies in grading of iAEs comprised different grading of intra-operative bleeding 
(n=45), bowel injury (n=13), adhesiolysis with serosal injury (n=11), other organ injury 
(n=10), hypotension (n=8), adhesiolysis (n=3) and cardiac ischemia (n=1). 
The consensus process revealed that intra-operative bleeding with transfusion of less than 
500cc packed cells was classified grade II. Bleeding requiring more transfusions, or 
transfusions including platelets or fresh frozen plasma was scored as grade III. Major blood 
loss during surgery requiring ongoing, extensive transfusion due to persistent hemodynamic 
instability was scored as grade IV. Adhesiolysis with a bowel injury managed by primary 
closure was scored as grade II, bowel injuries requiring resection and anastomosis as grade 
III. Adhesiolysis for longer than 30 min was scored as grade II.  
 
Table 3 Overview of iAEs and interventions per team 
Complication Team 1 Team 2 
Extensive major vessel bleeding 18 22 
Extensive diffuse bleeding 108 98 
Accidental ligation of major vessel 3 1 
Extensive adhesiolysis 174 202 
Bowel injury 93 63 
Other organ injury 24 21 
Other surgical - 2 
Hypotension 26 16 
Cardiac ischemia 1 1 
Intervention Team 1 Team 2 
Closure without resection  173 172 
Bowel resection and anastomosis 20 17 
Ligation of vessel - 1 
Reconstruction of vessel 7 8 
Haemostatic adjuvants 6 9 
Splenectomy 4  4 
Medicamentous intervention 57 27 
Unplanned blood transfusion 84 79 
Unplanned ICU admission and stabilization 3 4 
Adhesiolysis without need for bowel repair 83 81 
Other 10 24 
iAE = intra-operative adverse event, ICU = Intensive Care Unit 
 
Association with post-operative complications 
In 278 (36.8%) of all patients post-operative complications were observed. Seventeen 
patients (2.3%) died during the post-operative period. The median CCI of all patients with 
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analysis using the consensus on grading iAEs, increasing ClassIntra® grade, male gender, 
increasing age, current smoker (compared with non-smoker), increasing alcohol 
consumption, increasing ASA score, having a surgical iAE and having an anesthesiological 
iAE were significantly associated with post-operative complications (appendix table 1). In 
multivariable linear regression analysis, the severity of iAE was a significant and 
independent risk factor for a post-operative complication. A higher severity grade of iAE 
increased the risk of post-operative complications, with a mean difference (MD) in CCI of 
5.36 (95% CI 2.29 – 8.42) for grade 2 vs 0, 9.77 (95% CI 4.88 – 14.66) for grade 3 vs 0, and of 
16.12 (95% CI 6.44 – 25.80) for grade 4 vs 0. Grade 1 event was only scored in one patient, 
this patient developed a post-operative complication. Because of the small number of 
patients with grade 1 iAEs no reliable mean difference could be calculated. Other 
independent risk factors for post-operative complications were increasing age, increasing 
ASA score and male gender (table 4).  
The association between ClassIntra® and post-operative complications separately assessed 
for team 1 and team 2 showed no major differences in the association between both teams 
(appendix table 2,3). 
Anesthesiological iAEs were registered in 22 (2.9%) procedures, of which 15 (68.2%) were 
followed by a post-operative complication. Surgical iAEs were recorded in 320 (42.4%) 
procedures, of which 153 (47.8%) were followed by a post-operative complication. 
Univariable analysis reported a significant association between anesthesiological iAEs (MD 
22.75, 95% CI 14.04 – 31.46) and post-operative complications, as well as surgical iAEs (MD 
6.45, 95% CI 3.46 – 9.43) and post-operative complications.  
 
Post-hoc analysis 
Hypotension was the strongest predictor for any post-operative complications (MD 23.41, 
95%CI 12.93 – 33.90). Other organ injury (MD 18.90, 95%CI -4.22 – 42.02), bleeding (MD 
9.79, 95%CI 5.04 – 14.53) and adhesiolysis (MD 6.17, 95%CI 2.91 – 9.44) were predictors for 






Table 4 Multivariable linear regression analysis for the sum of post-operative complications 
(CCI®) 
 
Variable Patients with post-operative 
complications / total (%) 




  0 
  1 
  2  
  3 








  Ref. 
  11.85 (-25.94 – 49.65) 
  5.36 (2.29 – 8.42) 
  9.77 (4.88 – 14.66) 







Age    0.14 (0.03 – 0.25) p=0.012 
ASA score 
  1 
  2  
  3 







  Ref. 
  1.25 (- 2. 69 – 5.18) 
  12.36 (7.63 – 17.09) 







  Female 





  Ref. 








The high inter-rater agreement found in this study indicates that ClassIntra® is a reliable 
classification to grade iAEs in general abdominal surgery. In 4 out of 10 abdominal 
procedures iAEs were registered. An increasing ClassIntra® grade was significantly and 
independently associated with a higher number of post-operative complications in 
multivariable analysis. The small differences in the association of ClassIntra® grade with 
post-operative complications for team 1, team 2 and the consensus show that even though 
small differences were reported in the grades of iAE, the differences did not change the 
association with post-operative complications.  
 
ClassIntra® uses broad definitions to describe complications and their management. In the 
present study extensive adhesiolysis (≥30 min) was defined as an iAE. Reporting adhesiolysis 
as an iAEs might be somewhat controversial because adhesiolysis is often not perceived as 
a complication. However, adhesiolysis is an extra surgical procedure not part of the ideal 
intra-operative course, for which previous studies have reported an association with post-
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adhesiolysis might be inevitable to obtain sufficient exposure to the surgical field, extensive 
adhesiolysis meets all criteria of an iAE. Adhesiolysis shorter than 30 minutes was not 
graded as an iAE, as short adhesiolysis also does not seem to have major impact on post-
operative outcome.15 Considering adhesiolysis as an iAE may also contribute to increased 
awareness of adhesion-related complications during reoperations.  
 
IAE grading partially depends on the intervention performed to manage the complication, 
similarly to the Clavien-Dindo score. This approach is potentially subject to the preference 
of surgeons and anesthesiologists. For example, a comparable bowel injury might be 
managed by primary intestinal closure by one surgeon, while another opts for primary 
resection, resulting in a different grade.30 Main reasons for using the intervention 
performed to grade the severity of the iAE are the following: first, the intervention inflicted 
is a result of the assessment of the severity by the treating physician. Second, the 
intervention to treat the complication may influence the post-operative outcome, therefore 
the impact of an iAE is partly related to their management. Third, details of iAEs are often 
badly documented, whilst the therapy to treat the iAE is better and more objectively noted, 
rendering also retrospective assessment easier. In clinical practice, assessment of 
complications will always depend on the judgment of the treating physician. Nevertheless, 
uniformity in definition of complications has shown to be crucial for research and quality 
improvement programs.1-3  
 
A major strength of the present study is the use of detailed, prospectively gathered, intra-
operative data on adhesiolysis related injuries in general abdominal procedures. 
Prospective data registration averts the risk of missing data, facilitating reliable grading of 
iAEs and their management.31 In a substudy of the LAPAD study, comparing intra-operative 
observer notes with operative reports, almost 1 in 7 bowel injuries, and 1 in 5 other 
inadvertent organ injuries were not documented in operative reports.31 Furthermore, two 
out of three abdominal procedures today are reoperations, in which exposure to adhesions 
and subsequently adhesiolysis is very common.15 Adhesions in abdominal surgery often lead 
to prolonged operative time and the risk of inadvertent organ injury.15 In the ClassIntra® 




of non-abdominal procedures.5 Detailed data from a study with focus on abdominal 
adhesiolysis procedures therefore lends itself perfectly for the assessment of iAEs and the 
inter-rater agreement of ClassIntra® and its predictive value on post-operative 
complications. 
 
A potential limitation is that the LAPAD study solely included procedures from a tertiary 
referral clinic. Procedures performed in tertiary referral clinics are often more extensive 
procedures or anticipated difficult cases, resulting in a higher risk of iAEs. Also, over 90% of 
procedures performed in the LAPAD study consisted of open procedures, whilst nowadays 
the about half of abdominal surgical procedures is performed laparoscopically. 
Laparoscopic procedures are associated with a different risk profile for both intra- and post-
operative complications. Laparoscopic surgery is associated with lower blood loss, and a 
lower risk of iatrogenic splenic injuries.32,33 On the other hand, laparoscopic surgery is often 
more dependent on technology, thereby increasing the risk for organisational and 
equipment related events.34 Considering post-operative complications, laparoscopic 
surgery has a lower risk of complications such as superficial surgical site infection, however 
it does not seem to reduce other severe post-operative complications and mortality.35 
Although risk profiles for laparoscopy and open surgery differ, the multicenter validation 
study of ClassIntra® demonstrated that a higher grade of iAE incrementally increases the 
relative risk for post-operative complications. This increase seems consistent throughout 
different surgical subspecialties and different types of events despite potential differences 
in risk profile.5 
 
Another limitation of our study might be the pre-arranged rules and cut-off points for iAEs 
on adhesiolysis and hypotension. We applied as few rules as possible for interpreting iAEs, 
but felt that agreement on some items was inevitable, because definitions in the literature 
vary. Prior to the classification process, agreement on the classification of adhesiolysis and 
hypotension was obtained between the teams, without indication of severity according to 
ClassIntra®. Despite these pre-arranged rules on hypotension and adhesiolysis, 
classification of both iAEs still resulted in discrepancies in grading between both teams on 
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hypotension were strong predictors for post-operative complications. The ClassIntra® is a 
broad classification using general terms that are applicable to any kind of iAEs. Uniform 
definitions for common iAEs in abdominal surgery lack, e.g. for hypotension, complicating 
comparison of iAEs between different institutes. Consensus over the definition of such 
common events in abdominal surgery might improve overall grading of iAEs. 
 
An earlier initiative in the classifications of iAEs was by Kaafarani et al in 2014.30,36 There 
appear to be two major differences between ClassIntra® and Kaafarani.37 First, the 
Kaafarani score does not include anesthesiological iAEs. Anesthesiological iAEs are however 
recorded in 3-41% of all procedures.5 In our study anesthesiological iAEs were significantly 
associated with post-operative complications. Second, Kaafarani regards reoperations (e.g. 
for anastomotic leakage) within 7 days as an iAE, regardless of the fact that they occur post-
operatively. Multiple studies have shown associations between post-operative 
complications such as anastomotic leakage and factors unrelated to surgical injury, such as 
medication, patient factors, and microbioma38-41. Attributing reoperations to an iAE may 
therefore be an incorrect assumption.  
 
The broad acceptance of the clinical impact of iAEs and the use of standardized classification 
systems could lead to an increased awareness of iAEs in abdominal surgery, and facilitates 
comparison of intra-operative outcomes in research. The association between iAEs and 
post-operative complications might offer possibilities to detect and treat post-operative 




ClassIntra® has a high inter-rater agreement and is a reliable tool for the classification of 
iAEs in daily clinical practice as well as in research settings. This study confirms the 
association between iAEs and the increased risk of post-operative complications. An 
increasing grade of ClassIntra® was associated with a higher incidence of post-operative 
complications. Grading of intra-operative events in abdominal surgery might further 
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Adhesion barriers have proven to reduce adhesion-related complications in colorectal 
surgery. However, barriers are seldom applied. The aim of this study was to determine the 
cost-effectiveness of adhesion barriers in colorectal surgery. 
Methods 
A decision-tree model was developed to compare cost-effectiveness of no adhesion barrier 
with the use of an adhesion barrier in open and laparoscopic surgery. Outcomes were 
incidence of clinical consequences of adhesions, direct healthcare costs, and incremental 
cost-effectiveness ratio per adhesion prevented. Deterministic and probabilistic sensitivity 
analyses were performed. 
Results 
Adhesion barriers reduce adhesion incidence and incidence of adhesive small bowel 
obstruction in open and laparoscopic surgery. Adhesion barriers in open surgery reduce 
costs compared with no adhesion barrier ($4376 versus $4482). Using an adhesion barrier 
in laparoscopic procedures increases costs by $162 ($4482 versus $4320). The ICER in the 
laparoscopic cohort was $123. Probabilistic sensitivity analysis showed 66% and 41% 
probabilities of an adhesion barrier reducing costs for open and laparoscopic colorectal 
surgery, respectively. 
Conclusion 
The use of adhesion barriers in open colorectal surgery is cost-effective in preventing 
adhesion-related problems. In laparoscopic colorectal surgery, an adhesion barrier is 










Colorectal surgery commonly induces post-operative adhesion formation, causing a lifelong 
risk for small bowel obstruction, female infertility, and chronic visceral pain.1–4 Lysis of 
adhesions at reoperative surgery is associated with inadvertent organ injury, prolonged 
operative time, and an increased risk of post-operative complications and, therefore, higher 
costs.5–7 Several types of adhesion barriers are developed to prevent post-operative 
adhesion formation after abdominal surgery. In a recent systematic review and meta-
analysis on efficacy and safety of adhesion barriers, hyaluronate carboxymethylcellulose 
(HA/CMC) was proven to safely reduce the incidence of site-specific adhesions and the 
incidence of re-operations for adhesive small bowel obstruction after open colorectal 
surgery.8 However, despite the burden of post-operative adhesions, and the proven benefit 
of adhesion barriers, they are seldom applied. In a nationwide survey carried out in the 
Netherlands in 2009, just 13.4% of surgeons indicated that they had used any adhesion 
barrier in the previous year and a recent follow-up survey did not report much subsequent 
change.9,10 Doubts about cost-effectiveness and the need for adhesion prevention in 
minimally invasive surgery may explain the reluctance in the use of barriers. Previous cost-
effectiveness analyses of adhesion barriers have been based on costs of adhesion-related 
re-admissions and only concern open surgery.11,12 The efficacy data used were derived from 
second-look surgery studies, with a suggested 25–50% reduction in the number or density 
of adhesions with the use of a barrier.11,12 In the absence of data on reduction of adhesion-
related readmissions with the use of a barrier, costs were extrapolated from the reduction 
of adhesions. Since publication of these analyses, evidence on both the burden of adhesions 
and the effectiveness of adhesion barriers has increased substantially. Earlier, a re-
admission for postoperative small bowel obstruction was considered the most important 
complication.13 New evidence has clearly shown that difficulty due to dissecting adhesions 
at repeat abdominal surgery is an even bigger problem.14 Moreover, evidence on efficacy 
of adhesion barriers is no longer limited to adhesion incidence, but comprises clinically 
relevant endpoints.8 
A decision-tree model was developed in this study for the use of an adhesion barrier in open 




and considering cost and effect. The model was designed as an important contribution 
towards creating an evidence-based, decision-making protocol on the use of adhesion 
barriers in colorectal surgery. 
 
Material en methods 
Decision model 
A decision-tree model was designed with Microsoft Office Excel 2007 that evaluated the 
strategy of adhesion prevention with an adhesion barrier in both open and laparoscopic 
colorectal surgery. A decision-tree model is a simplified framework of complex real-life 
processes that uses a mathematical method to weigh the risks, benefits, and costs of clinical 
strategies.15 In the model, two strategies are compared: (1) current clinical practice, 
colorectal surgery without the use of an adhesion barrier, and (2) colorectal surgery with 
the use of an adhesion barrier (Fig. 1).  
Hypothetical cohorts of patients, who have undergone colorectal surgery (open or 
laparoscopic), were distributed over the different pathways in the decision-tree, based on 
a set of probabilities that were derived from recently published systematic reviews and 
observational and intervention studies. This allowed the synthesis of evidence and, thereby, 
evaluation of the effects and adhesion-related healthcare costs determined by the 
treatment decision. 
Adhesive small bowel obstruction (ASBO) and difficulties at reoperation were included in 
the model as potential consequences of adhesions. Female infertility and chronic visceral 
pain were not considered. Risk of infertility is only an additional reason for the use of an 
adhesion barrier in a very small and specific subgroup. Regarding chronic visceral pain, no 










The two target populations consist of patients who undergo a colorectal resection for a 
benign or malignant indication, by either an open or laparoscopic surgical approach. 
Colorectal resection is commonly performed for various indications; the main indication is 
colorectal cancer.16 Colorectal surgery has a relatively high incidence of postoperative 
adhesion formation.14,17 In 2016, in more than 85% of colorectal cancer resections 
performed in the Netherlands, laparoscopic techniques were used.18 There is recent 
evidence that laparoscopy is associated with a lower incidence of adhesions, particularly to 
the abdominal wall.19,20 
Probabilities 
In the model, the hypothetical cohorts of patients, who underwent a colorectal resection, 
with or without the use of an adhesion barrier, have different probabilities for the 
development of adhesions and subsequent development of ASBO, operative or 
conservative treatment for ASBO, and adhesiolysis at future repeat surgery. Probability 
estimates were derived from recent literature (Table 1).8,19,21–32  
PubMed, Embase, and the Cochrane Library were searched for relevant literature. Risk 
ratios for adhesions, ASBO, and operative treatment of ASBO, with the use of an adhesion 
barrier, are based on efficacy data for HA/CMC, as this is the only form of adhesion barrier 
with consistent evidence available on adhesion prevention in visceral surgery. HA/CMC is 
not easily applicable in laparoscopic surgery, and evidence for laparoscopy is lacking. Since 
there are no alternative barriers with sound evidence on safety and efficacy in laparoscopic 
colorectal surgery, efficacy data of HA/CMC in open colorectal resection was extrapolated 
to the laparoscopic model. The data on incidence of adhesions after open and laparoscopic 
colorectal surgery were derived from a recently published multicenter study.19 In this study, 
adhesions after open and laparoscopic colorectal cancer surgery are compared during 






Figure 1 Decision-tree model for evaluation of the use of an adhesion barrier in colorectal 
surgery 
 
In a recent systematic review on the value of adhesion barriers, there were no data on the 
total incidence of adhesions with the use of HA/CMC.8 A new search yielded no additional 
data on the total incidence of adhesions with the use of HA/CMC. Thus, adhesion 
incidence with HA/CMC was derived from the incidence of site-specific adhesions 
reported (i.e. midline, pelvic adhesions), by only including the anatomical site with the 
highest incidence of adhesions from each study.21–23 The peristomal site was not 
considered relevant for total adhesion formation after colorectal surgery. The efficacy is 
expressed as a risk ratio of adhesions with the use of HA/CMC versus no adhesion barrier 
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Table 1 Input probabilities in decision-tree model 
 Open Laparoscopic Adhesion barrier strategy 
Variable Probability α β Probability α β Ref. RR 95%CI Ref. 
Patients with 
adhesions  
0.889 80 10 0.623 38 23 19 0.51 0.43-0.61 8, 20-22 
Patients with 
ASBO 4 years 
















0.208 64 200 0.209 64 200 31    
α = patients with event; β = patients without event; RR = relative risk; CI = confidence interval; ASBO = adhesive 
small bowel obstruction 
The probability of ASBO and the probability of surgery for ASBO after colorectal surgery 
were derived from an update of the systematic review on the burden of adhesions after 
abdominal surgery (1990 to June 2016).24–31 Weighted mean follow-up of the studies was 
55.3 months. The probability of future repeat abdominal surgery was derived from a 
recently published, prospective cohort of patients, who underwent elective abdominal 
surgery.32 This cohort comprises mainly patients operated by open approach. Since the 
incidence of repeat abdominal surgery is not expected to be substantially different for 
patients operated on by laparoscopy or by open approach, the probability used in both arms 
of the model is based on the total cohort. In the 4 years following initial lower 
gastrointestinal tract surgery, 24% of patients underwent repeat abdominal surgery, 
including re-operations for ASBO. In the model, re-operations for ASBO were subtracted 
from the probability for repeat surgery to ensure that these re-operations were not 






An analysis of adhesion-related costs was performed with a healthcare perspective, 
including only direct healthcare costs for treatment (Table 2). All monetary values are 
presented in US dollars (USD/$). Euros were converted to USD using the exchange rate:  
1 Euro to 1.1264 USD.  
The mean number of films per patient reported in two of the three studies on adhesion 
prevention with HA/CMC in colorectal surgery was 3.3 films. The total costs for HA/CMC 
were based on the use of 3.3 films and the price of a HA/CMC film in 2016 in the 
Netherlands, adding up to a total cost of $629.68.21,33 For sensitivity analysis, a Beta-PERT 
distribution was assigned for the number of sheets per patient, ranging between 2 and 4. 
Costs of the barrier were varied according to the Beta-PERT distribution ($382–$763), Table 
2.  
The healthcare costs of ASBO were derived from a recently performed retrospective 
analysis of patients admitted to the Radboud University Medical Center with the diagnosis 
of ASBO.34 The costs for repeat surgery were derived from a recent, large, cohort study on 
adhesiolysis- related morbidity in abdominal surgery.5 
Data analysis 
Data were analysed using mean values for a base case analysis, to obtain percentages of 
ASBO, re-operation for ASBO, patients with adhesions, and direct healthcare costs for the 
two strategies, in the 4 years following colorectal surgery. The time frame was based on the 
mean 4 years’ follow-up periods of the studies, which underlie the probabilities for ASBO 
and repeat surgery. If the use of an adhesion barrier was more effective and more 
expensive, incremental cost-effectiveness ratios (ICER) were calculated to determine the 
additional costs for one patient, in whom adhesion formation was prevented. All presented 
ICERs are a comparison of the adhesion barrier strategy versus no barrier. If the adhesion 
barrier strategy was more effective and reduced costs, this was considered dominant, and 
ICERs were not calculated. A base case analysis was conducted for the two strategies in 





Cost-effectiveness of the prevention of adhesions after colorectal surgery with adhesion barriers 
 
175 







HA/CMC = hyaluronate carboxymethylcellulose; ASBO = adhesive small bowel obstruction; SD = standard 
deviation 
* For the number of sheets per patient a Beta-PERT distribution was assigned, ranging between 2 and 4. 
 
using a Monte Carlo simulation, to explore the impact of uncertainties in the model 
parameters, as shown in Tables 1 and 2. In the Monte Carlo simulation, 5000 samples were 
drawn from the parameter distributions. For each sample, the hypothetical patient cohort 
was run through the model based on these sampled parameters, representing the 
uncertainty in the cost-effectiveness estimation. Lognormal distributions were used for all 
risk ratios; beta distributions for probabilities and costs were described by normal 
distributions. Confidence intervals were calculated from the probabilistic sensitivity analysis 
using the percentile method.  
In addition, threshold analyses were conducted for the costs of the adhesion barrier and 
the probability of repeat surgery, in order to find the maximum values for these parameters 
at which the adhesion barrier saves costs. Deterministic sensitivity analysis was conducted 
to explore the influence of deviation in the efficacy of the different parameters on the cost-
effectiveness, assuming all other variables to be fixed. All parameters were individually 
changed to their lower and upper boundaries of the 95% confidence intervals. Results of 
the analysis are presented in a tornado diagram. Furthermore, a best- and worst-case 
scenario was calculated; for the worst-case scenario, the risk ratios for adhesions, ASBO, 
 Value SD Reference 
Costs HA/CMC $ 630 $ 382 - $ 763* 20, 32 
ASBO with operative treatment $ 18366 $2 831 33 
ASBO with non-operative treatment $ 2565 $ 299 33 
Repeat surgery - no adhesions $ 14063 $ 812 5 




and operative treatment of ASBO were all set to the upper limit of their confidence interval 
(Table 1). For the best-case scenario, all three risk ratios were raised to the lower limit of 
their confidence interval. 
 
Results 
Best case analysis 
With the parameters at their base case values, for the open colorectal surgery cohort, the 
adhesion barrier strategy was both more effective and less expensive than the no adhesion 
barrier strategy, whilst in the laparoscopic colorectal surgery cohort, the adhesion barrier 
strategy was more effective, but more expensive (Table 3). In open colorectal surgery, use 
of an adhesion barrier reduced the incidence of adhesions from 88.9% (95% CI 81.8 – 94.5%) 
to 45.3% (95% CI 37.3 – 54.6%) and the incidence of ASBO from 8.6% (95% CI 7.5 – 9.7%) to 
6.2% (95% CI 2.9 – 11.3%). The expected mean direct healthcare costs in 4 years after initial 
open colorectal surgery were reduced by $106, from $4482 (95% CI $3074 – $6284) per 
patient in the group without an adhesion barrier to $4376 (95% CI $3140 – $5892) in the 
group with an adhesion barrier. After laparoscopic colorectal surgery, the incidence of 
patients with adhesions was reduced from 62.3% (95% CI 49.9 – 73.8%) to 31.8% (95% CI 
24.3 – 40.7%) and the incidence of ASBO from 6.6% (95% CI 5.2 – 8.1% ) to 4.5% (95% CI 2.2 
– 9.2%) with an adhesion barrier. Costs increased by $163 per patient when an adhesion 
barrier was used. Direct health care costs over 4 years after laparoscopic colorectal surgery 
for the adhesion barrier group were $4482 (95% CI $3031 – $5591) versus $4320 (95% CI 
$2881 – $5709) for the no adhesion barrier group. In open colorectal surgery, the adhesion 
barrier strategy dominated the current, no-adhesion barrier practice. For laparoscopic 
colorectal surgery, the ICER for one patient with adhesions prevented was $123. Cost 
reduction for both open and laparoscopic colorectal surgery is mainly due to the reduction 
of readmissions for ASBO in the adhesion barrier arm. Reduction of costs is also due to the 
prevention of adhesions at reoperation and therefore reduction of operative time with a 
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Table 3 Results of base-case and deterministic sensitivity analysis in the open- and 
laparoscopic surgery cohorts 
 
Strategy Costs Percentage 
adhesions 
Percentage ASBO Costs per patient with 
adhesions prevented 
Open cohort 
Baseline     
   No barrier $4474 88.9% 8.6%  
   Barrier $4372 45.3% 5.8% Dominant 
     
Best-case scenario     
   No barrier $4474 88.9% 8.6%  
   Barrier $4129 38.2% 3.0% Dominant 
     
Worst-case scenario     
   No barrier $4474 88.9% 8.6%  
   Barrier $4789 54.2% 11.3% $908 
 
Laparoscopic cohort 
Baseline     
   No barrier $4179 62.3% 6.6%  
   Barrier $4220 31.8% 4.5% $135 
     
Best-case scenario     
   No barrier $4179 62.3% 6.6%  
   Barrier $4016 26.8% 2.3% Dominant 
     
Worst-case scenario     
   No barrier $4179 62.3% 6.6%  
   Barrier $4576 38.0% 8.7% $1663 







The results of the probabilistic sensitivity analysis are shown in Fig. 2a and b. The Monte 
Carlo simulation showed that the use of an adhesion barrier is always more effective in 
preventing adhesions and ASBO, for both open and laparoscopic colorectal surgery. The use 
of an adhesion barrier had a 66% probability of reducing costs in the open surgery cohort. 
In the laparoscopic surgery cohort, the probability was 41%. Threshold analysis in the open 
colorectal surgery cohort showed that using a barrier priced at $736 (95% CI $305 – $1187) 
or more no longer reduces costs. The same effect was seen with the re-operation rate 
lowered to 16% (95% CI 1 – 74%) or less. In the laparoscopic surgery cohort, the thresholds 
for cost-reduction with an adhesion barrier were a price of $592 (95% CI $256 – $954) and 
a reoperation rate of 24% (95% CI 3 – 100%).  
Results of the deterministic sensitivity analysis are shown in Fig. 3a and b. Variation of the 
costs of the adhesion barrier had the largest effect on the ICER for one patient with 
adhesions prevented in open and laparoscopic surgery. In the best-case scenario, applying 
an adhesion barrier in both open and laparoscopic colorectal surgery reduces costs. In the 
worst-case scenario, the ICER for one patient with adhesions prevented is $908 in the open 
colorectal surgery patient cohort and $1663 in the laparoscopic colorectal surgery patient 
cohort, Table 3. 
 
Discussion 
The routine use of an adhesion barrier in open colorectal surgery is cost-effective, 
considering a 4-year time frame. Whilst in laparoscopic colorectal surgery, the expenses are 
only $163 per patient, and the additional costs for one patient with adhesions prevented 
are $123. The findings in the present study are in agreement with a comparable study, 
which demonstrated cost savings in all types of open abdominal surgery and potential cost-





























Figure 2 A Scatter plot of Monte Carlo Simulation for open colorectal surgery, displaying 
costs (y-axis) and effect (x-axis) of adhesion barrier strategy. B Scatter plot of Monte Carlo 
Simulation for laparoscopic colorectal surgery, displaying costs (y-axis) and effect (x-axis) 





Figure 3 A Tornado diagram of variation of individual parameters in open colorectal 
surgery. B Tornado diagram of variation of individual parameters in laparoscopic 
colorectal surgery 
 
The present study has the advantage that it concerns a homogenous group of patients with 
a high risk of post-operative adhesion formation. This well-defined population enhances the 
clinical applicability of the results. In addition, more recent cost data are used in the present 
model, of which the majority were specifically for colorectal surgery. Costs are twice as 
much for operative treatment of ASBO and for the adhesion barrier compared with costs 
reported previously. A comparable underestimation of costs for the adhesion barrier and 
ASBO treatment was found in other cost-effectiveness reports from earlier this century.11,12 
The most important limitation of previous studies is the lack of evidence on efficacy of 
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The major strength of the present study is that the recently generated evidence for the 
burden of adhesions and the efficacy of adhesion barriers in colorectal surgery could be 
synthesized. We synthesized all available evidence to show the expected consequences of 
adopting adhesion barriers on both costs and effects, as well as the impact of the 
uncertainty due to a lack of evidence regarding these consequences. A limitation is the need 
to extrapolate data on the efficacy of adhesion barriers from open to laparoscopic colorectal 
surgery, due to scarce and inconsistent evidence with other formulas of HA/CMC (e.g. slurry 
made of film and spray) in laparoscopy.36–38 A deviating efficacy in laparoscopy would be 
highly relevant, particularly, because the majority of colorectal resections are currently 
performed by laparoscopy.18 In the worst-case scenario, assuming reduced effectiveness of 
the adhesion barrier (RR 0.61) resulted in an ICER of $908 in the open surgery cohort and 
$1633 in the laparoscopic surgery cohort, which for laparoscopy is more than a tenfold 
increase compared to base case analysis. Therefore, the modelled risk ratio (0.51) of 
adhesions with the use of an adhesion barrier should serve as reference standard for the 
development of novel adhesion barriers for laparoscopic use.  
With the rise of laparoscopy in colorectal surgery, open surgery is almost exclusively 
performed in cases that are not suited for a laparoscopic approach. One of the reasons for 
an open approach could be problems with adhesions during laparoscopic surgery. Open 
cases are therefore more prone to postoperative complications.5 This example illustrates 
the need for adhesion barriers in both laparoscopic and open surgery, to prevent future 
problems at repeat surgery.  
The time frame, within which the model applies, was limited to 4 years, whilst adhesion-
related complications or repeat surgery may occur many years later.13 However, 
approximately 60% of ASBO occurs within the first 4 years after lower abdominal surgery13; 
there is no data available for repeat surgery. Using a longer time frame would increase ASBO 
and repeat surgery rate, thereby potentially increasing the clinical benefit and cost-
effectiveness of the adhesion barrier strategy.  
Female infertility and chronic visceral pain, which are known consequences of adhesions, 




female patients undergoing colorectal surgeries at a young age. No consistent evidence is 
available regarding chronic visceral pain, and most costs are generated outside the 
hospital.4 The incompleteness of the model for these adhesion-related complications may 
have caused underestimation of adhesion-related costs, and thus an underestimation of the 
cost-effectiveness of the use of adhesion barriers.  
The model took into account the costs of repeat surgery depending on the presence of 
adhesions, and not the extent and severity of adhesions. Evidence shows that laparoscopic 
approach and use of an adhesion barrier reduce the incidence of adhesions and their extent 
and severity.8,19 Although reduction of extent and severity of adhesions potentially 
decreases adhesiolysis related complications and costs, the evidence was insufficient to 
consider including these variables in the model.5 Excluding the efficacy and costs related to 
reduction in severity and extent may have resulted in an overestimation of the adhesion-
related costs in the laparoscopic surgery cohort and an underestimation of the benefit of 
an adhesion barrier in both cohorts.  
The costs of an adhesion barrier were based on the unit costs in the Netherlands in 2016. 
The unit costs may change according to the volume of products required. Variation of the 
costs of an adhesion barrier had the largest influence in our model, Fig. 3a and b. Higher 
volumes may result in a lower unit cost, favouring the cost-effectiveness of the use of 
adhesion barriers in colorectal surgery.  
Due to a higher life expectancy and advances in surgical technology, an increasing number 
of patients undergo abdominal surgery multiple times during their lifetime.32 Adhesion 
formation is the most common long-term complication of abdominal surgery, and 
prevention of adhesion formation from initial abdominal surgery is the critical step in 
breaking the sequence of complications due to adhesions. Despite evidence of reduced 
adhesion formation with the application of adhesion barriers, adhesion barriers are seldom 
used in practice. Doubts about cost-effectiveness and the need for adhesion prevention in 
the ‘minimally invasive era’ probably underlie this reluctance.9 The present cost-
effectiveness analysis is based on the best evidence available for both open and 
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doubts. Since the use of an adhesion barrier in laparoscopic colorectal surgery involves extra 
costs, data on quality-adjusted life-years (QALYs) are required to value the benefits of 
adhesion barriers and to compare the costs per unit of effect gained to a cost-effectiveness 
threshold.39 In order to determine QALYs for adhesions and the use of adhesion barriers, 
future research should address patient-reported outcomes (PROs), such as functional status 
and quality of life. It is conceivable that adhesion-related complications will have a negative 
impact on PROs.40 
 
Conclusion 
The use of an adhesion barrier in open colorectal surgery will probably result in cost savings, 
and in laparoscopic colorectal surgery, this might be accompanied by limited additional 
costs. For laparoscopic colorectal surgery, more evidence on adhesion barriers is a 






1. Demco L. Pain mapping of adhesions. J Am Assoc Gynecol Laparosc. 2004; 11(2):181–3. 
2. Nieuwenhuijzen M, Reijnen MM, Kuijpers JH, van Goor H. Small bowel obstruction after 
total or subtotal colectomy: a 10-year retrospective review. Br J Surg. 1998;85(9):1242–5. 
3. Ording Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female 
fecundity before diagnosis, during disease, and after surgery compared with a population 
sample. Gastroenterology. 2002;122(1):15–9. 
4. van Rijckevorsel DC, de Vries M, Schreuder LT, Wilder-Smith OH, van Goor H. Risk factors for 
chronic postsurgical abdominal and pelvic pain. Pain Manag. 2015;5(2):107–16. 
5. ten Broek RP, Strik C, Issa Y, Bleichrodt RP, van Goor H. Adhesiolysis-related morbidity in 
abdominal surgery. Ann Surg. 2013;258(1):98–106.  
6. Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, Van Goor 
H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg. 
2000;87(4):467–71. 
7. Di Fabio F, Barkhatov L, Bonadio I, Dimovska E, Fretland AA, Pearce NW, et al. The impact of 
laparoscopic versus open colorectal cancer surgery on subsequent laparoscopic resection of 
liver metastases: a multicenter study. Surgery. 2015;157(6):1046–54.  
8. ten Broek RP, Stommel MW, Strik C, van Laarhoven CJ, Keus F, van Goor H. Benefits and 
harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. 
Lancet. 2014;383(9911):48–59. 
9. Schreinemacher MH, ten Broek RP, Bakkum EA, van Goor H, Bouvy ND. Adhesion awareness: 
a national survey of surgeons. World J Surg. 2010; 34(12):2805–12. 
10. van Steensel S, van den Hil LCL, Schreinemacher MHF, Ten Broek RPG, van Goor H, Bouvy 
ND. Adhesion awareness in 2016: an update of the national survey of surgeons. PLoS One. 
2018;13(8):e0202418. 
11. Wilson MS. Practicalities and costs of adhesions. Colorectal Dis. 2007;9(Suppl 2):60–5. 
12. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost 
effectiveness of adhesion reduction strategies. Colorectal Dis. 2002; 4(5):355–60. 
13. Parker MC, Ellis H, Moran BJ, Thompson JN, Wilson MS, Menzies D, et al. Postoperative 
adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery. Dis 
Colon Rectum. 2001;44(6): 822–29; discussion 9-30. 
14. ten Broek RP, Issa Y, van Santbrink EJ, Bouvy ND, Kruitwagen RF, Jeekel J, et al. Burden of 






Cost-effectiveness of the prevention of adhesions after colorectal surgery with adhesion barriers 
 
185 
15. Caro JJ, Briggs AH, Siebert U, Kuntz KM, Force I-SMGRPT. Modeling good research practices-
-overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. 
Value Health. 2012;15(6):796–803. 
16. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al. Adhesion-related 
hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. 
Lancet. 1999;353(9163):1476–80. 
17. Parker MC, Wilson MS, Menzies D, Sunderland G, Thompson JN, Clark DN, et al. Colorectal 
surgery: the risk and burden of adhesion-related complications. Colorectal Dis. 
2004;6(6):506–11. 
18. DICA. http://www.clinicalaudit.nl/jaarrapportage/2014/dsca.html. 2015. 
19. Stommel MWJ, Ten Broek RPG, Strik C, Slooter GD, Verhoef C, Grunhagen DJ, et al. 
Multicenter observational study of adhesion formation after open and laparoscopic surgery 
for colorectal cancer. Ann Surg. 2018;267(4):743–8. 
20. Ten Broek RP, Kok-Krant N, Bakkum EA, Bleichrodt RP, van Goor H. Different surgical 
techniques to reduce post-operative adhesion formation: a systematic review and meta-
analysis. Hum Reprod Update. 2013;19(1):12–25. 
21. Vrijland WW, Tseng LN, Eijkman HJ, Hop WC, Jakimowicz JJ, Leguit P, et al. Fewer 
intraperitoneal adhesions with use of hyaluronic acidcarboxymethylcellulose membrane: a 
randomized clinical trial. Ann Surg. 2002;235(2):193–9. 
22. Kusunoki M, Ikeuchi H, Yanagi H, Noda M, Tonouchi H, Mohri Y, et al. Bioresorbable 
hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: 
a prospective randomized clinical trial. Surg Today. 2005;35(11):940–5. 
23. Beck DE. The role of Seprafilm bioresorbable membrane in adhesion prevention. Eur J Surg 
Suppl. 1997;577:49–55.  
24. Bartels SA, Vlug MS, Hollmann MW, Dijkgraaf MG, Ubbink DT, Cense HA, et al. Small bowel 
obstruction, incisional hernia and survival after laparoscopic and open colonic resection 
(LAFA study). Br J Surg. 2014;101(9):1153–9. 
25. Benlice C, Stocchi L, Costedio M, Gorgun E, Hull T, Kessler H, et al. Laparoscopic IPAA is not 
associated with decreased rates of incisional hernia and small-bowel obstruction when 
compared with open technique: long-term follow-up of a case-matched study. Dis Colon 
Rectum. 2015;58(3):314–20. 
26. Lee SY, Park KJ, Ryoo SB, Oh HK, Choe EK, Heo SC. Early postoperative small bowel 
obstruction is an independent risk factor for subsequent adhesive small bowel obstruction 




27. Reshef A, Hull TL, Kiran RP. Risk of adhesive obstruction after colorectal surgery: the benefits 
of the minimally invasive approach may extend well beyond the perioperative period. 
Surgical Endosc. 2013;27(5):1717–20.  
28. Saklani AP, Naguib N, Shah PR, Mekhail P, Winstanley S, Masoud AG. Adhesive intestinal 
obstruction in laparoscopic vs open colorectal resection. Colorectal Dis. 2013;15(1):80–4. 
29. Eshuis EJ, Slors JF, Stokkers PC, Sprangers MA, Ubbink DT, Cuesta MA, et al. Long-term 
outcomes following laparoscopically assisted versus open ileocolic resection for Crohn’s 
disease. Br J Surg. 2010;97(4):563–8. 
30. Ng SS, Leung KL, Lee JF, Yiu RY, Li JC, Hon SS. Long-term morbidity and oncologic outcomes 
of laparoscopic-assisted anterior resection for upper rectal cancer: ten-year results of a 
prospective, randomized trial. Dis Colon Rectum. 2009;52(4):558–66. 
31. Scholin J, Buunen M, Hop W, Bonjer J, Anderberg B, Cuesta M, et al. Bowel obstruction after 
laparoscopic and open colon resection for cancer: results of 5 years of follow-up in a 
randomized trial. Surg Endosc. 2011;25(12):3755–60. 
32. Strik C, Stommel MW, Schipper LJ, van Goor H, Ten Broek RP. Risk factors for future repeat 
abdominal surgery. Langenbecks Arch Surg. 2016;401(6):829–37. 
33. Becker JM, Dayton MT, Fazio VW, Beck DE, Stryker SJ, Wexner SD, et al. Prevention of 
postoperative abdominal adhesions by a sodium hyaluronatebased bioresorbable 
membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 
1996;183(4):297–306. 
34. Krielen P, van den Beukel BA, Stommel MW, van Goor H, Strik C, Ten Broek RP. In-hospital 
costs of an admission for adhesive small bowel obstruction. World J Emerg Surg. 2016;11:49. 
35. ten Broek RP, Bakkum EA, Laarhoven CJ, van Goor H. Epidemiology and prevention of 
postsurgical adhesions revisited. Ann Surg. 2016;263(1):12–9.  
36. Fenton BW, Fanning J. Laparoscopic application of hyaluronate/carboxymethylcellulose 
slurry: an adhesion barrier in a slurry formulation goes where the available sheets cannot. 
Am J Obstet Gynecol. 2008;199(3): 325 e1. 
37. Fossum GT, Silverberg KM, Miller CE, Diamond MP, Holmdahl L. Gynecologic use of 
Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic 
myomectomy: a pilot study. Fertil Steril. 2011;96(2):487–91.  
38. Tsuruta A, Itoh T, Hirai T, Nakamura M. Multi-layered intra-abdominal adhesion prophylaxis 
following laparoscopic colorectal surgery. Surg Endosc. 2015;29(6):1400–5. 






Cost-effectiveness of the prevention of adhesions after colorectal surgery with adhesion barriers 
 
187 
40. Bouras G, Burns EM, Howell AM, Bagnall NM, Lee H, Athanasiou T, et al. Systematic review 
of the impact of surgical harm on quality of life after general and gastrointestinal surgery. 




Pepijn Krielen, Martijn W.J. Stommel, Richard P.G. ten Broek, Harry van Goor 
Intestinal obstructions. Intech Open (2020) 10.5772
9
Adhesive small bowel obstruction in 
the minimally invasive era
General discussion




Roughly 60% of all cases of small bowel obstruction are caused by adhesions. Adhesions are 
a form of internal scar tissue, which develop in over 45–93% of patients who undergo 
abdominal surgery. With this relatively high incidence, the population at risk for adhesive 
small bowel obstruction (ASBO) is enormous. Minimally invasive surgery reduces surgical 
wound surface and thus holds promise to reduce adhesion formation. The use of minimally 
invasive techniques results in a 50% reduction of adhesion formation as compared with 
open surgery. However, since ASBO can be caused by just a single adhesive band, it is 
uncertain whether a reduction in adhesion formation will also lead to a proportional 
decrease in the incidence of ASBO. Minimally invasive surgery might also improve operative 
treatment of ASBO, accelerating gastro-intestinal recovery time and lowering the risk of 
recurrent ASBO associated with adhesion reformation. We will discuss recent evidence on 
the impact of minimally invasive surgery on the incidence of ASBO and the role of minimally 
invasive surgery to resolve ASBO. Finally, we will debate additional measures, such as the 
use of adhesion barriers, to prevent adhesion formation and adhesion-related morbidity in 










As many as 60% of all episodes of small bowel obstruction (SBO) are caused by adhesions.1 
Adhesions are attachments of abdominal structures by internal scar tissue that are the 
result of healing of the peritoneum after it has been damaged, in most cases by surgery.2 
Adhesions can be filmy or dense and be present as an isolated band or as a ‘curtain’ or 
tangle with difficulty recognizing visceral structures. The degree of density and 
vascularization is traditionally classified using the Zühlke classification (Table 1).3 A more 
comprehensive and clinically relevant classification including projected locations of 
adhesions is the Peritoneal Adhesion Index (PAI) (Figure 1).4,5 
Table 1 Zühlke classification 
Table adapted from original publication: Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir, 1990: p. 1009-16 
 
Adhesions develop in 89 – 93% of patients undergoing open abdominal or pelvic surgery.6,7 
Incidence rates of adhesion formation are lower after minimally invasive surgery,  
45 – 62%.7,8 Adhesions can also develop after other causes of peritoneal trauma, such as 
inflammatory conditions or radiotherapy.2 The occurrence of adhesions does not only cause 
a lifelong risk of adhesive small bowel obstruction (ASBO). Other clinical consequences of 
adhesions are difficulties during reoperation, female infertility, and chronic visceral pain; 
Grade Description 
0 No adhesions or insignificant adhesions 
 
1 Adhesions that are filmy and easy to separate by blunt dissection 
 
2 Adhesions with beginning vascularization that can be dissected blunt but some sharp  
dissection is necessary 
 
3 Adhesions with clear vascularization that can only be dissected using sharp dissection 
 
4 Adhesions which strongly attached organs, dissection is only possible by sharp dissection, 
damage of organs is hardly preventable 
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making it the most common cause of long-term complications in peritoneal surgery.1 The 
incidence of ASBO is 2–3% in the first years after surgery in all patients who undergo 
abdominal or pelvic surgery.1 The risk of ASBO depends on the anatomical location of 
surgery and the extent of surgery and peritoneal injury.1–10 ASBO risk varies from 0.5% in 
abdominal wall surgery, 1.2% after upper gastrointestinal tract surgery to 3.2% in lower 
gastro-intestinal tract surgery and 4.2% in pediatric surgery.1  
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Given the high incidence of adhesions and adhesion-related complications, one would 
assume that every surgeon is aware of the risks of adhesions. However, awareness on the 
full size of the problem only arose in response to the publication of the Surgical and Clinical 
Adhesion Research (SCAR) study two decades ago. The SCAR large population based study 
demonstrated that one of three patients undergoing abdominal surgery is readmitted for a 
cause possibly related to adhesions.11 Subsequently adhesion-related complications gained 
increasing awareness of clinicians, hospitals and vendors, and adhesion reduction strategies 
were introduced. Laparoscopic surgeons hypothesized that minimally invasive surgical 
techniques would reduce peritoneal injury and thereby could solve the problem of adhesion 
formation. Other strategies to reduce adhesion formation were the development of 
adhesion barriers, the banishment of powdered gloves, and the introduction of new sealing 
devices.12  
Over the past decades, minimally invasive surgery has become the standard approach in 
many surgical disciplines. The rapid introduction of minimally invasive surgery was largely 
fueled by short-term benefits such as quicker recovery, reduced pain, and better cosmetic 
outcome.13 Furthermore, surgeons strongly believed in the effectiveness of minimally 
invasive surgical techniques to reduce adhesion formation and subsequent morbidity.14 For 
this reasons adhesion barriers are only seldomly used in minimally invasive surgery15, and 
are believed to be needed only in open surgery. Despite good evidence of effective 
reduction of adhesion formation and subsequent adhesion-related morbidity, the use of 
adhesion barriers in open surgery is also limited.16 Reasons for not using adhesion barriers 
are the lack of trust in adhesion reduction, the expected limited impact on adhesion-related 
complications, and the costs of the barriers.15 The limited use of adhesion barriers has 
slowed down the research and development of adhesion-prevention strategies in the past 
decade.  
Studies on adhesion formation in minimally invasive surgery report a reduction of 
approximately 50% in the extent of postoperative adhesions compared with open surgery.7 
Unfortunately, trials comparing open and minimally invasive surgery have not been 
designed and powered to compare long-term adhesion-related outcomes.17 Therefore, the 
effect of the broad implementation of minimally invasive surgery on clinically relevant 
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outcome parameters such as ASBO and readmissions is unknown.17 A reduction in adhesion 
formation, does not necessarily correlate with a proportionate reduction in the risk of ASBO; 
a single adhesive band may cause a life-threatening bowel obstruction, whereas extensive 
dense abdominal adhesions may be asymptomatic.18 Nevertheless, potential benefits of 
minimally invasive surgery in preventing adhesion-related morbidity seem compelling.  
Minimally invasive surgery may also play a role in the treatment of ASBO. Approximately 
25% of patients with ASBO require surgery to resolve the bowel obstruction1, and 
recurrence rates are high.19 The minimally invasive approach is hypothesized to accelerate 
recovery, and might also reduce risk of regrowth of adhesions and subsequent recurrence 
of ASBO. A caveat is the small working space and vulnerability of the bowel caused by the 
distention of the obstructed bowel that could result in iatrogenic injuries. In this chapter, 
we discuss recent evidence on the effects of the introduction of minimally invasive surgery 
on the burden of adhesions and ASBO. We further discuss the role of minimally invasive 
surgery in the treatment of patients with ASBO. We end with a contemplation on the 
awareness of adhesion-related complications and the value of adhesion barriers in 
minimally invasive surgery. 
 
2. The problem of adhesive small bowel obstruction 
The vast majority of adhesions develop after abdominal or pelvic surgery, although 
adhesions can also form after abdominal and pelvic radiation and peritoneal inflammation.2 
Adhesions are associated with a lifelong risk of ASBO. Incidence and morbidity of ASBO 
might be somewhat difficult to estimate and compare between studies based on different 
definitions for ASBO. Most accepted definition of ASBO is an episode of SBO with the 
presence of adhesions confirmed during reoperation. However, operative confirmation of 
adhesions is often not possible because many ASBO episodes are managed non-operatively. 
Therefore a second definition of ASBO is commonly applied: an episode of SBO interpreted 
as matching ASBO on radiological imaging after excluding other potential causes of bowel 
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In a systematic review, the incidence of SBO by any cause after surgery is estimated 9%.1 In 
42 etiological studies on SBO, adhesions accounted for 56% of all SBO episodes, either by 
operative confirmation or by excluding all other potential causes of SBO.1 The incidence of 
postoperative ASBO confirmed by surgery is estimated at 2.4%. Depending on the type of 
initial surgical procedure, the incidence varied between 0.5 and 4.2%.1 As mentioned, this 
estimate is conservative because most episodes of ASBO are managed non-operative.  
Another way to estimate the burden of ASBO is based on population studies. In the SCAR 
study more than one in three patients were readmitted for a cause possibly related to 
adhesions, and more than 1 in 20 patients (6%) who underwent open abdominal or pelvic 
surgery were readmitted for a directly adhesion-related cause.11 The most common 
diagnosis for a directly adhesion-related readmission was ASBO.11 More recent population 
studies in the UK and USA show that ASBO remains a major contributor to the morbidity, 
mortality and costs related to emergency abdominal surgery. In the UK in 2016, 51% of all 
emergency laparotomies were for ASBO.20 Similar results were found in the USA between 
2008 and 2011, where SBO needing adhesiolysis belonged to the top 5 of emergency 
surgical procedures.21 Given these numbers and the number of patients undergoing 
abdominal or pelvic surgery, the impact of ASBO on a population level is high. 
ASBO causes significant morbidity and a hospital admission for SBO is associated with 2.5% 
mortality.1 Initial non-operative management of ASBO includes gastric decompression, fluid 
resuscitation and nil per os, which is successful in 70–90%.1–23 In a sizable number of cases 
ASBO will result in emergency or delayed, after failed initial conservative management, 
abdominal surgery. Open or minimally invasive adhesiolysis to resolve the obstruction is 
associated with an incidence of 6–20% enterotomies.24,25 In general, complex adhesiolysis 
is associated with bleeding, sepsis, wound infections and increased mortality, even in the 
absence of bowel injury.26 Mean length of hospital stay for ASBO ranges from 4 to 13 days 
and generally depends the type of treatment and the treatment complications.1  
Both operative and conservative management of ASBO are associated with a risk of 
recurrent ASBO. Operative management includes repeated peritoneal injury with risk of 
adhesion reformation and re-ASBO. Non-operative management of ASBO does not dissolve 
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abdominal adhesions and harbors the risk of a new episode of ASBO. In a recent study of 
patients presenting with a first episode of ASBO, operative management was associated 
with a lower risk of recurrence compared with non-operative management (13% vs. 21%) 
after a median follow-up of 3.6 years.19 The study also showed an increased risk of ASBO 
with every previous episode of ASBO in accordance to findings done 25 years ago.27 Also 
the time between episodes of ASBO decreases with an increase in number of episodes.19 
Despite the higher recurrence rate after conservative treatment, current guidelines still 
recommend a trial of non-operative management of ASBO in order to avoid the risk of 
complications associated with surgical intervention.28  
Effort is made to predict the severity of ASBO using peri-operative scores.29,30 However, the 
scores are not widely adopted for clinical use. The American Association for the Surgery of 
Trauma (AAST) developed a score based on clinical, imaging, operative and pathologic 
criteria to grade disease severity of ASBO.31,32 The AAST grade uses clinical criteria (flatus, 
bowel sounds abdominal distention), pathologic criteria (bowel perforation), imaging 
criteria on CT (intestinal distention, transition point, contrast flow) and operative criteria 
(intestinal distention, impeding bowel compromise, peritonitis) to define the grade of ASBO 
on a scale from 1 to 4. A higher AAST score for emergency ASBO is associated with an 
increase in length of hospital stay, pneumonia, and more severe complications.33 Recently 
the Clinical Adhesion Score (CLAS) was developed, measuring the full spectrum of the long-
term burden of adhesion formation in post-operative patients. CLAS calculates the overall 
morbidity based on four domains: ASBO, difficulties during reoperation, female infertility or 
subfertility, and chronic abdominal pain (data not yet published). Evaluation of current and 
new adhesion prevention strategies regarding long-term clinical efficacy e.g. ASBO could 
benefit from using CLAS.  
The economic burden of ASBO is high. Operative management is the single most important 
determinant of costs. However, based on fewer recurrences of ASBO after surgical 
treatment, surgery may save costs at the long term.34 Several studies have been reported 
regarding the treatment costs of ASBO. Most have important limitations reporting part of 
the costs or costs based on reimbursement prices rather than true healthcare costs.35–37 We 
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including costs of length of stay, ICU days, operative time, medication, parenteral feeding, 
imaging studies and laboratory studies.38 This modeling revealed total healthcare costs of 
patients operated for ASBO of €16305 (SD €2513) with a mean hospital stay of 16.0 ± 11 
days. For non-operatively treated patients costs would be €2277 (SD €265) with a mean 
hospital stay of 4.0 ± 2.0 days. The majority of the costs were due to ward stay, operative 
time, ICU stay and (parental) feeding. All surgical procedures for ASBO in this study 
consisted of open adhesiolysis. Costs estimated in this study were higher compared with 
previous estimates of treatment costs for ASBO with comparable lengths of stay and, as a 
result of its design better reflecting reality.35–37 In the study we adhered to international 
guidelines for the diagnosis and treatment of ASBO increasing generalizability of outcomes 
for developed countries. Nevertheless costs may vary among countries due to differences 
in admission and discharge policies, and prices of diagnostics, materials, medication and 
feeding. 
 
3. The impact of minimally invasive surgery on morbidity of ASBO 
It has been suggested from a few studies that the decreased adhesion formation after 
minimally invasive surgery associates with a lower incidence of ASBO. This decrease seems 
limited compared with open surgery as concluded from one systematic review and one trial 
reported by our group.1,17 Differences in definitions of ASBO used, types of procedures, 
outcome parameters and length of follow-up in the studies, preclude a firm conclusion on 
the beneficial effect of minimally invasive surgery on development of ASBO.  
To estimate the impact of minimally invasive surgery at a population level on adhesion-
related complications, ASBO in particular, our group recently reported the results of the 
SCAR update study.39 Over 72,000 patients, who were operated between June 2009 and 
June 2011, were followed for a minimum of 5 years. Readmissions were classified, according 
to the initial SCAR study (1999), as directly-related to adhesions e.g. adhesive small bowel 
obstruction, possibly related to adhesions, e.g. any small bowel obstruction and 
reoperations potentially complicated by adhesions e.g. right hemicolectomy years after an 
appendectomy. Approximately 30% of all index procedures were minimally invasive. 
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Patients who underwent minimally invasive surgery were readmitted less frequently for 
directly related causes compared with patients after open surgery (1.7% vs. 4.3%). Possibly 
related readmissions and reoperations potentially complicated by adhesions were also less 
frequent (16.0% vs. 18.2% and 8.6% vs. 15.0%). Multivariate analysis revealed a 32% 
reduction in directly adhesion-related readmissions associated with minimally invasive 
surgery. Readmission rates were similar when comparing patients with open surgery in the 
SCAR and those in the SCAR update study. The overall small differences found in 
readmission rates could be explained by the difference in follow-up, 10 years in the SCAR 
study and 5 years in the SCAR update study. Despite the finding of a small reduction in 
readmission rates after initial minimally invasive surgery, the overall burden of adhesion-
related readmissions on a population level remains high.  
To further elaborate differences in adhesion-related readmissions between minimally 
invasive and open surgery, we analyzed patients with colorectal procedures (data not yet 
published). This type of surgery is known for its adhesion formation propensity and 
associated morbidity. Over 15,000 patients underwent colorectal surgery of whom almost 
one-third with a minimally invasive approach. For open colorectal surgery readmission rates 
were comparable between the SCAR study and the SCAR update study. Minimally invasive 
colonic and/or rectal surgery reduced the total number of directly adhesion-related 
readmissions. However in patients who underwent a (sub)total colectomy readmission 
rates were over 15% irrespective of an open or minimally invasive approach. Minimally 
invasive surgery did not reduce adhesion-related complications in rectal procedures. We 
concluded that an extended colectomy and rectal resection do not benefit from minimally 
invasive surgery regarding adhesion-related complications. We hypothesized that the large 
extent of the dissection and injury to the visceral and lateral parietal peritoneum needed in 
both surgical techniques abolishes the preventive effect of the minimally invasive technique 
on adhesion formation to the ventral peritoneum, where the injury is relatively limited for 
both approaches.  
The SCAR update study has demonstrated that minimally invasive surgery is associated with 
less adhesion-related readmissions. Hence, the overall burden of adhesion-related 
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to be a challenge in abdominal surgery, also in the minimally invasive era. Minimally invasive 
procedures were only performed in approximately one-third of procedures in 2009 – 2011, 
whereas currently in the Netherlands about 75% of colonic resections are performed 
minimally invasive (by laparoscopy or robot).40 On a population base a further decline in 
adhesion-related complications can be expected with an increase of minimally invasive 
abdominal operations. However, we like to warn against unbridled optimism regarding the 
overall impact of minimally invasive surgery on the burden of adhesions because open 
surgery is still being preferred when a complicated condition is expected in the abdominal 
cavity e.g. after multiple previous procedures, with large inflammatory mass or locally 
advanced cancer.41 Many of these conditions are complex specifically due to presence of 
adhesions at baseline surgery and the need to perform adhesiolysis before entering the 
operative area. It is known that the propensity to reform adhesions after adhesiolysis is 
higher than de novo adhesion formation. 
 
4. Management of adhesive small bowel obstruction 
Adequate management of ASBO depends on an initially correct diagnosis. Although ASBO is 
a common diagnosis with clear signs and symptoms, misdiagnosis and delayed diagnosis are 
a substantial clinical problem. Up to 50% of older patients are initially not adequately 
diagnosed.42 Failure to diagnose represents 70% of malpractice claims in ASBO.43,44 In this 
regard it is important to note that patients with ASBO can initially present themselves to a 
variety of physicians, including general practitioners, surgeons, internal medicine 
physicians, geriatricians and gastroenterologists. To improve diagnosis of ASBO, multiple 
specialists need to be involved in practice guidelines and protocols.  
Based on expert opinion the diagnosing of ASBO includes a medical history with an 
assessment of potential causes of SBO, e.g. previous abdominal surgery, inflammatory 
bowel disease, important symptoms such as vomiting, absence of stools or flatus, 
intermittent colicky abdominal pain and abdominal distention. Common pitfalls in 
diagnosing ASBO are the less prominent pain present in the elderly42, reporting of watery 
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diarrhea by patients with an incomplete obstruction and normal stool passage in the first 
days after onset due to stool still present in the colon.  
The recent update of the international guideline for diagnosis and management of ASBO 
gives the current best available evidence for management of ASBO once the diagnosis of 
bowel obstruction has been established.28 The first priority in management is to establish 
the cause of obstruction and to determine if urgent surgical treatment is required. ASBO is 
the single most common cause for SBO, the differential diagnosis includes strangulated 
abdominal wall or groin hernia, tumor, paralysis, constipation or bezoars. Laboratory tests 
should include blood count, CRP, electrolytes, creatinine and lactate. Imaging studies can 
include water-soluble contrast studies or computer tomography (CT) scans. CT scan is the 
preferred imaging technique for the diagnosis of ASBO, it can accurately rule out other 
causes of obstruction and identify patients who might require emergency surgery.28 Water-
soluble contrast enhances the diagnostic accuracy of CT scans. Signs that might suspect 
ASBO on imaging studies are an abrupt change in bowel diameter and the exclusion of other 
causes of SBO. The value of plain X-rays is limited.28  
Urgent surgery is required in case of signs of ischemia, perforation or strangulation of the 
bowel, generalized peritonitis and/or hemodynamic instability. No single test is highly 
sensitive for ischemia and strangulation. Sensitivity of physical examination for the 
detection of strangulation is only 48% in experienced hands.45 Laboratory tests indicating 
peritonitis or ischemia are a CRP above 75 and a white blood cell count above 
10.000/mm3.45–47 Again, a CT scan is most accurate in assessing strangulation and 
perforation and the need for emergency surgery.28 CT abnormalities indicating 
strangulation or perforation are free intraperitoneal air or fluid, closed loop obstruction, 
mesenteric edema or engorgement, mesenteric swirling, pneumatosis intestinalis, 
decreased or lack of bowel enhancement or thickened bowel wall.48–50  
If bowel obstruction is caused by adhesions, and signs of peritonitis, ischemia, and 
strangulation are absent, initial conservative treatment is reportedly safe. Conservative 
treatment is successful in 70 – 90% of all episodes of ASBO.1,23 Conservative treatment of 
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gastric tube. Further management includes fluid resuscitation, correction of electrolyte 
disturbances, nutritional support and prevention of aspiration. Optimal duration of a 
conservative trial is debated; prolonged management for more than 72 h has been 
associated with adverse outcomes and increased mortality.20,51–54 Water-soluble contrast 
studies seem useful in the follow-up of conservative management of ASBO. If contrast has 
not reached to colon 24–48 h following administration, continuation of conservative 
management is likely to fail and surgical management should be considered.28 An algorithm 
for the diagnosis and treatment of ASBO is presented in Figure 2.28 
4.1 Role of minimally invasive surgery in the management of ASBO 
Operative treatment of ASBO historically comprises an explorative laparotomy with 
adhesiolysis. The increased use of minimally invasive surgery has raised the question 
whether minimally invasive surgery is feasible and effective for the treatment of ASBO. 
Benefits of minimally invasive adhesiolysis are reduction of peritoneal injury possibly 
resulting in less adhesion reformation, a quick recovery and minimal post-operative pain. 
Twenty-five years ago the first cases of minimally invasive surgery for treatment of ASBO 
have been described.55 Thereafter a few series were reported but adequate comparative 
trials are scarce.56–60 Minimally invasive surgery for ASBO is challenging because there is 
little laparoscopic working space due to the distended bowel. Also visibility can be 
hampered by multiple adhesions. There are concerns that minimally invasive surgery 
increases the risk of iatrogenic bowel perforations.57 Suitability of minimally invasive 
surgery for ASBO further depends on patient characteristics. In case of hemodynamic 
instability open surgery is required because patients cannot tolerate the 
pneumoperitoneum.  
One randomized trial comparing minimally invasive and open surgery for ASBO has been 
performed.56 Only patients with a high suspicion of a single adhesive band causing the 
obstruction were included. Patients with confirmed or suspected peritoneal carcinosis, 
known multiple adhesions, previous open surgery for endometriosis, aorta, iliac vessels or 
Crohn’s disease, previous generalized peritonitis, abdominal malignancy, previous 
abdominal radiotherapy or recent operations within 30 days were all excluded. Patients  
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started with conservative management of ASBO. If the obstruction did not resolve patients 
were randomized between open and laparoscopic adhesiolysis. The trial was open label, 
therefore patients and care providers were not blinded. During 5 years 566 patients were 
included in the study, 104 patients underwent surgery, 51 were randomly assigned to the 
open surgery group, and 53 to the laparoscopic surgery group. Patients in the laparoscopic 
group had a shorter length of stay (4.2 days) compared with the open group (5.5 days). 
Mortality and postoperative complications did not differ between the groups.  
The few matched cohort studies comparing minimally invasive and open surgery for ASBO 
reported comparable results to those of the trial mentioned above.59,60 There seems a trend 
towards a faster recovery in selected patients. Studies showed no major differences in 
complications or mortality. A few studies specifically addressed the potential drawbacks of 
the minimally invasive approach and suggested an increased risk of bowel injury.59 Notably, 
the non-matched cohorts frequently claim large beneficial effects of the laparoscopic 
approach.40,58 However, these studies have a high risk of various types of selection bias, 
mainly excluding patients who are more sick or are suspected of multiple adhesions.  
It seems that minimally invasive adhesiolysis holds promise for patients with signs of a single 
adhesive band and an uncomplicated disease course. Further studies are needed to identify 
patients who can benefit from minimally invasive adhesiolysis and patients who can be 
harmed by minimally invasive treatment for ASBO. 
 
5. Future perspectives 
5.1 Awareness of adhesion formation by minimally invasive surgery 
Morbidity of adhesion formation in minimally invasive surgery is often underestimated. Less 
than 25% of surgeons and 5–83% of gynecologists routinely inform their patients about 
adhesions and the life term risk of adhesion-related complications.14,62 However, recent 
evidence shows that adhesion-related morbidity remains high in the minimally invasive 
era.39 Not informing patients about the risk of adhesions might therefore be considered 
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negligent. Increased awareness of adhesions might create an urge for the development and 
refinement of adhesion prevention strategies.  
Awareness of adhesions may improve by growing awareness for intra-operative 
complications in general. Impact of adhesions on the operative course of reoperations for 
ASBO or other indications is often underreported. In a prospective comparison of operative 
notes and observation by an independent researcher, one in seven iatrogenic bowel injuries 
was not reported in operative notes, and almost one in three minor injuries.63 In recent 
years, there is increasing scientific interest in the consequences of intra-operative events. 
IAEs are associated with 40% more hospital admissions, a twofold higher readmission rate, 
and with worse post-operative outcome.64–70 Recently the Classification of Intraoperative 
Complications (CLASSIC) has been developed as a new tool for systematic classification for 
intra-operative complications (iAEs).71 CLASSIC defines iAEs as any deviation from the ideal 
intraoperative course, including technical failures, surgical and anesthesiological difficulties. 
The score has been updated to five grades of severity (https://clinicaltrials.gov/ 
ct2/show/NCT03009929). Lysis of adhesions at reoperations is associated with post-
operative increase of sepsis, intra-abdominal complications, wound infections, longer 
hospital stay, and higher hospital costs.26,72 As such, adhesiolysis qualifies as an iAE if 
adhesiolysis is not the intended surgical procedure. We currently investigate the 
contribution of adhesiolysis and associated intra-operative complications e.g. bleeding, 
inadvertent enterotomy, to CLASSIC.  
Recent published guidelines may also increase awareness of adhesions and treatment of 
ASBO.28 An old saying on ASBO is ‘you must not let the sun rise on ASBO’, all patients 
presenting with ASBO were operated if conservative management failed to resolve the 
bowel obstruction within 24 h. Recent insights report that a conservative trial can safely be 
prolonged to 72 h.51,52 The current guideline states that conservative treatment should be 
instigated in all patients without signs of ischemia, perforation or strangulation of the 
bowel, generalized peritonitis and/or hemodynamic instability.28 Contradictory, some 
studies report lower recurrence rates of ASBO after surgical management of ASBO.19,27 A 
further disadvantage of prolonged conservative management is the further clinical 
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Minimally invasive surgery could change the paradigm again towards earlier surgical 
intervention because of faster recovery, reduced length of hospital stay and the mentioned 
lower recurrence rates of ASBO. 
5.2 Adhesion reduction strategies 
Considering the high impact of adhesion-related complications on a population level that is 
not substantially decreased by minimally invasive surgery, there is a pressing need to 
develop new adhesion reduction strategies.  
Until now the most promising approach for reduction of adhesion formation is routinely 
applying an adhesion barrier. Adhesion barriers are bioresorbable liquids, gels or films that 
keep injured peritoneal wound surfaces separated. During separation the peritoneal wound 
can heal with restoration of peritoneal tissue morphology and function without ‘scarring’ 
(adhesions). A large systematic review and meta-analysis in 2014 of 28 trials (n = 5191) 
showed benefits of several adhesion barriers in predominantly open abdominal surgery.16 
However, adhesion barriers are seldomly applied in abdominal or pelvic surgery.14 Only 1 in 
7 surgeons ever uses adhesion barriers.14 Reluctance of surgeons to use adhesions barriers 
seems caused by doubts about cost-effectiveness and the need and possibility of adhesion 
prevention in minimally invasive surgery.  
Cost-effectiveness of adhesion prevention in minimally invasive surgery is an important 
perquisite for implementation in every day practice. We performed a modeling study on 
cost-effectiveness of adhesion barriers in minimally invasive procedures with a high risk of 
adhesion formation.74 Two strategies were compared: current clinical practice (colorectal 
surgery without the use of an adhesion barrier) and colorectal surgery with the use of an 
adhesion barrier (hyaluronate carboxymethylcellulose). Whilst hyaluronate 
carboxymethylcellulose as such is not applicable in minimally invasive surgery and a gel 
form has not properly been studied in minimally invasive surgery, probabilities were 
extrapolated from data of open colorectal surgery. Probability estimates were derived from 
literature. Costs of treatment of ASBO were derived from our previous report.38 Cost of 
hyaluronate carboxymethylcellulose was estimated on $630, based on the mean number of 
films using an adhesion barrier was more effective than not using a barrier in minimally 
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invasive surgery, but it was more expensive. However, mean expected direct healthcare 
costs in the 4 years following index surgery increased with only $163 per patient. Cost 
estimates in this modeling study only included direct health care costs. Societal costs (e.g. 
absence from work) were not modeled in this study. Therefore an increase of $163 in direct 
health care may be neglectable considering potential gain in societal costs. Further research 
is needed on long term savings regarding socioeconomic costs with adhesion barriers also 
including the new SCAR update data of minimally invasive surgery.  
An important limitation of most barriers is the inability to properly use these in minimally 
invasive surgery. Most barriers were developed more than two to three decades ago and 
were films intended for use in open surgery. This limitation and the disregard needing 
barriers in minimally invasive surgery have impeded implementation and continued 
research and development of barriers suitable for minimally invasive surgery (and open 
surgery). Recently some new barriers have been developed suitable for minimally invasive 
surgery. Studies on these new barriers are performed mostly in gynecologic populations, 
and show effectiveness reducing adhesions.76,77 The important next step in adhesion 
prevention is the development of a new generation of barriers suitable for minimally 
invasive use in general surgery.78,79 Using increased knowledge of the pathophysiology of 
adhesions, new barriers consist of bioactive and targeted technology e.g. modulation of 
inflammation.2 Pilpel and colleagues developed a liquid solution modulating the fibrin 
matrix which is generated by the hemostatic system after peritoneal injury.80 This novel 
therapy is currently tested in animal models. Robertson and colleagues are testing a drug 
(L-Alanyl-L-Glutamine) to regulate the formation of adhesions due to hypoxia and oxidative 
stress caused by surgical injury of the vascular supply to the tissue caused by surgical 
intervention.81 The first results of this drug in a double-blinded placebo controlled study 
show that L-Alanyl-L-Glutamine is safe to use and is effective at reducing adhesion 
formation after laparoscopic myomectomies.82 Definitive results from this study are 
expected in due time. When proven safe, effective and affordable in patients, these new 
bioactive and targeted technology agents should be administered during index minimally 










Adhesion-related morbidity remains a clinically relevant problem in the minimally invasive 
era. Minimally invasive surgery is associated with only a modest reduction in adhesion-
related readmissions and incidence of ASBO. The growing body of scientific evidence 
provides the clinician with a firm guideline for the diagnosis and treatment of ASBO. 
Minimally invasive surgery in the management of ASBO appears to be safe and effective 
alternative to open adhesiolysis, however in a very selected patient group. To allow as many 
patients as possible to benefit from a minimally invasive approach future research should 
focus on the selection criteria for minimally invasive surgery in ASBO. Adhesion-related 
morbidity is often underestimated and complications of adhesiolysis underreported. Raising 
awareness of adhesions therefore remains important. Using newly proposed scores for 
intraoperative complications, may increase awareness for the intra-operative events 
caused by adhesions. Adhesion barriers can safely reduce adhesion formation, are cost-
effective in open colorectal surgery and effective with slightly higher costs in minimally 
invasive surgery. Future research should focus on new bioactive barriers that are easily 
applicable in minimally invasive abdominal surgery and safe to use. Preventing adhesions 
during first minimally invasive surgery is key to break the sequence of intra- and 
postoperative adhesion (re)formation related complications. 
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For many years, minimally invasive surgery was believed to offer the solution for post-
operative adhesion formation and associated complications.1,2 Widespread confidence in 
the tissue-sparing effect of laparoscopy, combined with the limitations of first-generation 
adhesion barriers, has almost entirely halted further research into adhesion prevention in 
minimally invasive surgery.3,4 This thesis aimed to determine whether laparoscopic surgery 
indeed has solved the “adhesion problem”. To this aim, it was important to determine 
whether the clinical burden of post-operative adhesions has, in fact, decreased with the rise 
of laparoscopic surgical interventions for upper gastro-intestinal, hepato-biliary-pancreatic, 
colorectal, urological and gynecological diseases. 
Chapter 2 provides evidence from a large registry study demonstrating that while minimally 
invasive surgery in the abdominal and pelvic cavity is indeed associated with a reduction in 
adhesion-related complications, post-operative adhesions nonetheless continue to 
represent a significant driver of morbidity. In the five years following minimally invasive 
surgery, one in seven patients was readmitted for a cause possibly related to adhesions.5 A 
substantial proportion of the readmissions were for adhesive small bowel obstruction 
(ASBO). 
In Chapter 3, the impact of laparoscopy on adhesion-related complications was evaluated 
for colorectal surgery in particular. Colorectal surgery is notorious for bearing a high risk of 
adhesion-related complications; since laparoscopic colorectal surgery has become the 
standard treatment in many developed countries, it would be expected that this transition 
away from open surgery would have a substantial beneficial impact on the incidence of 
readmissions related to adhesion formation.6,7 After laparoscopic colorectal surgery, we 
observe that 2.4% of patients were readmitted within five years for reasons directly related 
to adhesions, compared with 7.5% in open colorectal surgery. This difference was smaller 
for patients who had undergone rectal surgery, a group of patients with an almost twofold 
higher readmission rate compared to colonic surgery.8 When outcomes were compared 
with those of the original colorectal SCAR study by Parker et al. in 2004, readmission rates 
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4.8% vs. 7.5%. Changes of incidences of complications over time could not be reliably be 
attributed to the advent of laparoscopic colorectal surgery due to the limited availability of 
major laparoscopic surgery in the initial SCAR study. 
ASBO is a frequent post-operative complication, even after minimally invasive surgery. 
However, there is a paucity of high-quality evidence regarding optimal treatment for ASBO. 
In Chapter 4, an updated guideline for the diagnosis and management of patients with ASBO 
is presented.9 Indications for conservative and operative management of ASBO have 
shifted. Previous guidelines recommended operative treatment when symptoms did not 
subside within 24 hours after initiating optimal non-operative treatment. The guideline for 
ASBO now states that a non-operative trial for ASBO is safe to continue for 72 hours in the 
absence of signs of ischemia. CT scans should be performed in the diagnostic work-up given 
their 90% accuracy in predicting the need for acute surgical intervention.10-12 When 
operative treatment is indicated, a minimally invasive approach may be beneficial. It should 
be noted that the latter recommendation was not based on conclusive evidence, as studies 
to date concerning laparoscopic adhesiolysis for ASBO have been small and potential prone 
to several biases. 
In Chapter 5, the role of minimally invasive surgery was delineated for operative treatment 
of patients with ASBO, including the first randomized controlled trial (RCT) on this topic.13 
Minimally invasive surgery hypothetically reduces the peritoneal wound surface area, 
resulting in less adhesion reformation, less pain, and faster recovery. However, concerns 
were raised that laparoscopic treatment of ASBO would result in more harm than benefit, 
especially considering the potentially higher risk of iatrogenic bowel injuries compared with 
open procedures.14 In this chapter, all papers regarding minimally invasive surgery were 
reviewed, and a meta-analysis was conducted. Results of this analysis showed that a 
minimally invasive approach is non-inferior to an open approach, but only when strict 
patient selection criteria are applied.  
Abdominal reoperations, including for ASBO, are often complicated by severe and dense 
adhesions. Previous studies reported an increase in post-operative complications including 




surgeons still have doubts about the extent of the clinical consequences of adhesions 
caused by abdominal/pelvic surgery, resulting in widespread neglect of the potential of 
adhesion reduction strategies. Awareness of the intra-operative consequences of adhesions 
would benefit from a broadly accepted and validated score on intra-operative adverse 
events, which would have a predictive value for post-operative complications. A new score 
for intra-operative adverse events, ClassIntra®, was previously developed and validated in 
a multicenter study, in which the Radboud University Medical Center was a participant.16 
However, specific variants of intra-operative adverse events, including adhesiolysis-
associated bowel injuries, were not captured in this “all types of surgery” validation study. 
Furthermore, the inter-rater agreement was performed on vignettes and not real cases. In 
Chapter 6, a good inter-rater agreement of ClassIntra® was found for a well-defined cohort 
of elective abdominal operations with and without adhesiolysis. Adhesiolysis was one of the 
two strongest predictors of post-operative complications (OR 6.17; 95%CI 2.91 – 9.44). This 
confirmation of the association between intra-operative adverse events due to adhesiolysis 
and post-operative complications has direct implications for post-operative care, and 
should serve to increase awareness of adhesion-related morbidity and adhesion prevention.  
Given the high incidence of adhesion-related post-operative complications, the financial 
impact of adhesions on health care system is substantial. Previous cost estimates of 
admissions for ASBO are outdated and mostly based upon reimbursements.17,18 Chapter 7 
provides accurate cost estimates for patients who are admitted with ASBO, using micro-
costing methods. The mean hospital stay for an episode of ASBO with operative treatment 
was 16 days, compared with 4 days for non-operative treatment. The in-hospital expense 
for an episode of ASBO with an operation was €16.305, in contrast to €2.277 for an episode 
without surgery.19 This chapter provides a reliable cost-estimate for a modeling study on 
the impact of preventing adhesion-related complications with routine use of adhesion 
barriers in colorectal surgery, presented in Chapter 8. The use of a barrier in minimally 
invasive surgery would effectively reduce adhesion-related complications such as ASBO and 
complications from reoperations, while incurring only marginally higher health care costs.20 
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expected to be high. The slight increase in direct health care costs was considered to be 
neglectable compared to anticipated societal savings. 
 
Adhesions and ASBO when minimally invasive surgery is the standard of care 
While minimally invasive surgery does significantly reduce adhesion formation and 
adhesion-related complications, it does not completely prevent adhesion formation after 
abdominal surgery.5,21 A key question is if this reduction in adhesion formation is sufficient 
to prevent early- and long-term adhesion-related complications. The development of a 
single adhesive band after laparoscopic surgery, for example, could theoretically be more 
dangerous than a larger peritoneal area of adhesions in its capacity to induce a life-
threatening bowel obstruction. In contrast, during repeat surgery, a single adhesive band 
has a minimal risk of iatrogenic organ injury compared with dense and extensive adhesions. 
Thus, a reduction of adhesion formation may have different effects depending on the type 
of adhesion-related complication. A recent observational study from our research group 
examining patients who had liver surgery after either laparoscopic or open colorectal 
surgery showed that adhesions to the ventral abdominal wall were significantly lower in the 
laparoscopic group compared with the open group, whereas adhesion formation in other 
areas of the peritoneal cavity were comparable.21 It is plausible that the risk of ASBO over 
the course of a patient’s lifetime will not decrease after minimally invasive surgery, but that 
the risk of an abdominal entry-related injury at repeat surgery will decrease after minimally 
invasive surgery. The dualistic effect of adhesion reduction was indirectly assessed in the 
SCAR update study by differentiating between readmissions directly (e.g. ASBO) and 
indirectly (e.g. reoperation) related to adhesions. However, this type of registry-based 
study, absent details on the disease and treatment characteristics, is not sufficient to 
answer the question of whether a reduction of adhesions is clinically relevant in the context 
of all adhesion-related early and long term complications. National cancer surgery registries 
generally collect more details on operative procedures and post-operative adverse events. 
However, these are also not suitable because follow-up data are limited and focus on 




approaches using big data, artificial intelligence, and linkage of various databases are 
promising in their capacity to consider more detailed information on consequences of 
operations and risks for an individual level.23,24 Intelligent analyses of existing databases 
could obviate the need for starting a laborious and expensive registry for adhesion 
formation and related complications in minimally invasive surgery.  
Despite uncertainty regarding the benefits of minimally invasive surgery, we expect that 
incidences of adhesion-related complications will further decline in immediate future. 
Support for this expectation lies in the increased use of laparoscopy in major abdominal and 
pelvic procedures, surgeons’ improved skill of surgeons, refinement of minimally invasive 
operative techniques and equipment, and around-the-clock availability of laparoscopic 
services for abdominal emergencies such as ASBO in many institutions. Nevertheless, 
adhesions and ASBO will remain as some of the most substantial problems after minimally 
invasive surgery. Incidences of anastomotic leakage (4-20%)25,26 and incisional hernias (1-
26%)27,28 are similar or only moderately higher than those of ASBO5, albeit with differing 
follow-up times. 
Current international guidelines concerning the diagnosis and treatment of ASBO do not 
reflect the rise of minimally invasive surgery, and contain several recommendations that no 
longer comport with optimal management.29 Unfortunately, the latest systematic review of 
the literature reporting a benefit of minimal invasive surgery in the treatment of ASBO 
reached its conclusions on the basis of suboptimal evidence.13 Chiefly, this evidence was 
subject to reporting biases, with studies only examining “easy” cases of ASBO successfully 
treated by laparoscopic adhesiolysis. Substantial practice variations in the diagnosis and 
treatment of ASBO also make it difficult to draw conclusions on the optimal role of 
minimally invasive surgery in ASBO. Protocols and practices vary between countries, 
hospitals, and even individual doctors.  
Patients with ASBO initially present to a variety of doctors including surgeons, gastro-
enterologists, internists, geriatricians, and general practitioners. Initial and operative 
management often depend on the knowledge and skill of the consulting doctor and his/her 
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abdominal cancer surgery in an older person may be managed very differently by a medical 
oncologist and geriatrician versus an experienced surgeon; the latter may be more likely to 
take into account the 12-50 percent chance that the SBO is caused by adhesions and not by 
cancer recurrence.30-34 
Our research group is currently performing a nationwide snapshot study on the 
management of ASBO in The Netherlands to determine practice variations in diagnosis, 
treatment, and associated outcomes, including the harms and benefits of laparoscopic 
adhesiolysis. Results from the study are anticipated to be finalized by late 2021, and could 
identify areas for future research. For example, we anticipate this work will clarify best 
practices regarding intra-professional collaboration for diagnosis and triage to intensive 
care units, use of laparoscopic approaches versus open surgery, and adherence to existing 
guidelines of management of (A)SBO. While we expect to find the general advantages of a 
minimally invasive approach such as accelerated recovery time and reduced post-operative 
pain35, the question of operative safety (e.g. iatrogenic bowel defects) remains to be 
answered, as well as whether we can preemptively identify patients at greatest risk for 
adhesion-related intra-operative adverse events.14 We are additionally interested in 
examining if centers with significant experience in minimally invasive surgery tend to initiate 
operative treatment earlier than the 72 hour window recommended by the guidelines for 
non-operative trial.9  
By design, this study will not provide reliable information tailored to the individual patient. 
Individualization would, for example, demand rigid profiling of a patient with ASBO with 
scoring of clinical signs, symptoms, and radiological findings. Such scoring would only be 
accepted when it is easy to apply, and when it is validated for the post-operative 
complications that impact relevant patient reported outcomes measures (PROMs). In this 
context we refer to the LASSO trial, where selection criteria were described to randomize 
for laparoscopic or open surgery relieving ASBO, such as abdominal surgical history limited 
to solely laparoscopies or a maximum of 3 laparotomies, adequate bowel decompression 





A shaky point in the decision-tree regarding operative treatment of ASBO is frequently in 
the interpretation of results from currently-available imaging modalities, particularly in 
cases of recurrent and intermittent ASBO in the absence of ischemic symptoms. In these 
conditions, the decision over whether or not operative treatment would benefit long-term 
outcomes is considered to be more complicated than with an initial first presentation of 
ASBO. Good visualization of adhesions and determination of their contribution to the 
(partial) bowel obstruction(s) would support such decision-making. A promising novel 
imaging technique to visualize adhesions is cine-MRI.37-39 Cine-MRI uses motional slides to 
visualize sliding of organs; in case of adhesions there will be abnormal or absent visceral 
sliding of organs. This technique has proven to be beneficial in the decision regarding where 
to enter the abdominal cavity in case of a reoperation, and to interpret abdominal 
complaints such as those occurring after an incisional hernia repair with a mesh.38,40 Our 
group has substantial experience employing cine-MRI in patients with chronic abdominal or 
pelvic pain to determine eligibility for adhesiolysis. A treatment strategy with cine-MRI, 
shared-decision making, and adhesiolysis with application of barriers in patients with 
chronic abdominal pain was demonstrated to enable successful selection of appropriate 
patients for elective adhesiolysis, resulting in long-term pain relief in 80% of patients.41 
Adhesions mapping with cine-MRI revealed reliable information about the localization and 
extent of adhesions, and in some cases areas of distended bowel were accurately visualized. 
The mapping was also used to support the decision of open abdominal entry and 
adhesiolysis versus laparoscopic adhesiolysis. The yield of the cine-MRI in patients with 
chronic pain is promising for operative decision making in patients with recurrent episodes 
of semi or acute ASBO. Additionally, with increasing availability of MRI around-the-clock in 
hospitals, cine-MRI could be researched for cases of an initial acute episode of ASBO, 
compared with other imaging modalities such as CT or ultrasound.  
An important knowledge gap in ASBO handled by minimally invasive surgery is the 
occurrence of a recurrent episode of ASBO. Current data report a reduction in recurrent 
ASBO after operative treatment, which was primarily performed via open adhesiolysis. Five-
year readmission rates were around 20 percent for patients who underwent non-operative 
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Although not reported, we expect that the 25 percent decrease in admission rates was 
achieved without the use of an adhesion barrier after adhesiolysis. From a biological 
standpoint, knowing that reformation of adhesions is more aggressive than initial adhesion 
formation, adhesion barriers could reasonably be expected to further lower the recurrence 
rate.45-47 It is known from animal experiments that most current barriers have limited 
efficacy in reducing adhesion reformation.48 Our unpublished data of an animal cecal 
abrasion-peritoneal side wall injury study, in which Hyalobarrier® was applied to prevent 
adhesion reformation, showed a 90 percent reduction of adhesions at the injured area. This 
finding is promising because Hyalobarrier® gel has been developed for minimally invasive 
surgery. 
The first human data on ASBO recurrence rates after minimally invasive surgery are 
expected in three years when the follow-up from the first RCT on minimally invasive surgery 
and ASBO -the LASSO trial- is completed.36 Unfortunately, this trial will not provide a 
complete answer to this topic, and not for all patients with ASBO, because inclusion criteria 
for laparoscopic adhesiolysis were rather strict. Only patients with a high likelihood of a 
single adhesive band were included, and the sample size of the study is relatively small. 
Although the LASSO trial will add some evidence on recurrent ASBO after minimally invasive 
surgery, further research will be needed. Such research should focus more on individual 
patient and disease characteristics predicting long term benefit of minimally invasive 
surgery regarding ASBO and other adhesion-related complications. Individual patient and 
disease characteristics may include the innate propensity to form peritoneal adhesions, the 
adhesiogenic nature of the disease in question, and peri-operative course of the prior 
surgeries.49,50 Our research group is currently running a trial to specify genetic factors that 







Adhesion prevention in the minimally invasive era 
Despite now widespread use of minimally invasive surgery, peritoneal adhesions will 
continue to form and affect many patients’ lives, and the healthcare system write large. 
Therefore, the need for adequate adhesion reduction strategies has not subsided. 
Two to three decades ago, adhesion barriers were marketed as the solution to adhesion 
formation. Most barriers at that time were bioresorbable membranes or films intended to 
separate injured peritoneal wound surfaces until healing after open surgery.51 Despite 
evidence that these barriers are safe to use and effectively reduce adhesion formation, 
broad use in abdominal and pelvic surgical procedures was not achieved.1,2,51 This may be 
due to doubts about barriers’ effectiveness, poor handling capabilities of films in minimally 
invasive surgery, perceptions that barrier use in minimally invasive surgery would not add 
additional value given the relatively high costs of the barriers, and/or some of the comments 
made by surgeons and gynecologists.1 Obviously, there is a need for new formulations of 
anti-adhesive agents such as gels and sprays that are more easy to handle in minimally 
invasive surgical settings.15,52 These new agents should also demonstrate safety and efficacy 
in adhesion reformation, as two out of three abdominal operations are reoperations, 
including adhesiolysis for ASBO.15 In animal and human studies, efficacy of barriers 
preventing reformation of adhesions is a neglected area of research, despite the critical 
need for barriers felt most by surgeons confronted with an adhesion-related complication 
or when performing adhesiolysis. Animal data suggest that adhesion reformation is more 
difficult to prevent than de novo adhesion formation, findings which must be taken into 
account when developing and testing new anti-adhesive agents.48 Future clinical studies 
should encompass both patients with virgin abdomens and patients with a history of 
previous abdominal operations.  
An almost-forgotten adhesion reduction strategy in minimal invasive surgery is peritoneal 
conditioning. The CO2 pneumoperitoneum in minimally invasive surgery induces 
mesothelial cell hypoxemia, resulting in an inflammatory reaction and subsequent adhesion 
formation.53 Nitrous oxide (N2O) addition to CO2 has been shown to result in decreased 
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addition of N2O, cooling of the abdomen to 30oC, gentle tissue handling, aspiration of 
adhesiogenic factors (e.g. blood, remaining fibrin), and post-operative administration of 
dexamethasone has been shown to reduce adhesion formation in abdominal surgery.47,55 
Lowering the intra-abdominal pressure results in improved perfusion of the peritoneum and 
is hypothesized to result in peritoneal tissue hypoxemia; however, it has not been clinically 
proven to further reduce adhesion formation.56 Although all these measures can be 
undertaken at very low costs with minimal negative consequences, preconditioning of the 
peritoneum has not become routine. It would be of interest to study combinations of 
peritoneal conditioning and barriers minimizing adhesion formation in minimal invasive 
surgery. 
Novel adhesion reduction strategies in minimally invasive surgery 
When new anti-adhesion strategies are developed, they should meet the requirements for 
use in minimally invasive surgery. Most important are: ease of handling through a trocar 
and with peritoneal gas insufflation, reduction of adhesion reformation as well as de novo 
adhesion formation, and manufacturing ability at relatively low costs. Improved 
understanding of the pathology of adhesions has paved the road for the development of 
bioactive substances interfering with the adhesion formation process.57-59 Our group is 
engaged in two promising strategies: a solution modulating the fibrin matrix, and a drug 
regulating hypoxia and oxidative stress caused by surgical injury.50,60 In the first strategy, a 
selection of coagulation enzymes are extracted from human blood plasma and, processed 
as a solution that is sprayable (Eiobio, EIO Biomedical, Nazareth, Israel).50 The coagulation 
enzymes facilitate clotting at peritoneal wound surface sites and form thin fibrin fibers that 
are heavily crosslinked. The fibrin network that develops leaves less interval spaces for 
innate fibrin formation and adhesion forming cells to integrate, with the net result of 
‘normal’ healing of the peritoneum. Endogenous plasminogen will eventually activate 
fibrinolysis and dissolve the fibrin matrix in due time.50 The solution has proven to reduce 
adhesion formation in an animal study.50 Results from this study and an ongoing clinical trial 




The second adhesion reduction strategy, L-Alanyl-L-Glutamine (Evitar®, Temple® 
Therapeutics, Geleen, The Netherlands), interferes with adhesiogenic processes on a 
cellular level, suppressing hypoxia-induced levels of factors that trigger the inflammatory 
cascade and induce tissue fibrosis. Upregulation of hypoxia-induced factors by surgical 
disruption of the vascular supply, result in lactate formation and induction of profibrotic 
effectors that promote fibrin deposition and neovascular growth. This drug has proven to 
reduce hypoxia-induced triggers in in-vitro experiments.60 A proof-of-concept trial exploring 
safety and efficacy of this drug on post-operative adhesion formation after myomectomies 
also showed promising results (unpublished data).  
Always use an adhesion barrier? 
Results of our population-based and cost-modelling studies support routine use of an 
adhesion barrier during a first operation in the peritoneal cavity. Health-care providers and 
insurance companies should invest in the routine use of barriers anticipating an overall 
reduction in adhesion-related morbidity and associated costs. This reduction would not only 
include ASBO but also complications at reoperation, female sub- or infertility and chronic 
abdominal pain. Currently, however, the increase in-hospital expenses that are not 
reimbursed, discourages broad use. Clinicians and policymakers in these hospitals will need 
a methodology that specifies which patients would benefit the most from barrier use. Based 
on the data from the Scottish National Health Service our research group is currently 
developing a simple tool to predict the risk of reoperation based on specific patient and 
surgical parameters. This nomogram, when externally validated, will provide surgeons with 
an overview of the individual risk for resurgery or ASBO in the first, second or fifth year after 
index surgery. When the risk for repeat surgery or ASBO exceeds a certain level, the patient 
and surgeon may discuss the application of an adhesion barrier during index surgery. Cut-
off scores for the use of an adhesion barrier have yet to be defined in cost-effectiveness 
studies based on this nomogram. Cost-effectiveness is positively affected by low costs of a 
barrier. In the modeling study presented in Chapter 8, variations in the costs of an adhesion 
barrier had the largest impact on their cost-effectiveness.20 Thus, the starting point for the 
development and introduction of new adhesion reduction strategies must be 
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Concluding statements on anti-adhesive strategies in minimal invasive surgery are:  
• Newly marketed adhesion reduction strategies should be easy to use in minimally 
invasive surgery, reduce adhesion reformation as well as de-novo adhesion 
formation, and be mass-manufacturable at relatively low costs. 
• Furthering our understanding of the pathophysiology of adhesion formation is key 
for developing bioactive agents that reduce adhesion formation. 
• Increased use of adhesion barriers in all abdominal and pelvic operations, both 
minimally invasive and open, is an important step forward in reducing long-term 
consequences of adhesions in surgical patients. A new validated nomogram can 
support surgeons in daily clinical care to identify patients who would benefit the 
most from adhesion reduction strategies. 
• Combining adhesion reduction strategies, current and new, might offer the 
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Adhesies (verklevingen) ontstaan tussen organen en de buikwand als reactie op schade 
aan het peritoneum, het buikvlies dat alle buikorganen bedekt. De meest voorkomende 
oorzaak van schade aan het peritoneum is een operatie in de buik. Bijna alle patiënten die 
een open buik operatie ondergaan, ontwikkelen adhesies. Iets meer dan de helft van de 
patiënten die een kijkoperatie (laparoscopie) ondergaan ontwikkelen adhesies. Andere 
oorzaken van peritoneale schade zijn buikvliesontsteking, tumoren en radiotherapie. 
Adhesies geven een levenslang risico op dunne darmobstructies (strengileus). Daarnaast 
kunnen adhesies vrouwelijke onvruchtbaarheid, chronische pijnklachten en onbedoelde 
schade aan andere organen tijdens een volgende operatie veroorzaken. Het beperken van 
de schade aan het peritoneum door de minimaal invasieve eigenschappen van een 
laparoscopische operatie werd gezien als dé oplossing om adhesies en de mogelijke 
gevolgen daarvan te voorkomen. Het breed gedragen vertrouwen in laparoscopie als de 
oplossing voor adhesie-gerelateerde problemen en de beperkte effectiviteit en 
toepasbaarheid van beschikbare adhesie remmende middelen, heeft ervoor gezorgd dat 
adhesiepreventie in de afgelopen jaren weinig aandacht heeft gekregen. De belangrijkste 
groep van adhesie remmende middelen zijn de zogenoemde adhesiebarriers. 
Adhesiebarriers zijn middelen die na een operatie in de buik worden achtergelaten om 
wondoppervlakken van elkaar te scheiden, waardoor deze oppervlakken niet aan elkaar 
kunnen verkleven. De studies in dit proefschrift gaan over de vraag in hoeverre 
kijkoperaties het “adhesie probleem” hebben opgelost, en of er nog aanvullende 
maatregelen nodig zijn om de ziektelast van adhesies te verminderen. Om antwoord te 
krijgen op deze vraag hebben we onderzocht of het voorkomen van postoperatieve 
adhesie-gerelateerde complicaties is afgenomen met de toename van laparoscopische 
ingrepen. Samenvoeging van bewijs uit meerdere studies in een model geeft inzicht in de 
kosteneffectiviteit van adhesiebarriers in het voorkomen van adhesie-gerelateerde 
problemen na laparoscopie. Een andere studie verduidelijkt de rol van een 
laparoscopische ingreep in het voorkomen en behandelen van adhesie-gerelateerde 
problemen.  
In hoofdstuk 2 werd de invloed van een algemene toename van het aantal laparoscopische 
ingrepen onderzocht op het voorkomen van adhesie-gerelateerde problemen. 
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Hypothetisch zouden adhesie-gerelateerde problemen evenredig minder moeten zijn 
geworden met de toename van het aantal laparoscopische operaties. Hiervoor werd 
landelijke data gebruikt van de Scottish National Health Service (NHS). Alle patiënten die 
tussen 2009 en 2011 voor het eerst een buikoperatie ondergingen zijn geïncludeerd in deze 
studie. Op basis van diagnose- en operatiecodes werden heropnames die een relatie 
hadden met adhesies, gedurende vijf jaar geregistreerd, waaronder opnames voor 
strengileus. Heropnames werden onderverdeeld in de volgende drie categorieën: 1) zeker 
gerelateerd aan adhesies (bv. strengileus), 2) mogelijk gerelateerd aan adhesies en 3) 
heroperaties mogelijk gecompliceerd door adhesies. 
Gedurende de studieperiode werden er 72.270 patiënten geopereerd, waarvan 30% 
laparoscopisch. Heropnames zeker gerelateerd aan adhesies kwamen minder vaak voor in 
de groep patiënten met een laparoscopische ingreep (1.7%) in vergelijking met de groep 
patiënten die een open operatie ondergingen (4.3%). Het risico op een zeker aan adhesie 
gerelateerde heropname was erg afhankelijk van het type operatie dat uitgevoerd was. 
Daarbij was het type operatie niet evenredig verdeeld tussen de open en de laparoscopische 
ingrepen. Na correctie voor het type operatie lag het aantal heropnames voor zeker aan 
adhesie-gerelateerde complicaties ongeveer 30% lager in de laparoscopiegroep. Het risico 
op een zeker aan adhesie-gerelateerde complicatie was het laagst bij patiënten die een 
verwijdering van de galblaas ondergingen, namelijk slechts 1%. Het risico was het hoogst na 
operaties aan de endeldarm (11%) en aan de dikke darm (10%). Veertig procent van alle 
zeker aan adhesie-gerelateerde heropnames was ten gevolge van strengileus. Er werd ook 
een afname gezien in het voorkomen van het aantal heropnames mogelijk gerelateerd aan 
adhesies (16.0% vs. 18.2%) en heroperaties mogelijk gecompliceerd door adhesies (8.6% vs. 
15.0%). Deze studie bewijst dat adhesie-gerelateerde problematiek minder vaak voorkomt 
na laparoscopische ingrepen. Desalniettemin blijft de ziektelast van adhesies 
indrukwekkend, ook voor patiënten na een laparoscopische ingreep. Vervolgstappen zullen 
moeten worden ondernomen om de ziektelast van adhesies verder tegen te gaan. 
Veelbelovend hierin is de ontwikkeling van laparoscopische technieken om het peritoneale 
wondoppervlak nog verder te reduceren. Daarnaast komen er nieuwe adhesiebarriers 




In hoofdstuk 3 werd er specifiek gekeken naar de patiënten die een operatie aan de endel- 
of dikke darm hebben ondergaan in de studiepopulatie van hoofdstuk 2. Dikke- en 
endeldarm (colorectale) operaties staan bekend om het hoge risico op adhesieformatie en 
de daaraan gerelateerde complicaties. In de afgelopen twee decennia is een 
laparoscopische benadering de standaard geworden in colorectale chirurgie. Voor deze 
groep wordt dan ook de grootste en meest relevante daling in het voorkomen van adhesie-
gerelateerde heropnames verwacht. Na een laparoscopisch uitgevoerde colorectale 
operatie werd 2.4% van de patiënten in de vijf jaar na operatie heropgenomen voor een 
zeker aan adhesies gerelateerd probleem, in de groep patiënten met open colorectale 
chirurgie was dit 7.5%. Het verschil tussen de open en laparoscopische groep was minder 
groot in de groep patiënten met een endeldarm operatie. Vergeleken met operaties aan de 
dikke darm werden deze patiënten twee keer vaker opgenomen voor zeker aan adhesie-
gerelateerde problemen. Bij het vergelijken van deze resultaten met die van een eerdere 
studie met data van de NHS, viel op dat de incidentie van zeker aan adhesie-gerelateerde 
heropnames in de open colorectale chirurgie groep was toegenomen van 4.8% in de 
eerdere studie naar 7.5% in de huidige studie. Verschillen over tijd in het aantal heropnames 
in de laparoscopiegroep konden niet betrouwbaar worden bepaald, omdat het aantal 
laparoscopische operaties in de eerdere studie hiervoor te klein was. Het persisterende 
hoge risico op adhesie-gerelateerde complicaties in deze hoog risicogroep benadrukt de 
noodzaak voor de verdere (door)ontwikkeling van strategieën om adhesies te verminderen.  
Een van de veelvoorkomende problemen van adhesies is strengileus, zelfs na een 
laparoscopische ingreep. Ondanks het vaak voorkomen van deze complicatie zijn er weinig 
studies van goede kwaliteit beschikbaar over de optimale behandeling voor strengileus. In 
hoofdstuk 4 werd een bijgewerkte richtlijn gepresenteerd voor de optimale diagnostiek en 
behandeling van strengileus. In verschillende databases werd gezocht naar literatuur met 
betrekking tot de diagnostiek en behandeling van strengileus. Deze literatuur werd kritisch 
geanalyseerd en systematisch gepresenteerd in de bijgewerkte richtlijn. 
De meeste gevallen van strengileus worden conservatief behandeld, dat wil zeggen zonder 
een operatie. De conservatieve behandeling bestaat uit ‘rust’ geven aan de darm, door niet 
te eten en te drinken en de druk op de darm te verminderen met een maagslang. Om 
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uitdroging te voorkomen, krijgen patiënten met een strengileus een infuus met vocht. In 
sommige gevallen is een operatie noodzakelijk om de adhesie(s) die de darm afknellen door 
te snijden of weg te nemen. De indicaties voor de conservatieve en operatieve behandeling 
van strengileus zijn veranderd in de loop der jaren. In voorgaande richtlijnen werd 
operatieve behandeling aangeraden indien er na 24 uur optimale conservatieve 
behandeling geen verlichting was van de symptomen. De nieuwe richtlijn stelt nu dat een 
conservatieve behandeling veilig kan worden gecontinueerd voor 72 uur, indien er geen 
tekenen zijn van een belemmering van de bloedtoevoer naar de darm. Een CT-scan wordt 
aanbevolen, omdat met deze beeldvorming goed kan worden voorspeld of acuut operatief 
ingrijpen noodzakelijk is. Wanneer er wordt besloten operatief te behandelen, lijkt een 
laparoscopische operatie enkele voordelen te bieden. De aanbeveling voor een 
laparoscopische benadering is echter niet gebaseerd op sterk wetenschappelijk bewijs, 
omdat de studiepopulaties klein waren en de relatief eenvoudige gevallen 
oververtegenwoordigd waren in de laparoscopiegroep. 
In hoofdstuk 5 is de rol van de laparoscopische benadering bij een strengileus verder 
onderzocht. Zoals eerder besproken is het peritoneale wondoppervlak kleiner na een 
laparoscopische operatie in vergelijking met een open operatie. Dit biedt het theoretisch 
voordeel dat er minder recidief adhesies ontstaan, dat er minder pijn is na de ingreep en 
dat de patiënt sneller herstelt. In eerdere publicaties werd echter bezorgdheid geuit over 
het feit dat het laparoscopisch opheffen van een strengileus, in vergelijking met open 
procedures, meer nadelen dan voordelen oplevert vanwege het grotere risico op onbedoeld 
darmletsel. In dit hoofdstuk werden alle artikelen over laparoscopische operaties voor een 
strengileus systematisch onderzocht, en werd er een meta-analyse uitgevoerd. Een 
beperking van deze systematische review en meta-analyse was dat veel studies 
retrospectief waren. Ook was er sprake van een forse selectiebias, want de groep patiënten 
die een laparoscopische ingreep had ondergaan, had vaker een ‘eenvoudige’ strengileus. Bij 
de moeilijke casus was, volgens geldende richtlijnen, meestal een open benadering 
toegepast. Vanwege deze selectiebias gaf vergelijking van deze twee groepen een mogelijk 
vertekend beeld van de resultaten ten faveure van de laparoscopiegroep. Om te voorkomen 




waarbij vertekening door selectie onwaarschijnlijk was, meegenomen in de primaire 
analyse. Alle andere studies werden meegenomen in de sensitiviteitsanalyse. De resultaten 
van de primaire analyse lieten zien dat een laparoscopische behandeling van een strengileus 
even goede (en slechte) resultaten geeft als een open behandeling. In de 
sensitiviteitsanalyse leek een laparoscopische benadering een voordeel op te leveren; de 
postoperatieve sterfte was lager, de duur van de ziekenhuisopname korter, en er waren 
minder ongeplande heroperaties. Deze studie concludeert dat een laparoscopische 
benadering van strengileus niet onderdoet voor een open benadering, maar alleen bij een 
bepaalde, goed omschreven groep van patiënten. 
Heroperaties in de buik, onder andere voor strengileus, worden vaak gecompliceerd door 
uitgebreide en straffe adhesies. Eerdere studies rapporteren een toename van 
postoperatieve complicaties, waaronder overlijden, sepsis en bloeding wanneer een 
uitgebreide adhesiolyse (het losknippen van adhesies om toegang te krijgen tot het 
operatieterrein) noodzakelijk was. Veel chirurgen hebben echter nog steeds twijfels over de 
omvang van de adhesieproblemen, zeker na een laparoscopische operatie. Dit resulteert 
erin dat strategieën die adhesies kunnen voorkomen weinig worden toegepast. De 
bewustwording van de complicaties ten gevolge van adhesies bij heroperaties zou kunnen 
toenemen als de heroperaties beter en systematischer worden gedocumenteerd. Op deze 
manier kunnen complicaties die tijdens een operatie plaatsvinden ten gevolge van 
adhesiolyse worden gerelateerd aan complicaties die na de operatie optreden. 
Recent werd een nieuwe classificatie voor complicaties die op kunnen treden bij 
(her)operaties ontwikkeld, ClassIntra®. Deze score is gevalideerd in een multicenterstudie 
waaraan het Radboudumc deelnam. In deze studie werd niet gekeken naar de verschillende 
types complicaties, bijvoorbeeld een onbedoeld darmletsel door adhesiolyse. Bovendien 
werd de overeenstemming tussen verschillende beoordelaars over wat en hoe ernstig een 
peroperatieve complicatie was, bepaald op grond van een beperkt aantal fictieve casussen 
in plaats van op praktijkvoorbeelden. In hoofdstuk 6 werd met behulp van eerder 
prospectief verzamelde gedetailleerde data uit de LAPAD studie over het optreden van 
complicaties tijdens een geplande buikoperatie en het optreden van postoperatieve 
complicaties, gekeken naar de overeenstemming tussen verschillende beoordelaars van de 
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ClassIntra®. Ook werd de voorspellende waarde onderzocht van de hoogste ClassIntra® 
score op het voorkomen van postoperatieve complicaties. In het totaal werden data 
bekeken van 755 buikoperaties. Twee teams scoorden voor elke operatie de complicaties 
volgens de ClassIntra®. Analyse toonde een goede overeenkomst in ClassIntra® scores 
tussen beide teams. Adhesiolyse was een van de drie sterkste voorspellers voor 
postoperatieve complicaties (OR 6,17; 95% BI 2,91 - 9,44). Andere voorspellers van 
postoperatieve complicaties waren bloedingen tijdens de operatie en beschadiging aan 
andere organen. De bevestiging van het verband tussen aan adhesiolyse gerelateerde 
complicaties tijdens een operatie en de postoperatieve complicaties, heeft belangrijke 
klinische implicaties voor de directe postoperatieve zorg. Resultaten van deze studie 
benadrukken het belang om een groter bewustzijn te creëren met betrekking tot de kennis 
van de adhesie-gerelateerde ziektelast. Hierdoor zal ook het draagvlak toenemen voor het 
ontwikkelen en toepassen van aanvullende strategieën om adhesies te voorkomen. 
Door de hoge incidentie van de adhesie-gerelateerde postoperatieve complicaties, hebben 
adhesies ook aanzienlijke financiële gevolgen voor de gezondheidszorg. Eerdere 
schattingen van de kosten voor een opname voor strengileus zijn inmiddels verouderd en 
grotendeels gebaseerd op niet uniforme prijsafspraken tussen ziekenhuizen en fabrikanten 
en/of verzekeraars. Het gebrek aan een goed inzicht in de kosten belemmert de 
implementatie van strategieën om adhesies te verminderen. Hoofdstuk 7 geeft een 
gedetailleerde schatting van de kosten die gepaard gaan met een opname voor strengileus. 
Over een periode van twee jaar werden alle opnames gescreend voor patiënten met de 
diagnose strengileus in het Radboudumc. In het totaal waren er 39 patiënten die voldeden 
aan de inclusiecriteria. Van deze patiënten werd 49% operatief behandeld. De gemiddelde 
opnameduur voor een patiënt met een operatieve behandelde strengileus was zestien 
dagen, vergeleken met vier dagen voor een niet-operatief behandelde patiënt met een 
strengileus. De ziekenhuiskosten voor een operatief behandeling bedroegen € 16.305, 
tegenover € 2.277 voor een behandeling zonder operatie. De resultaten in dit hoofdstuk 
vormden een belangrijke basis voor het opzetten van een vervolgstudie naar de 
kosteneffectiviteit van adhesiereductiestrategieën. In hoofdstuk 8 werd een model 




hoog risico op adhesie-gerelateerde klachten, namelijk zij die een colorectale operatie 
ondergaan. In het model werd gekeken naar de 4-jaars kans op het ontwikkelen van 
adhesie-gerelateerde problematiek, gedefinieerd als een strengileus of problemen bij 
heroperaties. Verschillende online zoeksystemen werden gebruikt om de relevante 
gegevens in de literatuur te vinden voor de kansberekeningen in dit model. Hierbij werden 
gewogen kansen bepaald voor de verschillende mogelijke gebeurtenissen in het model. Het 
model toonde aan dat het routinematig gebruik van een adhesiebarrier na colorectale 
kijkoperaties de kans op adhesie-gerelateerde complicaties effectief vermindert tegen een 
geringe stijging van de kosten. Maatschappelijke kosten voor de behandeling van 
strengileus waren in dit onderzoek niet meegenomen. We beschouwden de geringe stijging 
van de directe zorgkosten als verwaarloosbaar in vergelijking met de verwachte 
maatschappelijke besparingen. We concludeerden dat het gebruik van adhesiebarriers in 
patiënten met een hoog risico op adhesie-gerelateerde problemen kosteneffectief is.  
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uit afgelopen jaren. Dank voor de steun op alle serieuze momenten maar bijzonder dank 
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Lieve pap en mam, niet altijd had ik zin om de vragen te beantwoorden: hoe staat het er nu 
voor met je proefschrift? Heb je nog iets gepubliceerd? Nu dit project zijn einde heeft 
bereikt, wordt het misschien ook wat makkelijker om uit te leggen wat ik al die jaren heb 
gedaan. Ik bereid me vast voor op de vragen die nu komen gaan aan de hand van wat jullie 
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zoals ik zou willen dat ze liepen. Je kon me er ook goed op wijzen, dat het soms even 
genoeg was en dat het nu tijd was voor ontspanning. Nu dit project af is, beloof ik dat ik 
hier meer tijd voor heb. Zonder jouw steun en vertrouwen stond ik hier nu niet. Je bent 






Pepijn Krielen was born on July 7th, 1990 in Malden the 
Netherlands as the oldest of three siblings. After 
graduating from the Nijmeegse Scholengemeenschap 
Groenewoud in Nijmegen he started his study 
Biomedical Sciences on the Radboud University. After 
completing his Bachelor of Science degree he switched 
to Medicine. During his internships he developed a 
strong affinity for the academic field of surgery. He 
started as a research student in the field of adhesions 
at the department of surgery of the Radboud University 
Medical Center. After graduating in November 2016 he 
started as surgical resident (ANIOS) at the Radboud University Medical Center. He 
developed an urge to teach medical students several aspects of the surgical working field. 
Together with the Radboud Health Academy (RHA) and the Hogeschool Arnhem Nijmegen 
(HAN) he developed an interprofessional acute health care training. He started his thesis on 
abdominal adhesions and adhesive small bowel obstruction on the 1st of January 2017 
under the supervision of prof. H. van Goor, Dr. M.W.J. Stommel and Dr. R.P.G. ten Broek at 
the Radboud University Medical Center. During his time as PhD candidate he presented the 
results of his research on several national and international meetings. On the 1st of January 
2019 he started as surgical resident (ANIOS) at the Canisius Wilhelmina Hospital in 
Nijmegen. During his clinical duties he finalized his PhD thesis. He will start as a surgical 
resident at the beginning of 2021. He is pursuing a career in surgery, combined with 






P. Krielen, M.W.J. Stommel, P. Pargmae, N.D. Bouvy, E.A. Bakkum, H. Ellis, M.C. Parker, E.A. 
Griffiths, H. van Goor, R.P.G. ten Broek. Adhesion-related readmissions after open and 
laparoscopic surgery: a retrospective cohort study (SCAR update). Lancet. 2020 Jan 
4;395(10217):33-4 
P. Krielen, M.W.J. Stommel, R.P.G. ten Broek, H. van Goor. Adhesive Small Bowel 
Obstruction in the Minimally Invasive Era. Intech Open (2020) 10.5772 
P. Krielen, S. Di Saverio, R.P.G. ten Broek, C. Renzi, M. Zago, G. Popivanov, P. Ruseclli, R. 
Marzaioli, M. Chiarugi, R. Cirocchi. Laparoscopic versus open approach for adhesive small 
bowel obstruction, systematic review and meta-analysis of short term outcomes. JTACS 
(2020) 88(6):866-874 
P. Krielen, J.P.C. Grutters, C. Strik, R.P.G. ten Broek, H. van Goor, M.W.J. Stommel. Cost-
effectiveness of the prevention of adhesions and adhesive small bowel obstruction after 
colorectal surgery with adhesion barriers: a modelling study. World J Emerg Surg. 2019 Aug 
16;14:41 
P. Krielen*, R.P.G. ten Broek*, S. Di Saverio, F. Coccolini, W.L. Biffl, L. Ansaloni, G.C. 
Velmahos, M. Sartelli, G.P. Fraga, M.D. Kelly, F.A. Moore, A.B. Peitzman, A. Leppaniemi, E.E. 
Moore, J. Jeekel, Y. Kluger, M. Sugrue, Z.J. Balogh, C. Bendinelli, I. Civil, R. Coimbra, M. De 
Moya, P. Ferrada, K. Inaba, R. Ivatury, R. Latifi, J.L. Kashuk, A.W. Kirkpatrick, R. Maier, S. 
Rizoli, B. Sakakushev, T. Scalea, K. Søreide, D. Weber, I. Wani, F.M. Abu-Zidan, N. De'Angelis, 
F. Piscioneri, J.M. Galante, F. Catena, H. van Goor. Bologna guidelines for diagnosis and 
management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-
based guidelines from the world society of emergency surgery ASBO working group. World 
J Emerg Surg. 2018 Jun 19;13:24 




P. Krielen*, B.A. van den Beukel*, M.W.J. Stommel, H. van Goor, C. Strik, R.P.G. ten Broek. 
In-hospital costs of an admission for adhesive small bowel obstruction. World J Emerg Surg. 
2016 Oct 6;11:49 
* Both authors contributed equally 
P. Krielen, R.P.G. ten Broek, K.W. van Dongen, M.C. Parker, E.A. Griffiths, H. van Goor. 
Adhesion-related readmissions after open and laparoscopic colorectal surgery in 16 524 
patients (SCAR update colorectal). Submitted 
P. Krielen*, L. Gawria*, M.W.J. Stommel, S. Dell-Kuster, R. Rosenthal, R.P.G. ten Broek, H. 
van Goor. Inter-rater agreement of the classification of intra-operative adverse events 
(ClassIntra®) in abdominal surgery. Submitted  
* Both authors contributed equally 
P. Krielen, J.M. Bakia, J.P.M. Frölke. Allergic Reaction to Percutaneous K-Wires after 
Osteosynthesis. Arc Cas Rep CMed. 2017;3(3): 146 
P. Krielen, M. Dirven, W.B. Barendregt. Patient presenting with hoarseness based on 
Ortner’s syndrome. Submitted 
 
Data Management Summary 
 
250 
Data Management Summary 
Data obtained during the construction of this thesis was archived according to the Findable, 
Accessible, Interoperable an Reusable (FAIR) principles. The SCAR update and SCAR 
colorectal update studies (chapter 2 & 3) used data from the Scottish Medical Record 
Linkage Database, managed by the Information and Statistics Division of the National Health 
Service (NHS) Scotland. This database contains records from 1981 onwards for all Scottish 
inpatient and daycare hospital admissions, excluding psychiatric or maternity admissions. 
Follow-up of individual patients’ readmissions is included in this database. Data from the 
NHS database are annually validated at hospital level. For research purposes we requested 
necessary data from the NHS. Variables were coded using publicly available classification 
systems, e.g. ICD-10 and OPCS-4 codes. Accessing the data was only possible via an 
approved network after a double step verification. Data were made available for analysis 
during a year after the start of both studies.  
All existing (meta)data files of chapter 4-8 were digitally stored in a structured and logical 
manner on a local server of the department of surgery of the Radboud university medical 
center (H:\COMMON\Krielen). Servers were centrally backed-up on a regular basis. Data 
files were accessible by the appropriate members of the research group. Codebooks were 
documented, describing all (meta)data in detail. To prevent errors in the data, all saved files 
were provided with the date of the last editing of the data. Using this system, previous 
versions could always be accessed to check potential errors. All data can be requested 
through the appropriate members of the department of surgery of the Radboudumc upon 
reasonable request. 
The review in chapter 6 was performed according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The protocol of this systematic 
review and meta-analysis has been registered on PROSPERO CRD42018107087 
(http://www.crd.york.ac.uk/prospero). Data were analyzed using Review Manager 
(RevMan). 
All data generated and collected for this thesis, with the exclusion of data for chapter 2 & 
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